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ABSTRACT 
Metalloproteins are a fascinating class of proteins that function at the heart of several 
important biological processes including photosynthesis, respiration, and nitrogen fixation. It is 
even more amazing, considering that nature uses a small set of tertiary structures and metal 
centers to perform all these different functions with efficiency and selectivity. How nature tunes 
the activity within these scaffolds has been the area of research for many years. The goal of this 
work is to understand the underlying mechanisms of such tuning with a special focus on the role 
of subtle changes of residues in the secondary coordination sphere of the metal ion, an 
underexplored area of study. I use protein engineering techniques not only to shed light on the 
mechanisms underlying such changes, but also to design new functionalities within our scaffold 
proteins and to enhance their properties for specific purposes, such as fuel generation. 
This work is divided into three main sections. In the first, I focus on characterizing a novel 
metalloprotein, N. mar_1307, from the organism Nitrosopumilus maritimus. While the protein 
shares a protein fold and Type 1 copper coordination site with other common electron transfer 
cupredoxins, the lack of an axial residue creates an open binding position in the Cu center, 
leading to a novel enzymatic function, NO oxidation. The purification, characterization, and 
activity assays of the protein are described in detail in chapter 2. 
The second and major focus of this work is on tuning the reduction potential of azurin, a 
common electron transfer protein. In chapter 3 I demonstrate that how by making mutations 
around the Cu site, and replacing Cu with Ni I can obtain an azurin variant with a reduction 
potential of nearly 1V, the highest potential that can be observed under physiological conditions, 
along with other variants with negative potentials. Chapter 4 describes the characterization of a 
series of Phe114 mutants that were used to understand the role of this critical secondary sphere 
residue in tuning the reduction potential of the Cu site. Chapter 5 demonstrates the Marcus 
inverted region of electron transfer in a series of azurin variants with different reduction 
potentials. Finally, I show my initial attempts toward the design of a high-throughput screening 
platform for the directed evolution of azurin in chapter 6. 
In chapters 7 and 8, I focus on the design of novel functionalities in one of our model 
scaffolds, cytochrome c peroxidase (CcP). Chapter 7 describes the work done to enhance the 
Mn(II) oxidation activity in a designed model of manganese peroxidase within the CcP scaffold 
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based on modifications of the second coordination sphere around the Mn(II) binding site. In 
chapter 8 I report the design and characterization of a novel CcP variant that shows catalase-like 
activity in “as-purified” form and forms a heme-protein crosslink in the heme-bound form.  
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CHAPTER 1 
 
INTRODUCTION 
* Portions of this chapter are from a submitted review to Biophys. Biochim. Acta-Bioenerg. As “Designed and fine-tuning redox 
potentials of metalloproteins involved in electron transfer in biology” (Hosseinzadeh P., Lu Y.) 
 
1.1. Metalloproteins, primary ligands and secondary ligands 
Any protein that contains at least one bound metal ion is called a metalloprotein and this 
classification is regardless of the role the metal ion is playing or whether the metal ion is present 
alone  or is coordinated via an organic framework. Several metal ions can be found within 
protein scaffolds. The most common metal ions in biology are Fe, Cu, Zn, Mg, Ca and Mn. 
Other metal ions such as Co, W, V, Ni,and Mo can also be found but in less abundance.  
The metal ion can simply serve a structural role within the protein. For example, in Zn-finger 
proteins the Zn ion stabilizes a kink in the structure, making it optimal for DNA binding.1 
However, the role of metal ions is not limited to structural stabilization as metalloproteins can 
also participate in storage of metal ions, electron transfer, ligan binding (e.g, O2, NO, H2), and a 
variety of catalytic activities.2  
 Each metal ion within a protein is directly coordinated by the so-called “primary ligands”. 
Residues that are in some contact with primary ligands but are not coordinating the metal ion are 
called “secondary coordination residues”. The primary ligands determine the geometry of the 
metal site and some of its most important features.  The arrangement of ligands dictates metal 
geometry and spin based on the ligand field theory. The most common geometries of metal ions 
are shown in figure 1.1a. Figure 1.1b demonstrates an example of how the ligand field can affect 
the d-orbital splitting of a transition metal ion. Such effect is due to selective stabilization of one 
or more sets of d-orbitals over the others in the given field.  
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Figure 1.1.(a) Most common coordination geometries of metal ions. (b) Ligand field splitting of d orbitals in 
selected ligand field geometries. 
Another feature of the ligand is its softness, a factor that can be determined based on the 
hard-soft acid base theory (HSAB). Soft ligands prefer soft metal ions whereas hard ligands 
would better coordinate hard metal ions. Whether or not a hard ligand is used in place of a soft 
ligand can affect the equilibrium between one oxidation state of the metal ion vs. the other. 
Table 1.1 shows the hardness and softness of different metal ions and their preferred ligands. As 
a general rule, the smaller the ionic radii or the higher the charge, the harder a metal ion is. 
 
Table 1.1. Classification of acids and bases based on HSAB theory.  
 Acids Bases 
Hard H+, Li+, K+,Mg2+, Ca2+, Mn2+, Al3+,      Ln3+, 
Cr3+, Co3+, Fe3+, VO2+, MoO3+,     SO3, CO2 
H2O, ROH, NH3, RNH2, RCO2-, Cl-, 
F-, PO43-, HPO42-, H2PO4-, SO42- 
	   3	  
Table 1.1 cont.   
Intermediate Fe2+, Co2+, Ni2+, Cu2+, Zn2+, Pb2+,    Sn2+, SO2, 
NO+, Ru2+ 
Imidazole, pyridine 
Soft  Cu+, Ag+, Au+, Tl+, Hg+, Cd2+, Pd2+,   Pt2+, Hg2+ RSH, R2S, CN-, I-, S2O32- 
 
Within a protein scaffold, several amino acids can potentially to coordinate metal ions. A 
list of these amino acids and their features are shown in table 1.2.  
Table 1.2. Endogenuous biological ligands. Adapted from ref. 2 
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While metal ions can be directly coordinated to protein residues, some of them are found in 
proteins within organic frames. The most well-known frame is protoporphyrin ring which can 
accommodate Fe ion. Several types of porphyrins are found in nature with different features, 
shown in figure 1.2. Corins are Co containing counterparts of porphyrins. Pterins are another 
common frame clustering W and Mo.  
 
      
Figure 1.2.Different types of hemes and a corin. 
 
1.2. Functions of metalloproteins 
 
Metalloproteins are involved in a variety of physiological functions vital for cell survival. 
These functions can be categorized in many ways. One such way is to divide them into two 
broad categories, redox-based functions and non-redox functions. Table 1.3 summarizes the 
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most common transition metal centers in biology, their geometry, preferred ligands, and their 
most common functions. 
Table 1.3. Biologically relevant transition metal ions. Adapted from ref 2  
Metal Function Common 
oxidation 
states 
dn Common 
coordination 
number 
Effective 
geometry 
Spin state 
Co Oxidase, alkyl group 
transfer 
+2 d7 4 Td 3/2 
5 C4v 3/2 
 D3h 3/2 
6 Oh ½ 
 Oh 3/2 
+3 d6 6 Oh 0 
 Oh 2 
Cu Oxidase, dioxygen 
transport, electron 
transfer 
+1 d10 2 Linear 0 
3 Trigonal 0 
4 Td 0 
6 Oh 0 
+2 d9 4 Td ½ 
 D4h ½ 
5 C4v ½ 
 D3h ½ 
6 Oh ½ 
+3 d8 6 Oh 1 
Fe Oxidase, dioxygen 
transport/ storage, 
electron transfer, 
nitrogen fixation 
+2 d6 4 Td 2 
 D4h 2 
5 C4v 2 
 D3h 2 
6 Oh 0 
 Oh 2 
+3 d5 4 Td 5/2 
 C4v 5/2 
5 3/2 
6 Oh ½ 
 Oh 5/2 
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Table 1.3 cont. 
 Mn Photosynthesis, 
oxidase, structure 
+2 d5 4 Td 5/2 
5 D3h 5/2 
6 Oh ½ 
 Oh 5/2 
+3 d4 5 C4v 2 
 D3h 2 
6 Oh 1 
 Oh 2 
+4 d3 4 Td 3/2 
6 Oh 3/2 
Mo 
 
 
    [MoO]3+ 
Nitrogen fixation, 
oxidase, oxo transfer 
+3 d3 6 Oh 3/2 
+4 d2 6 Oh 1 
+5 d1 4 Td ½ 
   5 C4v ½ 
   6 Oh ½ 
 +6 d0 4 Td 0 
    [MoO2]2+    6 Oh 0 
Ni Hydrogenase, 
hydrolase 
+2 d8 4 Td 1 
 D4h 0 
5 C4v 1 
 C4v 0 
 D3h 1 
 D3h 0 
6 Oh 1 
+3 d7 4 D4h ½ 
5 C4v ½ 
6 Oh ½ 
 Oh 3/2 
+4 d6 6 Oh 0 
W dehydrogenase +4 d2 6 Oh 1 
    [WO]+3  +5 d1 5 C4v ½ 
6 Oh ½ 
  +6 d0 4 Td 0 
5 C4v 0 
   [WO2]2+    6 Oh 0 
V 
 
   [VO]2+ 
 
   [VO2]+ 
Nitrogen fixation, 
oxidase 
+2 d3 6 Oh 3/2 
+3 d2 6 Oh 1 
 +4 d1 5 C4v ½ 
6 Oh ½ 
 +5 d0 6 Td 0 
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1.2.1. Non-redox functions 
While metalloproteins are mostly known for their redox functions, they perform a wide range 
of other functions as well. As mentioned earlier, some metalloproteins have a metal ion as a 
structural element. Two Ca2+ binding sites are present in manganese peroxidase and are 
suggested to give stability to the protein. Disruption of the Ca2+ binding sites causes thermal 
susceptibility in the protein. This thermal inactivation is due to some overall protein structural 
changes and distinct changes in heme environment 3. The presences of distal Ca2+ gives enzyme 
extra compactness and rigidity 4. Presence of metal ion is necessary for proper binding of 
substrate in a number of enzymes including polymerases. Mg2+ is necessary for coordinating to 
the phosphate backbone of the DNA and placing them in the right position for reaction to 
happen.5 Metal binding to a metalloproteins can be a means to regulate gene transcription and 
protein expression. Metal-responsive transcription factor-1 (MTF-1) is one such protein. In 
normal condition the protein shuttles between the cytosol and the nucleus. Direct binding of 
excess Zn or indirect release of Zn due to Cd binding to metallothioneins will direct MTF-1 to 
the nucleus where it can recruit transcription machinery and regulate gene expression.6  
Binding to metal ions can cause drastic structural changes in a metalloprotein and hence 
changes its function. A very well-studied example of such a case is the protein calmodulin. 
Binding of Ca2+ ion to calmodulin will result in drastic structural changes in the protein (see 
figure 1.3). These structural changes in turn influence protein localization, different modes of 
binding to other proteins, and target-specific activation.7  
Table 1.3 cont.       
Zn Structure, hydrolase +2 d1 4 Td 0 
5 C4v 0 
 D3h 0 
6 Oh 0 
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Figure 1.3. Structures of apo-calmodulin (left figure, PDB: 1QX5) and Ca2+-bound calmodulin (figure in right, PDB 
ID: 1CLL) 
Metalloproteins can sometimes serve as storage for the metal ion, releasing their content 
when required. Ferritins are probably the most well-known example of metal storage proteins 
acting as huge cages for iron.8 Metal ions can be found in the active site of proteins, facilitating 
the reactions through acting as a Lewis acid. Zn2+ plays such a role in a variety of enzymes 
including carbonic anhydrase the mechanism of which is shown in figure 1.4.9,10  
 
Figure 1.4. Proposed mechanism of CO2 hydration by carbonic anhydrase. Adapted from ref. 11  
1.2.2. Redox-based functions 
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In redox-based functions, the metal ion goes through a transition between different oxidation 
states. Such a change in redox state can be used to simply transfer electrons, to perform an 
enzymatic function, or to facilitate delivery of a small molecule. Electron transfer (ET) is one of 
the best-studied functions of metalloproteins and some metalloproteins are evolved to just 
perform this function. The most common classes of metalloproteins involved in ET are 
cupredoxins (including type 1 copper (T1Cu) proteins and CuA centers),11-17,18 ,19,20 cytochromes,20-27 
and FeS proteins.20,28-34 Each class performs ET between different types of redox partners with 
different range of reduction potential (E°). Cupredoxins usually function at the high end while 
FeS centers are mostly involved in low reduction potential ET chains.20  
Redox transition of the metal ion can be accompanied by a catalytic reaction. Numerous 
metalloenzymes have been reported catalyzing a variety of functions, some of which are 
essential for life on earth. Cytochrome c oxidases (CcOs) are the terminal  enzymatic complexes 
in oxidative ET chain, turning O2 into water and enabling aerobic respiration.35,36 P450s are one 
of the most diverse classes of heme enzymes performing several functions such as oxidation, 
hydroxylation, and alkylation with specificity and high efficiency using very similar reaction 
mechanisms.37-43 Hydrogenases can perform one of the most kinetically difficult reactions on 
earth, catalyzing the reversible oxidation of molecular H2.44-49 Reduction potential of the metal 
center is one of the most important features of these sites for their function as it controls and 
directs ET events, a requirement for the catalytic activity of above proteins. 
1.3. Approaches to study metalloproteins 
Researches have been interested in studying metalloproteins from the early days of protein 
biochemistry. Myoglobin was the first proteins being crystallized in 1958 by the work of 
Kendrew et al.50 How these proteins function and what factors contribute to their activity was 
among the questions that has sparked the interest of several scientists throughout the years. To 
address such questions, two main approaches have been taken, the top-down approach and the 
bottom-up approach. A combination of these approaches, so-called the “biosynthetic approach” 
is also being developed recently. In this section, I will briefly explain the two approaches first 
and spend some time describing the biosynthetic approach. 
1.3.1. The top-down approach 
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The most common way of gaining mechanistic insights into the activity of metalloproteins 
was the common biochemical approach. In this approach, specific residues in the protein that are 
hypothesized to be important for the activity are mutated to other residues. A decrease in or 
abolishment of the activity is an indicator of a critical role for that residue. The biochemical 
approach has yielded numerous insightful results with regards to finding critical residues and 
elements contributing to specific features of metalloproteins. However, there are certain 
drawbacks to this approach, mostly arising from the complexity of metalloproteins.  
One such example is the case of heme copper oxidises (HCOs) and nitric oxide reductases 
(NORs). Heme-copper oxidases (HCOs)51-66 and nitric oxide reductases (NORs)67-70 are two 
structurally homologous membrane proteins that catalyze 4e- reduction of O2 to H2O, and 2e- 
reduction of NO to N2O, respectively. The free energy generated from the O2 reduction by 
HCOs is used to drive proton (H+) translocation across the membrane, which is then used to 
synthesize ATP. NORs, on the other hand, do not drive H+ translocation.71 Despite the different 
functions, both enzymes’ active sites consist of a proximal His-coordinated heme, with the major 
difference being the identity of the nonheme metal (CuB in HCO and FeB in NOR), and its 
primary and secondary coordination spheres (SCS) (Fig. 1.5).  The CuB is ligated by three His, 
one of which is covalently cross-linked to a Tyr,72 while FeB is coordinated by three His and a 
Glu.68 And two more conserved Glu’s form a hydrogen-bonding (H-bonding) network to the 
active site in cNOR.73-75 One of the most intriguing questions about these enzymes is why HCOs 
are efficient in O-O bond cleavage using a 4e- reduction process, whereas NORs are effective in 
N-N bond formation using a 2e- reduction process.  
 
Figure 1.5.  Overlays of (a) HCO (1V54, orange) & CuBMb model (green);25(b) cNOR (3O0R, yellow) & FeBMb 
(3K9Z, green);30,229 (c) SiR (1AOP, orange) & Fe4S4-CcP model (green).50 
CuB 
FeB 
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Studies of native heteronuclear metalloenzymes have provided a plethora of information 
about the enzymes’ structure and function.52,53,64,65,76,77 Despite much progress, it remains difficult 
to address the above questions, including those mentioned above, for several reasons. First, many 
of these enzymes are large, membrane-bound systems (e.g. ~200 kDa for bovine HCO) that are 
difficult to express in large quantities and with the homogeneity required for biochemical and 
biophysical studies. Moreover, the enzymes often contain multiple metal cofactors, which 
complicates the study of the active centers due to overlapping spectroscopic features. For 
example, signals of a low-spin heme far from the heme-Cu center dominate the UV-vis and 
magnetic circular dichroism (MCD) spectra of HCOs.78 To address this issue, isotopic or spin 
labeling are often required. In contrast to smaller and simpler mononuclear or homonuclear 
enzymes, such labelings are often very difficult to do at selective site(s) for heteronuclear 
enzymes with additional cofactors (e.g. 57Fe labeling only at the FeB site in NOR). The active 
sites of these enzymes are similar (e.g., using heme-nonheme metal centers), yet can catalyze 
diverse reactions (e.g., 2e- and 4e- reductions of NO and O2). One way to overcome such an 
obstacle is to compare different enzymes in this family to provide a holistic view. However, it is 
difficult to provide fair comparisons of functional properties of different sites (e.g., CuB and FeB) 
that reside in very different protein environments. To address this, one nonheme metal such as 
CuB in HCO could be replaced with another such as Fe, to find out if the replacements will 
confer any different reactivity. Unfortunately, it is extremely difficult to selectively remove and 
replace the nonheme metal in the native enzymes, most of which are membranous, and such 
efforts have resulted in inactive or misfolded proteins (even when the native metal ion was added 
back), which are not biologically relevant.79 Finally, a common practice is to use site-directed 
mutagenesis (SDM) to replace conserved residues in one enzyme with others in another. While 
this approach is effective in examining individual enzymes, it is difficult to draw general 
conclusions across two or more enzymes since outcome is difficult to reconcile between different 
enzymes, especially when similar mutations cause different effects.75 
1.3.2. The bottom-up approach  
To address the limitations of the top-down appraoch, several chemists took the lead and 
designed synthetic models of the active sites of metalloproteins. These models provide an 
excellent tool for focusing on specific features of the ligands and metal ions themselves and will 
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provide an easier platform for studying such active sites and can complement the biochemical 
top-down approach by providing insights into whether necessary structural elements are enough 
for the function of the enzymes. Multiple successful examples of designing a metal active site 
has been reported during the past couple of decades and those studies provided much insight into 
the activity of the active sites of interest.80 One such example is the diiron models of 
hydrogenases. Detailed studies of these models resulted in a better understanding of the native 
system.81 Models of heme porphyrins provide scientist with a simple system to gain experimental 
insights about the features of Fe-O2 bonding.82 Models of Mo ligated to pterin cofactor were used 
to understand the role of the strength of NH…S hydrogen bond in the reactivity of the model.83 
The synthesis of small molecule models for HCOs and NORs active site also has been an 
effective approach used by several well-known bioinorganic chemists, including Drs. Richard H. 
Holm,84-87 James P. Collman88-101 and Kenneth D. Karlin,102-122  and several leading researchers in 
Europe123-126 and Japan.127-130  
This minimalist approach can serve as a touchstone whereby the knowledge obtained from 
the biochemical, spectroscopic, and X-ray structural studies can be tested. Since the model 
systems lack other metal-binding sites, they can simplify many structural and functional 
characterizations and aid to deconvolute spectroscopy. The success of these models is a 
milestone in bioinorganic chemistry and these models will continue to play an important role in 
understanding the structure and function of metalloproteins. However, as pointed out by Dr. 
Collman in a review, the synthetic model approach has limitations and challenges.94 For 
example, in case of models of HCOs and NORs, in the approach of studying stoichiometric 
reactions of reduced synthetic models with O2 under nonprotic conditions,131 “the availability of 
protons in aqueous media may fundamentally change the dioxygen reactivity of the FeCu 
core”.99 Synthetic models often result in relatively stable and unreactive bridging oxo or peroxo 
derivatives with much shorter Fe-Cu distances than that in HCO. Collman attributed this 
problem to the nonprotic conditions, because the presence of protons in HCO may destabilize 
the ferric peroxo intermediates (to form the putative ferric-hydroperoxo intermediate, which is 
known to be very reactive in many heme enzymes). Collman’s group has tried to overcome this 
limitation by studying their models in biologically relevant conditions using electrocatalytic 
methods. However, as noted in his review, “this method makes the use of spectroscopic 
techniques to characterize the system during the catalysis extremely challenging; so far, 
	   13	  
electrocatalytic studies have been a kinetic method”.99 Without spectroscopic results, insights 
into native HCOs are limited. Collman went on to point out that one of the most interesting and 
challenging areas in biomimetic modeling is to incorporate synthetic models into a better-
defined chemical environment, such as self-assembled monolayers. In addition, it has become 
increasingly clear from biochemical and biophysical studies that non-covalent interactions, such 
as active site waters and the associated hydrogen bonding network, play a critical role in HCO 
and NOR function. This issue is at the frontier of the chemistry and biology and extremely 
difficult to address because it requires careful design and synthesis of rigid ligands with precise 
positioning of functional groups, as demonstrated recently by several groups.132,133 Moreover, the 
active site models usually are synthesized and perform under non-physiological conditions, 
which in some cases questions the transferability of the results obtained to physiological 
conditions. Reduction potential of metal cofactors in general is usually higher inside proteins 
than in their model counterparts.134 
1.3.3. Biosynthetic approach 
An effective alternative approach towards making synthetic models is to use the same type of 
"ligands" and structures as native enzymes, which we model with small, stable, easy-to-produce 
and well-characterized proteins as the scaffold. We call this approach “biosynthetic modeling.” 
135,136 Compared to small organic ligands, proteins possess several unique features that make them 
an ideal choice for assembling protein models. First, they can fold into a rigid scaffold where 
different metal-binding centers can be readily placed in predefined orientations. Second, site-
directed mutagenesis (SDM) eliminates the need for protecting groups and complicated synthesis 
commonly employed in organic synthesis. Third, the protein scaffolds provides additional 
protection for the metal-binding site, yielding more stable metal-binding centers. Fourth, the 
complex protein framework of metalloenzymes is amenable to site-specific (as opposed to 
solvent-induced) modulation of the secondary coordination sphere of the metal-binding site.137 
For example, although the pKa for free glutamic acid is around 4, pKa’s for multiple glutamic 
acids in a single protein may range from 4.0 to 8.2 depending on the local electrostatic 
environment and hydrophilicity.138 Finally, biosynthetic models are synthesized and function 
under physiological conditions using aqueous solvents, and are biodegradable ligands and 
therefore, environmentally benign.  
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The historical lack of biosynthetic models using proteins as ligands is mainly due to 
difficulties in the construction, expression, and purification of proteins. While this situation may 
have been true a decade or two ago, the rapid development of molecular biology and protein 
biochemistry has made it possible to synthesize proteins as easily as, or in some cases even more 
easily than, small molecules. A major advantage of biosynthesis is that, unlike small molecule 
syntheses where a modification of the ligand might result in quite a different yield, cost, and time 
investment, a similar protein ligand modification results in less variation of these parameters. 
These advances in biosynthesis make it much easier to prepare recombinant proteins in a short 
time (e.g., in a few days) with high yields (e.g., up to a few grams of proteins per liter). At the 
same time, protein ligands can retain all the structural features of native enzymes, such as rigidity 
and long-range or secondary sphere interactions, while significantly reducing the complexity of 
purification and characterization.  
Furthermore, current advances in computational protein design provide us with an invaluable 
tool to use as a guide in our engineering. There have been multiple reports of successful 
engineering of novel functionalities and drugs inside protein scaffolds using a variety of 
computational programs such as Dezymer,139,140 metal search, 141,142 and more recently, the Rosetta 
Suite,143-145 with very exciting achievements. 139 146 147-154 The ability to incorporate unnatural amino 
acids using either expressed protein ligation155 or orthogonal tRNA/tRNA synthetase systems156 
allows us to introduce novel functionalities inside our protein scaffolds, providing a unique 
opportunity to study the subtle effect of specific features such as charge distribution without 
structural perturbation, a task that is not practical in complex protein systems. Because the 
proteins we have chosen are easy to characterize and crystalize, it is also easier for us to offer 
deep insights into the reaction mechanisms that they mimic. The ultimate goal of protein 
engineering is to use de novo protein scaffolds, and much progress has been made in building 
existing or novel functionalities inside such scaffolds.157-161 However, de novo design of protein 
scaffolds has its own challenges. In our approach, we overcome the scaffold difficulties by 
focusing mostly on designing the active site inside already available natural scaffolds. Being 
subjected to evolution and selection, this natural repertoire is more stable against mutations than 
de novo scaffolds. Moreover, the higher diversity in natural scaffolds than de novo motifs enables 
us to mimic a greater number of activities. Based on this approach, we have succeeded in 
demonstrating the importance of these long-range interactions in fine-tuning redox potentials of 
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azurin beyond the natural range of cupredoxins,137 and in conferring and fine-tuning enzymatic 
activities.162-164  
An overall comparison of the approaches mentioned above is summarized in table 1. 4. 
Native enzymes Synthetic models Biosynthetic models 
Difficult to obtain homogeneous sample in large 
quantities 
Long synthesis of models of 
heteronuclear centers with low yields 
Easy to obtain large quantities in short 
times 
Function under physiological conditions Usually functional under non-
physiological conditions 
Function under physiological conditions 
SCS interactions differ in same enzymes from 
different sources 
Very difficult to incorporate SCS 
interactions into the model 
Role of SCS interactions can be easily 
studied through SDM in one scaffold 
Residing in different protein environments hampers 
the comparison between similar enzymes 
Different active centers can be designed 
within the same overall scaffold 
Different active centers can be designed 
within the same overall scaffold 
Difficult to crystallize Easy to crystallize; can be soaked Easy to crystallize; can be soaked 
Overlapping features of other metal cofactors Focus only on the active center Focus only on the active center 
Difficult to remove cofactors such as heme or 
nonheme metal ions without loss of function and/or 
structure 
Can use different cofactors Easy to replace heme, nonheme metal ion, 
or other cofactors 
Difficult to trap intermediates using site specific 
labeling 
Intermediates can be trapped Site specific labeling is easily achievable 
via techniques such as UAA incorporation 
Difficult to perform systematic studies of specific 
features such as heme E°, pKa of residues, and ET 
rates 
Amenable to systematic studies using 
different ligands or reaction conditions 
Amenable to systematic studies using 
cofactor replacement or UAA incorporation 
 
1.4. Thesis goals and outlook 
Metalloproteins form 50% of all the proteins on earth165 and play essential roles for 
maintaining life on earth. Photosynthesis, respiration, DNA replication, and nitrogen 
assimilation are just a few examples of reactions that rely on presence of metalloproteins. 
Despite their importance, there are still many proteins that are reported as putative metal binders 
without their physiological function being understood. Moreover, there are several questions 
regarding the known proteins that remain elusive. This thesis aims to address such issues.  
In chapter two, I describe my efforts in purifying and characterizing a putative Cu-binding 
protein from the marine archaea, Nitrosopumilus maritimus. While the protein is hypothesized to 
be a simple cupredoxins, my coworkers and I showed that it has an open binding site and have 
NO oxidation activity.  
Chapters three to five focus mainly on addressing the question of what are the factors 
important in tuning the reduction potential in azurin, as a case study for cupredoxin class of ET 
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proteins, what are the applications of such tuning and whether we can engineer this protein to 
span the entire range of physiological potential. I would first start with description of the 
successful design of azurin to span the entire range of physiological potential, from 970 to -950 
mV vs. standard hydrogen electrode (SHE) using only five mutations and two metal cofactors, 
Ni and Cu. I will then talk about more detailed studies of the role of residue 114 in such tuning 
in chapter four. Chapter five focuses on one application of the designed proteins, which is to 
provide a platform to study and understand Marcus inverted region in protein systems. Along 
these lines and as a means to provide more robust proteins as redox reagents, in chapter six I 
describe my efforts in designing a high-throughput screening platform to obtain stable variants 
with desired reduction potentials. 
Chapter seven is focused on my attempts in understanding the role of interactions beyond the 
primary metal ligands to tune the activity and metal binding in our MnP model in CcP, MnCcP. I 
showed here how adding or removing hydrogen bonds to the metal ligand will affect metal 
binding. I also showed the effect of removal of steric hindrance and increasing flexibility in the 
activity. 
In chapter eight, I will describe the characterization of a new CcP variant in which the loop 
containing residues 178 to 180 is replaced with that in MnP. I describe the unexpected results of 
presence of a Cys residue in position 184 in the protein. The catalase-like activity of the as-
purified protein is investigated together with my studies in characterizing this state. Also, 
comprehensive studies of the heme-protein crosslink that is formed during heme addition to the 
protein are provided.  
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CHAPTER 2 
 
PURIFICATION AND CHARACTERIZATION OF A NOVEL CUPREDOXIN-LIKE 
PROTEIN FROM NITROSOPUMILUS MURITI  
* Portions of this chapter are taken from a manuscript, not submitted yet, as “A novel purple cupredoxins from Nitrosopumilus 
maritimus displays NO oxidase activity” (Hosseinzadeh P.*, Marshall N.M.*, Tian S.*, Hemp J., Mullen T., Gao Y-G., Nilges 
M.J., Robinson H., Gennis R.B., Lu Y.). Marshal N.M. started the purification and initial characterizations. Tian S. performed 
activity assays and related figures. Dr. Hemp J. initially found the sequence and designed the expression vector without the 
transmembrane helix. 
 
2.1. Introduction 
Every year new classes of microorganisms1 and species are being discovered. A recent study 
has estimated that 86% of all organisms on earth and 91% of species in the ocean have yet to be 
fully described.2 While some of these organisms are new strains of a previously know species, 
some are entirely new ones with functions essential to life on earth. One such organism is 
Nitrosopumilu maritimus, discovered in a filter in the Seattle aquarium3 and soon shown to be a 
major player in N2 cycle on earth. In this chapter, after a brief introduction to N2 cycle in general 
and N. mar. in specific, I will focus on my efforts in understanding a small putative cupredoxin 
from this archeon, N.mar._1307. 
2.1.1. N2 cycle 
Nitrogen gas is an essential nutrient and among the most abundant molecules on the earth 
atmosphere composing about 78% of the total air content. Despite its abundance as a gas, this 
form of nitrogen cannot be absorbed by most organisms and should be converted to ammonia 
(NH3) in order to be absorbed by plants and being used in building blocks of life, amino acids, 
(deoxy)ribonucleotides, and sugars.4 The process of adsorbing gaseous N2 and changing it into 
NH3 is called nitrogen fixation. Nitrogen fixation is only a part of the N2 cycle. Other parts 
involved in changing the ammonia back to gaseous N2 to close the cycle. Figure 2.1 shows a 
schematic view of the cycle.4 
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Figure 2.1. Schematic representation of N2 cycle on earth. Figure adapted from ref. 4 
Nitrification is referred to a series of reactions in the N2 cycle through which the NH3 is 
converted to nitrite and then nitrate. Before discovery of archea, nitrification was believed to be 
solely carried out by bacteria.5 Several studies focused on understanding of the nitrification 
process in bacteria.  A summary of the results is shown below. In the first step, NH3 is converted 
to the intermediate hydroxylamine (NH2OH) by a class of enzymes called ammonia 
monooxygenase. This intermediate is then converted to nitrite upon the action of hydroxylamine 
oxidoreductase. Nitrite would then be converted to nitrate by nitrite oxidoreductase.6,7 
1. 2 NH4+ + 3 O2 → 2 NO2− + 2 H2O + 4 H+ (Nitrosomonas) 
2. 2 NO2− + O2 → 2 NO3− (Nitrobacter, Nitrospina) 
3. NH3 + O2 → NO2− + 3H+ + 2e− 
4. NO2− + H2O → NO3− + 2H+ + 2e− 
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Later, several families of archaea were shown to be involved in denitrification as well,8,9 first 
of which was Thaumarchaeota.10 In contrast to ammonia-oxidizing bacteria (AOB), the 
enzymology and reaction steps in ammonia-oxidizing archaea (AOA) is less well-established. 8,9 
For example, the quest for finding a putative hydroxylamine oxidoreductase in one of the most 
abundant of such archaea, Nitrosopumilus maritimus, which is suggested to be a major player in 
N2 cycle in the oceans, has failed so far. 
2.1.2. Nitrospumilus Maritimus 
Nitrosopumilus maritimus (N. mar.) was discovered in a filter in the Seattle aquarium by 
ribosomal RNA sequencing.3 This and similar strains have since been shown to exist throughout 
the oceans in the world.11-27 N. mar.  is a straight rod-shape archeaon of 0.5-0.9 mm length and 
0.17-0.2 mm diameter (Figure 2.2).  
 
Figure 2.2. TEM (c) and SEM (d) of N. mar. Scale bars are 0.1 mm. Figures from ref. 3 
What is interesting about N. mar. is the large number of genes encoding putative copper 
proteins in its genome. N. mar is missing the genes coding for cytochromes c, the most 
ubiquitous class of electron transfer (ET) proteins and appears to have replaced these by 
cupredoxin-like proteins. While N. mar still utilizes many heme proteins for other functions, 
copper proteins appear to have evolved to completely take over the role of electron transfer. In 
some cases, functions carried out by heme proteins in every other known form of life are 
believed to be performed by copper proteins in N. mar.  
N. mar has been shown to grow and oxidize ammonia even at the low ammonia 
concentrations found in the ocean.3,14 Therefore, it is a major player in converting dissolved 
ammonia in the oceans to nitrite, a critical step in the global nitrogen cycle.13,14,24,26  
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Given the important role that N. mar plays in the global nitrogen cycle, and its unusual 
replacement of heme-based ET proteins with copper-based counterparts, isolating, purifying and 
characterizing some of the cupredoxin-like proteins from the N. mar would expand our 
understanding of the interplay between heme-based and copper-based biochemical processes. 
Furthermore, many of the smaller cupredoxin-like proteins are proposed to be involved in critical 
metabolic pathways in N. mar, including a putative mononuclear copper protein that could 
catalyze NO oxidation to NO2-.24 Therefore it would be interesting to find out structural features 
responsible for such function. 
2.1.3. N.mar_1307 
Soon after realization of the critical role of N. mar. in the N2 cycle,  genomic-based studies 
were performed to discover enzymes with putative role in denitrification process. Along with 
several candidates with enzymatic activity, a putative Cu-binding protein was discovered that 
was highly expressed in the organism with ammonia-dependent expression. The protein, called 
N. mar_1307 was predicted to be anchored to membrane via a single trans-membrane helix and 
to have a common cupredoxin fold and (His)2-Cys Cu-binding motif. Due to these structural 
similarities, a common ET role was predicted for the protein. Dr. James Hemp (who performed 
the initial studies mentioned above) then asked us to characterize this protein.  
Herein, I describe the purification and characterization of N. mar_1307. Our results suggest a 
more interesting role for this highly expressed protein and interesting new chemistries for a type 
1 Cu (T1 Cu) protein. 
2.2. Materials and methods 
2.2.1. Cell culture and expression of N. mar proteins 
The protein coding DNA sequences of N. mar_ 1307 was cloned into the pET-22b 
periplasmic expression vector (Novagen) from genomic DNA. N. mar_ 1307 natively has an N-
terminal helix that anchors the protein to the cell membrane. These membrane associated helices 
were omitted from the cloned sequence here in order to result in solubly expressed protein. 
Rosetta strain E. coli (Novagen) were then transformed with the cloned sequences. This 
strain of E. coli was used because the codon usage of N. mar is very different from that of E. coli 
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and Rosetta cells have extra translational machinery and tRNAs to compensate for this. 
Transformed cells were then used to streak LB plates with 100 mg/L ampicillin. These plates 
were incubated at 37°C overnight to obtain single colonies. Single colonies were then used to 
inoculate 5 mL LB cultures with 100 µg/mL of ampicillin, which were then incubated at 37°C 
until an OD600 of 0.6-0.8 was achieved. A 2 L portion of 2xYT media was then inoculated with 1 
mL of the 5 mL culture and 100 mg/L of ampicillin. The 2 L cultures were then incubated at 
37°C overnight, typically reaching an OD600 of around 1.5 after 18 hours. In the morning, cells 
were induced with 100 mg/L of Isopropyl β-D-1-thiogalactopyranoside (IPTG) and allowed to 
express protein at 37°C for an additional 4 hours. After expressing for 4 hours, proteins were 
extracted via the osmotic shock procedure outlined below. 
The volumes in the procedure outlined below were scaled based on the volume of the 
original culture. After harvesting the E. coli by centrifugation, the cells were re-suspended in 1/8 
the volume of the original culture of a solution containing 20 % w/v sucrose, 50 mM tris HCl 
buffer at pH 8.0, and 5 mM ethylenediaminetetraacetate (EDTA). The cells were incubated in 
this solution at room temperature for 1 hour and re-harvested. The supernatant was discarded 
and the cells were re-suspended in 1/8 the volume of the original culture of a solution with 4 
mM NaCl and 1 mM dithiothreitol (DTT) to lyse the periplasmic membrane. Cells were left in 
this solution for 10 minutes at 4°C to effectively lyse the periplamsic membrane. Solids were 
then removed by centrifuging and the supernantant was collected. The pH of the supernatant was 
then lowered to 4.0 by slowly adding a solution of 500 mM sodium acetate at pH 4.0 (1/10 the 
volume of the supernatant). Lowering the pH in this way caused more solids to precipitate, 
which were again removed by centrifuging and the supernatant was collected.  
2.2.2. Column purification of N. mar_1307 and re-constitution with copper 
After extracting the protein from the cells by the osmotic shock procedure above, the pH of 
the N. mar_1307 supernatant solution was raised to 6.0 by slow addition of aqueous NaOH. The 
supernatant was then applied to a FF Q-sepharose column (50 mL, GE Healthcare) equilibrated 
in 50 mM sodium acetate buffer at pH 6.0 by adding the beads directly to the supernatant and 
letting it shake on an orbital shaker at 4°C overnight. The protein was eluted from the column by 
a NaCl gradient on an Akta basic FPLC (GE Healthcare). The desired protein typically eluted at 
around 300 mM NaCl. 
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N. mar_1307 was then reconstituted with copper by adding a slight excess of CuSO4 to the 
partially purified protein solution. Full incorporation took several hours to complete. It was 
believed that the slow incorporation of copper compared to some other cupredoxin proteins may 
have been due to binding of another exogenous metal in the metal binding site, but first 
dialyzing the protein versus an excess of EDTA to remove exogenous metal did not increase the 
copper incorporation rate. The increase in absorbances at 415 and 570 nm were monitored to 
estimate copper incorporation. Full copper incorporation was assumed to be the point at which 
no further increase in the visible absorbances was seen upon addition of more copper. Copper 
incorporated protein was then separated from non-copper bound protein and other contaminants 
by re-applying the protein to a Q-sepharose column and re-eluting it with a NaCl gradient. The 
purity of the final protein solution was assessed with SDS-Page and electrospray ionization mass 
spectrometry (ESI-MS). 
2.2.3. Electrochemical characterization of N. mar_1307 
The reduction potential of the copper site in N. mar_1307 was measured by a modified 
protein film voltammetry (PFV) techniques reported previously.28,29 Pyrolitic graphite edge 
electrodes (PGEs) were modified with a layer of multi-wall carbon nanotubes (1 mg/ml in DMF, 
sonicated for 4 hours to homogeneity) overnight.  10 mM 1-pyrene butyric acid in DMF was 
added to electrode. After 1 hour, the electrode was rinsed and a mixture of freshly prepared 1-
ethyl-3-(3-dimethyl aminopropyl carbodimide (0.4 M) and N0hydroxy sulfosuccinamide (0.1 M) 
was added for 20 min. the electrode was rinsed and a solution of 1 mM protein reconstituted at 
pH 4 was added to the electrode and incubated for 45 min. The CV values were recorded at scan 
rates from 0.01 to 1 V/s in 50 mM Tris buffer pH 8 with 200 mM NaCl. 
2.2.4. Spectroscopic characterization of N. mar_1307 
ESI-MS was collected on a Waters Quattro II Tandem Quadrupole/Hexapole/Quadrupole 
instrument by adding formic acid to samples to ionize. UV-visible spectra of N. mar_1307 were 
collected on a Carey 5E (Varian) in temperature independent (TIP) pH 7.0 buffer. For pH studies 
of the UV-visible absorbances, the protein was exchanged into mixed buffer consisting of 50 
mM sodium phosphate, 50 mM sodium acetate, 40 mM MES, 40 mM MOPS, 40 mM CAPS and 
100 mM NaCl at the various pH values. The protein was brought to each pH by exchanging it 
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into the proper buffer with a PD-10 size exclusion column (GE Healthcare). EPR spectra were 
taken at 30 K in TIP 7, or UB at different pH (4, 7 or 9) buffer as a glass with 20% glycerol. 
Spectra were collected on a Varian 122 spectrometer with an Air Products Helitran cryostat. 
2.2.5. Crystallization of N. mar_1307 
Crystals of N. mar_1307 were grown by the hanging drop vapor diffusion method. Protein 
solution was prepared in 50 mM sodium acetate buffer at pH 6.0 to a concentration of about 2 
mM. A 2 µL portion of this protein solution was then mixed with 2 µL of a well buffer solution 
consisting of 0.1 M TrisHCl at pH 8.0, 20mM CuSO4, 0.1M LiNO3 and varying amounts of 
polyethylene glycol (PEG). The highest quality crystals formed from wells with 35 % w/v PEG 
4000 after about 2 months at 4°C. 
2.2.6. Activity tests 
Cu(II) Loaded N.mar_1307 protein solution in 50 mM BisTris pH7.0 buffer was degassed in 
a Schlenk line and transferred to an anaerobic chamber (Coy Laboratories). Five molar 
equivalents of NONOate solution (from a 50 mM stock solution) was added to 2000 µl of 150 
µM Cu(II)-N. mar_1307 solution in 50 mM BisTris pH7.0 buffer. The UV-vis spectra were 
monitored by an Agilent 8453 photodiode array spectrometer located inside the chamber. The 
extinction coefficient at 560 nm (ε560nm = 906 M-1cm-1) was used to calculate the concentration 
of Cu(II)-N.mar_1307 solution. The concentration of Proli NONOate (Cayman Chemical, MI) 
was determined using ε252nm = 8400 M-1cm-1. 
EPR spectra were collected at 30 K on an X-band Varian E-122 spectrometer at the Illinois 
EPR Research Center equipped with an Air Products Helitran Cryostat and EIP frequency 
counter. The EPR samples were prepared same as described above except 2.0 mM protein 
concentration was used for better resolution. Glycerol was added to a final 20% v/v and the 
solution was quickly frozen in liquid nitrogen. 
2.2.7. Griess assay 
The Griess reagent kit for nitrite quantitation containing N-(1-naphthyl)ethylenediamine 
dihydrochloride, sulfanilic acid and nitrite standard solution was purchased from Life 
technologies and stored refrigerated at 4 oC, protected from light. Sodium nitrite solutions with 
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concentrations between 1-100 µM were prepared by diluting the nitrite standard solution with 
Millipore water. Equal volumes of N-(1-naphthyl)ethlyenediamine and sulfanilic acid was mixed 
to form the Griess reagent. A mixture of 10 µL of Griess reagent, 30 µL of the nitrite-containing 
sample and 260 µL of Millipore waterwas incubated for 30 minutes at room temperature. To 
obtain the standard curve, concentration of nitrite was plotted against absorbance of the mixture 
at 548 nm, measured relative to the reference sample containing 10 µL Griess reagent and 290 
µL Millipore water. 
To investigate whether the protein produces nitrite, Cu(II)-N.mar_1307 was mixed with 5 
molar equivalents of Proli NONOate solution in 100 mM Tris pH8.0 according to the procedure 
described above. After the solution turned colorless, 30 µL of the solution was mixed with 10 µL 
of Griess reagent and 260 µL of Millipore water. In the meanwhile, a solution of only Proli 
NONOate in 100 mM Tris pH8.0 was used as a control which was also incubated with Griess 
reagent at room temperature for 30 min. Measure the absorbance at 548 nm and read nitrite 
concentrations corresponding to the absorbance of experimental samples from the standard plot. 
2.2.8. Protein oligomerization analysis 
4-20% pre-cast SDS gels from BioRad was used for gel analysis. The protein was loaded on 
the gel either before or after crosslinking with gluteraldehyde. Gluteraldehyde crosslinking 
protocol was adapted from previous reports.30 In brief, 2.3% gluteraldehyde was added to protein 
in different concentrations and the reaction proceeded for 5 min at room temperature. The 
protein was then mixed with blue stain and run for one hour at 120 V. Native gels were prepared 
using the protocol previously used in our lab.31 
Gel chromatography was performed on a 50 ml sephadex size exclusion column. The 
standard was from life technologies, catalog number LC0725. Buffer was 50 mM sodium 
acetate, pH 6.3.  
2.3. Results and discussion 
2.3.1. Expression of N. mar proteins 
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An inspection of the amino acid sequence of the N. mar_1307 suggests that it contains an N-
terminal transmembrane helix (Figure 2.3). N. Mar_1307 was cloned without this anchor to 
obtain the soluble copper-containing domain.  
 
 
Figure 2.3. Structure-based sequence alignment of Nmar 1307 and a number of other cupredoxins proteins. The 
initial sequence shown in a red box is the membrane part that we excluded to express the protein in a soluble form. 
The protein was expressed in E. coli and purified by using two consecutive ion exchange 
chromatographic steps (Figure 2.4).  
 
Figure 2.4. (a) FPLC trace of metal free Nmar-1307. The blue line indicates absorption at 280 and the green line 
represents the concentration of buffers. Collected fractions are shown in red box. After metal reconstitution, the 
holo-protein is loaded into a second Q FF column. The trace is shown in (b). 
 
An electrospray ionization mass spectrometry (ESI) of the purified protein showed a peak 
with a mass of 10,746±1 Da (see Figure 2.5), which is within the experimental error of the 
calculated mass of apo-N.mar_1307 (10,747 Da). No other major peak was observed in the mass 
range, indicating that the N. Mar_1307 was successfully expressed and purified in its copper-
free apo form.  
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Figure 2.5. Representative ESI-MS of N. mar_1307. 
Addition of Cu(II) to the apo-N. Mar_1307 converted the colorless protein to one with a 
purple color. After column purification protein was shown to be > 95 % pure based on SDS-
PAGE (Figure 2.6).  
 
Figure 2.6. SDS-PAGE gel of column purified N. mar_1307 both before and after copper incorporation. 
 
The UV-visible spectroscopy of the resulting protein (Figure 2.7) is strongly dependent on 
the pH at which the Cu titration occurs. with peaks at 412 nm and 560 nm with extinction 
coefficients at pH 4 of 732 ±6 M-1cm-1 and 906 ±8 M-1cm-1, respectively.  
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Figure 2.7. Titration of Cu(II) at two different pH results in different intensities of observed peaks. The protein 
concentration is the same in two samples. 
SDS-PAGE analysis of protein crosslinked with gluteraldehyde as well as gel filtration 
analysis showed that the protein is in a dimer state in solution and this dimer state can be formed 
by heating the protein in the presence of stain (Figure 2.8). Interestingly, even without 
crosslinking, the protein forms a covalent dimer upon addition of dye and hearting in the holo 
state. 
 
400 500 600 700
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
ab
s 
(A
U
)
wavelength (nm)
 Nmar_Tris8
 NmarUB4
	   34	  
 
Figure 2.8. Gel filteration and SDS-PAGE analysis of the protein suggests a dimeric state in the solution. 
2.3.2. Electron Paramagnetic Resonance spectroscopy 
The EPR spectrum, shown in Figure 2.9, is also highly pH-dependent. Below pH 5, the 
spectrum is similar to that of a typical T1, blue cupredoxins (see table 2.1).32 At pH > 5 and is 
most similar to the Cys49Ala variant of the copper chaperone BSco from B. subtilis.33  
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Figure 2.9. Representative UV-vis and EPR spectra of Cu(II) addition into N. mar_1307 at pH 4, 7, and 9. The red 
dotted lines are simulation results. 
Table 2.1. Simulation parameters of EPR of different N. mar_1307 Species. 
Sample species gx, gy, gz Ax, Ay, Az (10-4 cm-1) 
UB-9 100% one species 2.0587, 2.0391, 2.2270 17.6,   7, 191.3 
UB-7 Mostly one species, 
N splitting added 
2.0633, 2.0375, 2.2351 
3,   33,   19 
14.3,   3.3,  194.3 
16,   44,  13 
UB-4 51.5 % species 1 
48.5% species 2 
2.0330, 2.0561, 2.2741 
2.0567, 2.0493, 2.2659 
67,   9.7,  61.3 
47.3,   0.3,  92.7 
 
The copper in the high-pH species was readily removed by the addition of EDTA to the 
solution.  In contrast, EDTA did not remove the copper from the low-pH protein species (Figure 
2.10) . These data suggest that the affinity of the apo-protein for Cu(II) is substantially greater 
for the low-pH species. 
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Figure 2.10. The representative EPR spectra of EDTA treated holo-N. mar_1307 at pH 7. 
2.3.3. Structure of Nmar-1307 
The three dimensional structure of N. mar_1307 (Figure 2.11a) was determined by X-ray 
crystallography. The protein crystallized with 4 molecules in the asymmetric unit, with each of 
the four molecules being the same except for different conformations of a few surface residues 
that display a high degree of freedom.  
 
Figure 2.11. Crystal structure of N. mar_1307. a) Full structure with the backbone shown in ribbon representation 
and the primary copper ligands in stick. B) Zoom in of the copper binding site with nearby amino acids shown in 
ball-and-stick representation. The coordinating water is shown as a red ball. 
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Relevant crystallographic parameters are provided in Tables 2.2 and 2.3. The copper is 
coordinated to one Cys and two His in a trigonal plane (SγCys83-Cu = 2.30 Å, NδHis43-Cu = 1.97 Å 
and NδHis86-Cu = 1.99), which closely resemble typical values for a cupredoxin.34 However, 
unlike most T1 cupredoxins that contain a Met, Leu or Gln residue in the axial position above 
the trigonal plane, in N. mar_1307 the site is occupied by a water ligand. Based on sequence 
homology with other cupredoxin proteins, the residue that is in the same position in the sequence 
of N. mar_1307 as the axial ligand in other cupredoxins is Arg89. The structure of N. mar_1307, 
however, clearly shows that Arg89 rotates away from the copper creating an open coordination 
site (figure 2.11b). The next closest possible copper ligands are the Oδ from Asn11 or the Oη 
from Tyr20. Both atoms are > 4 Å from the most likely copper position, which is much too long 
to consider these residues strong copper ligands. Extra electron density 2.31 Å from the T1 Cu is 
assigned as a water molecule within the Cu coordination sphere. This water is 2.44 Å and 3.01 Å 
away from potential hydrogen bonding groups of Asn11 and Tyr20, respectively. On the other 
side of the trigonal plane, a backbone carbonyl oxygen atom from Pro42 is located near the 
copper center as in other cupredoxin proteins, such as azurin, where computational work has 
shown that there is a strong ionic interaction between the copper and the dipole from the 
oxygen.35 However, the distance between the oxygen and copper in N. mar_1307 is more than 4 
Å, suggesting that any ionic contribution would be weak.  
Table 2.2. Crystallogrpahic parameters from data collection of N. mar_1307 crystal. 
Resolution range (Å) 45.87  - 1.6 (1.657  - 1.6) 
Space group P 41 21 2 
Unit cell 68.887 68.887 184.45 90 90 90 
Total reflections  
Unique reflections 59603 (5817) 
Multiplicity  
Completeness (%) 99.97 (99.74) 
Mean I/sigma(I) 17.74 (5.31) 
Wilson B-factor 18.70 
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Table 2.2. cont.  
Reflections used for R-free  
R-work 0.1703 (0.2032) 
R-free 0.1918 (0.2411) 
CC(work)  
CC(free)  
Number of non-hydrogen 
atoms 
3609 
  macromolecules 3012 
  ligands 6 
  water 591 
Protein residues 384 
RMS(bonds) 0.006 
RMS(angles) 1.07 
Ramachandran favored (%) 97 
Ramachandran allowed (%)  
Ramachandran outliers (%) 0 
Clashscore 2.57 
Average B-factor 22.90 
  macromolecules 20.80 
  ligands 24.10 
  solvent 33.40 
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Table 2.3. Relevant bond length near the Cu binding site of N. mar_1307 
Atoms Chain A (Å) Chain B (Å) Chain C (Å) Chain D (Å) Average 
distance (Å) 
SγCys83-Cu 2.30 2.32 2.29 2.29 2.30 
NδHis43-Cu 1.97 1.98 1.95 1.99 1.97 
NδHis86-Cu 1.99 1.99 1.99 1.99 1.99 
OPro42-Cu 4.29 4.36 4.23 4.34 4.30 
OδAsn11-Cu 3.98 3.93 3.96 3.89 3.94 
OδAsn11-Owater 2.49 2.40 2.46 2.43 2.44 
OηTyr20-Cu 4.94 4.80 4.89 4.87 4.87 
OηTyr20-Owater 3.06 2.95 2.87 3.18 3.01 
Owater-Cu 2.28 2.30 2.44 2.22 2.31 
 
2.3.4. Electrochemical characterization of N. mar_1307 
The presence of a water ligand in the oxidized form of the protein was further confirmed by 
cyclic voltammetry experiments. A representative cyclic voltammogram (CV) of T1-Cu like N. 
mar_1307, reconstituted with Cu(II) at pH 4, is shown in Figure 2.12. A strong current response 
that was dependent upon protein was seen at 263±24 mV vs. Ag/AgCl (468 mV vs SHE) upon 
voltage sweep in 50 mM TrisHCl, pH 8.0 The unusually big separation between the oxidative 
and reductive peak in the CV spectra also suggests a high reorganization energy associated with 
redox process which can be contributed to the loss of water in the reduced state. The same water 
coordination and loss thereof have been observed previously in nitrosocyanin.36 CV of EDTA 
titrated sample gave very similar results (figure 2.12) 
 
Figure 2.12. CV of N. mar_1307 on modified PGE and of EDTA-treated sample on DDAB-treated PGE. (first at 10 
mV/S and the later at 200 mV/s) 
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2.3.5. NO oxidation assay 
The open coordination site and binding of a solvent molecule directly to the copper, which is 
probably absent in the reduced form based on CV data, suggest that this protein might be an 
enzyme.  The ability of N. mar_1307 to oxidize NO to NO2 was tested.  Exposure of 0.15 mM of 
N. mar_1307 to 5 molar equivalents of NO at pH 7.0 resulted in slow bleaching of the visible 
absorbances, suggesting reduction of the copper site to Cu(I) and subsequent oxidation of NO to 
NO2- (Figure 2.13a).  
 
Figure 2.13. a) Time course of UV-vis spectra upon bleaching the LMCT bands of Cu(II)-N.mar1307 with 1ml NO 
gas in 100 mM Tris buffer pH8.0 under anaerobic condition. b) x-band EPR spectra of Cu(II)-N.mar1307 reacting 
with NO in 50 mM BisTris pH7.0: Cu(II)-N.mar1307 before reaction (black), 1 min after reacting with NO (red), 10 
min after reacting with NO (green) and 30 min after reacting with NO (blue). 
NO2- production was confirmed using the Griese assay (figure 2.14).37 Monitoring the 
reaction through EPR showed a decrease in signal from the T1-like EPR active species, while 
the signal from the weakly absorbing species remained intact (Figure 2.13b). These data suggest 
that the purple species is the active form of the protein 
 
Figure 2.14. (a) , (b) show standard curve of Griese reagent for NO2- production. (c) Production of NO2- in buffer 
control (27.9 µM) compared with N. mar_1307 (40.2 µM) after 30 min time with starting ?? concentration of NO. 
The NO2- production is buffer is due to side reaction of NONOate. 
400 600 800 1000
0.05
0.10
0.15
ab
so
rb
an
ce
 (A
u)
wavelength (nm)
0 1000 2000 3000 4000 5000 6000
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
ab
so
rp
tio
n 
(A
u)
time (s)
412 nm absroption
560 nm absorption
2400 2700 3000 3300 3600
B (gauss)
 Cu(II)-Nmar1307
 Cu(II)-Nmar1307 + 5eq.NO 1min
 Cu(II)-Nmar1307 + 5eq.NO 10min
 Cu(II)-Nmar1307 + 5eq.NO 30min
400 500 600 700 800
0.0
0.1
0.2
0.3
ab
so
rb
an
ce
 (A
u)
wavelength (nm)
 0 uM
 20 uM
 40 uM
 60 uM
 80 uM
 100 uM
0 20 40 60 80 100
0.00
0.05
0.10
0.15
0.20
0.25
0.30
A
bs
or
ba
nc
e 
at
 5
48
 n
m
Nitrite concentration (mM)
400 600 800
0.00
0.05
0.10
ab
so
rb
an
ce
 (A
u)
wavelength (nm)
 Nmar1307
 control
	   41	  
Without a way to reoxidize the Cu, the reactivity studies were limited to a single turnover. 
2
2 2[ ] 2 [ ]aqNO H O Cu NO H Cu
+ − + ++ + + +Ä    
 The reaction with NO is highly pH dependent. Complete reduction of Cu(II) to Cu(I) by NO is 
observed only at pH > 7.0. At pH 5.0, no bleaching of the ligand-to-metal charge transfer 
(LMCT) bands is observed. We also observed that at pH 5.0, the reduced N. mar_1307 is 
oxidized by NO2- to result in a Cu(II) species identical to the original Cu(II) form of N. 
mar_1307 and presumably aqueous NO. At pH 7.0, no Cu(II) species formation was observed 
upon treatment of reduced N. mar_1307 with NO2-. 
2.4. Summary and conclusion 
The high midpoint potential of the Cu (468 mV) favors the oxidation of NO to nitrite under 
standard state conditions (Em7=200mV SHE, for NOaq). Acidic conditions will increase the Em7 
by about 120 mV per pH unit below pH 8. Hence, it is consistent with the observations that at 
pH 8 and an excess of NO and no nitrite, the reaction will favor the 1-electron reduction of NO 
to nitrite.  At lower pH and an excess of nitrite over NO, the reaction with the result in the 
reduction of the Cu in N. mar_1307.  
Physiologically, N. mar. converts ammonia to nitrite. In Nitrosomonas europaea, this is 
accomplished by the ammonia monooxygenase, which generates hydroxylamine, and 
hydroxylamine oxidoreductase, which converts hydroxylamine to nitrite.  However, no gene that 
can be annotated as hydroxylamine oxidoreductase is present in the genome of N. mar.  It is 
possible that the pathway utilized by N. mar. differs from the canonical pathway.  Possibly, NO 
is the produced and then oxidized to nitrite by N. mar._1307.  Such production of NO has 
recently been observed in ammonia aoxidizing archaea.38 However, an immediate electron 
acceptor remains to be identified to reoxidize N.mar_1307 and multiple turnovers demonstrated.  
What is clear from the current work is that N. mar_1307 is a unique cupredoxin which has an 
axial water molecule that can be displaced, allowing 1-electron chemistry to a substrate. The 
midpoint potential of the Cu is sufficiently high at pH 8 to oxidize NO to nitrite under conditions 
where the ratio of NO/nitrite is sufficiently high. Other copper-containing nitrite reductases 
contain a type-2 copper at the active site coordinated to three His and water and the favored 
direction of the reaction favors the reduction of nitrite to NO due to the relatively low midpoint 
potential of the electron donor. In the case of N. mar_1307, the type-1 copper has a relatively 
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high midpoint potential and it is reasonable to assume that the electron acceptor has an even 
higher potential, hence shifting the direction of the catalyzed reaction to favor the formation of 
nitrite.  Given that N. mar. is a significant producer of oceanic nitrite, it is important to clarify 
the enzymology. 
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CHAPTER 3 
 
DESIGN OF A SINGLE SCAFFOLD PROTEIN, AZURIN, TO SPAN THE ENTIRE 
RANGE OF PHYSIOLOGICAL REDUCTION POTENTIAL 
* Portions of this chapter are from a manuscript submitted to PNAS, as “Design of a single scaffold protein that spans the entire 
2V range of physiological redox potential” (Hosseinzadeh P.*, Marshall N.M.*, Chacόn K.N., Yu Y., Nilges M.J., Blackburn 
N.J., Lu Y.). Marshall N.M initiated the projects and performed several initial assays and experiments that are presented in the SI 
and CV data of the protein. EXAFS simulations were performed by Chacόn K.N. and some of EXAFS data were collected by 
Chacόn K.N. and Yu Y. 
* Portions of the introduction are from a review submitted to Biophys. Biochim. Acta as “Designed and fine-tuning redox 
potentials of metalloproteins involved in electron transfer in biology” (Hosseinzadeh P., Lu Y.) 
 
3.1. Introduction 
3.1.1. Importance of tuning Reduction potential 
The reduction potential (E°) of a metal center is best described as the tendency of the center 
to acquire electrons and thus to be reduced (Eq. 3.1). The more positive the value of E°, often 
called high E° centers, the more favorable the reduction of the metal center becomes, and thus it 
is called an oxidant.1 Similarly, centers with less positive values of E° are often referred to as 
low E° centers and their oxidation is more favorable, hence are better reductants.1 𝑀!   +   𝑛𝑒!   →   𝑀!!!                                                                       Eq. 3.1 
As can be deduced from the definition, the value of E° is relative. The most common 
standard used for defining the E° value is the standard hydrogen electrode (SHE) which is the 
potential of a platinum electrode in a theoretical electrode/solution interface, where the 
concentration of H+ is 1 M. The value of SHE has been arbitrarily assigned to be 0.0 mV. All E° 
values mentioned in this review are referred vs. SHE. Any factor that stabilizes a higher 
oxidation state or destabilizes a lower oxidation state of the metal ion will decrease the E°, i.e. 
the metal ion is easier to be oxidized or more difficult to be reduced. Similarly, factors 
stabilizing lower oxidation states of the metal ion will increase E°, causing the metal to be 
reduced more easily. 
Another important factor to consider when discussing ET is the rate at which the process 
occurs. Several factors can influence the rate of ET, based on Marcus equation (Eq. 3.2).  𝑘!" =    !!ℏ   |𝐻!"|! !!!"!!! exp −   (!!!!°)!!!!!!                          Eq. 3.2 
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where kET is the rate constant of electron transfer, HAB is the electron coupling between the 
initial and final states, λ is the reorganization energy, and ∆G° is is the total Gibbs free energy 
change for the ET reaction, often called the driving force of the reaction.2 
Among the factors that influence the ET rate, E° can play a major role, as it provides the 
driving force (∆G°) for the ET reaction. By tuning E° of different metal centers within a protein, 
the ET rate can be precisely controlled. A primary example of such tuning is observed in ET 
reactions in photosynthesis and respiration.  
In photosynthesis, the reaction center, also called light harvesting complex, is responsible for 
harvesting the energy in the form of light through several chlorophylls and pigments to ensure 
the maximum capture of visible light. 3,4 In the light-dependent stage of photosynthesis, the 
excited chlorophyll in photosystem II (PS-II) loses one electron, which is first transferred to a 
quinone (plastoquinone in plants) and then to cytochrome b6f, an ET protein (plastocyanin in 
plants), and finally photosystem I (PS-I). Upon additional exposure to light, the electron is 
excited and transferred to another molecule, usually a membrane bound FeS protein, then to 
ferredoxins, and through the action of ferredoxin-NADPH reductase (FNR), to its ultimate 
acceptor, NADP+. The electron that left PS-II is restored through oxidation of water.3,4  Through 
these series of reactions electrons flow thermodynamically downhill. The energy provided by 
these electrons results in the generation of a proton gradient across the membrane, which is later 
used to produce ATP through the action of ATP synthase. The newly produced NADPH will 
then take part in the next stage of photosynthesis, called the dark cycle, to help store the energy 
in the form of C-C bonds via a process called carbon fixation.5,6 Special requirements for 
proteins that are involved in photosynthetic reaction centers have been discussed by Dutton and 
coworkers in detail.3,7 The production of a proton-motive force, and subsequently ATP, is 
dependent on the downhill movement of electrons, which in turn is controlled by the E° of the 
redox partners involved in each reaction (Figure 3.1). 
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Figure 3.1. (a) Schematic representation of molecules involved in light stage of photosynthesis. (b) Z-scheme of 
photosynthesis showing the electron flow and the potential of redox pairs involved. Figures adapted with permission 
from Ref. 5 (Copyright © 2004, Rights Managed by Nature Publishing Group and 8 (Copyright © 1992, Kluwer 
Academic Publishers., respectively. 
Similar tuning of the E° is also observed in the respiratory electron transport chain (Figure 
3.2). In aerobic respiration, electrons generated from the oxidation of NADH to NAD+ are 
transferred to complex I (NADH-coenzyme Q reductase), and then to ubiquinone (coenzyme Q). 
Ubiquinone can also accept electrons from complex II (succinate dehydrogenase) that are 
generated through conversion of succinate to fumarate. Reduced ubiquinone will then pass its 
electrons to complex III (cytochrome bc1), then to cytochrome c, and finally to complex IV 
(cytochrome c oxidase) which transfers electrons to their ultimate acceptor, O2, generating water 
in the process.9-13  
a	  
b	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Figure 3.2. (a) Schematic representation of molecules involved in aerobic electron transport chain. Figure adapted 
from Ref. 11 Copyright © 2012 Elsevier B.V. (b) Associated redox potentials. 
 
In addition to controlling rates of ET, tuning E° can regulate biological reactions. In several 
cases, the E° of a metalloprotein is changed upon binding to a substrate or to its cognate redox 
partner in a manner that facilitates the reactions. For example, cytochrome P450s are a class of 
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enzymes that catalyze activation of O2 and then transfer the oxo group to many organic 
substrates. In the absence of the target, the enzyme has a low E° which prevents its reduction by 
its redox partner and is thus stable. The binding of the target substrate into active site, however, 
raises the E°, making the enzyme reducible by its redox partner, and allowing the reduced 
enzyme to bind O2, activating it for oxo-transfer reactions such as epoxidation.14-21 
Similarly, the reduction processes in cytochrome bc1 are tightly regulated in order to avoid 
the formation of dead-end products. As a result, the system incorporates a way to ensure that 
cytochrome c is not reduced by the Rieske center before heme bL is reduced. To achieve this 
goal, E° of the Rieske center is regulated by binding to quinone. The principle of regulation is 
based on the finding that semiquinone has a strong affinity for the reduced  Rieske center and the 
strong binding increases the E° of Rieske center, due to presence of a cation radical 
(semiquinone). Before the ET reaction, deprotonated hydroquinone binds the oxidized Rieske 
center and reduces the Reiske center by giving an electron and changing to semiquinone in the 
first ET step. However, this reduction resulted in reduced Rieske that has a strong affinity for the 
semiquinone, and hence its redox potential will increase. The increase in E° does not allow the 
reduced Rieske center to transfer electrons to cytochrome c.  In the second ET step, on the other 
hand, the heme bL will oxidize the semiquinone to quinone, which has a lower affinity for 
Rieske protein Consequently, the E° of Rieske becomes low again, enough to transfer electrons 
to cytochrmome c.22-24 Finally, interaction between plant-type ferredoxins and their redox partner 
ferredoxin/NADPH oxidoreductase (FNR) cause a change in E° of both proteins, facilitating ET 
between the two redox partners.25,26 
3.1.2. Factors affecting redox potentials of ET centers and strategies to fine-tune them 
In this section we will provide an in-depth review about the factors involved in tuning E°, as 
one of the most practical ways of designing tailor-made ET proteins.  
3.1.2.1. Metal ions 
The role of metal ions in determining the range of reduction potential of a metalloprotein is 
known to be very important. Depending on the metal ion and the valent states it’s going through, 
the value of E° can vary substantially. Not all potentials are accessible to metal pairs and, 
especially in biology with the limited ligands offered, not all transitions are possible. In general, 
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copper is known to be on higher ends of redox potential range, while iron serves mostly as a low 
E° redox center.27 The transitions that a metal center can go through are a major determinant of 
the overall range of E° for a metalloprotein. The main reason for the higher reduction potentials 
observed in the [4Fe-4S] clusters in high potential iron-sulfur proteins (HiPIPs) compared with 
those in ferredoxins (100-500 mV vs. -600-100 mV, respectively)27 is the different transitions 
they go through ([4Fe-4S]2+/3+ vs. [4Fe-4S]1+/2+ , respectively).28-31 
The number of metal ions in the metal center is also an important determining factor for the 
redox potential of both ions. The presence of a positively charged metal ion will directly affect 
redox potentials of neighboring metals and more importantly, any changes in the redox state of 
one metal ion will influence overall redox state of the other ions. One such effect is observed in 
binuclear centers such as CuA or [2Fe-2S] clusters in which the orbitals of the metals are mixed, 
resulting in a spin paired system with half integer charges on each metal.32-36 
Even in systems in which the metal centers are not as close, one can see cooperativity 
between metal centers. Cooperativity of the nearby hemes in multiheme cytochromes is one such 
example.37-39 It has been suggested that interactions between the hemes in cytochrome c3 around 
28 Å for heme I and II in tetraheme c554 can change the values of E° of other hemes within the 
protein by 50-60 mV.40-42 Electrostatic interactions and local aromatic groups are proposed to be 
the main mediators of such redox-dependent effects43 (Figure 3.3). Spin state of a metal ion and 
the transitions it goes through also have effects on its redox potential. For example, low spin 
heme sites have shown to have lower redox potentials.44 In cytochrome P450cam, the low spin 
heme has a potential of -270 mV while the high spin state has a potential of -170 mV.45 
  
Figure 3.3. (a) The arrangement of hemes in tetraheme c554 with their corresponding redox potentials. (b) The redox 
potential windows of tetraheme c554. Figures reprinted with permission from Ref. 46. Copyright © 2013 Elsevier 
B.V.  
a	   b	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3.1.2.2. Ligands in the primary coordination sphere 
In addition to the identity of the metal ion and its valent states, the ligands coordinated to the 
metal ions are major contributors to E° of that ion, conferring their contribution through changes 
in geometry and electronic properties. While a combination of all these effects determine the E° 
of a site, some are more prevalent in specific proteins, and we use those as examples to better 
explain such effects. Some metal ions have different preferences for certain geometries in their 
different oxidation states. Cu is one example of a metal ion which accommodates a tetragonal or 
square pyramidal geometry in its oxidized Cu(II) form while preferring a tetrahedral or linear 
geometry in its reduced Cu(I) form.47 If the active site of a protein has a ligand geometry more 
similar to the tetragonal form, Cu(II) is stabilized and a decrease in E° is observed.  
A metal ion’s preference for soft vs. hard ligands can also be used as a means to tune the E°. 
In general, higher oxidation states of a metal ion are considered to be harder, due to higher 
charge and lower radii. Thus, the presence of a hard ligand would preferentially stabilize higher 
oxidation states, resulting in a decrease in E° values. For example, the Fe(II) heme is softer than 
Fe(III) heme, therefore softer ligands such as His would favor the lower oxidation state in 
comparison with a harder ligand, ultimately increasing E°.48  
Electron donating features of the primary ligands is also a major factor contributing to E° of 
the site. The  proximal ligand of Tyr with high pKa is responsible for catalase to have a very low 
E° <-500 mV 49. On the other hand, the proximal Cys with lower pKa than that of Tyr makes cyt 
P450 to have higher E° (E°= -170 mV in high spin and -270 mV in low spin p450 45). Finally the 
proximal His with even lower pKa caused the myoglobin to display even higher E° (E° = +50 
mV)50-52 (Figure 3.4). Mutation of the proximal His to either Cys or Tyr decreased the E° in Mb 
from +50 mV to -230 mV and -190 mV respectively, owing to the more electron donating ability 
of the new ligands.50 Longer bond lengths between proximal His ligands and Fe in peroxidases is 
suggested to decrease electron density on heme, increasing the redox potential.53,54 Similarly, it 
has been shown that one of the main reasons behind the higher potentials found in [2Fe-2S] 
Rieske centers compared to [2Fe-2S] ferredoxins is the replacement of Cys ligands in ferredoxin 
with less electron donating His ligands in Rieske proteins.30,55 Mutation of Cys ligands in FeS 
proteins to less electron donating ligands such as Ser resulted in an increased E° in cases where 
the cluster remained intact.23,56-58  
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Figure 3.4. Effect of changing the proximal ligand in heme proteins. The more electron donating the proximal 
ligand is, the higher the redox potential will be. 
Similar trends are observed with the electron donating nature of the distal ligand of heme 
proteins. In general, the more electron donating the distal ligand is, the more the higher redox 
states will be stabilized, increasing E°. Met ligation to heme results in an overall 100-150 mV 
increase in reduction potential compared with His ligation if all other factors remain the same59-61 
(Figure 3.5). Replacement of His with Met in cytochrome c results in an increased E°62,63 while 
the Met to His replacement causes the reverse effect.60  
 
Figure 3.5. Role of axial ligand in potential of cytochromes 64,65. 
The electron donating or withdrawing features of the porphyrin functional groups also affect 
heme E° 48 due to delocalization of d orbitals into the π-system of the porphyrin ring 66. Having 
more electron withdrawing groups on heme will create an electron poor Fe ion, hence increasing 
the E°.51,52  
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Heme distortion or ruffling can also contribute to E°. The degree of ruffling will influence 
the electronic structure of the porphyrin67,68 and has been shown to decrease delocalization of π 
electrons.69-75 Inducing heme distortion by protein changes have shown that the E° can be 
changed by 170 mV in heme-nitric oxide/oxygen protein74 (Figure 3.6).  
 
 
Figure 3.6. Changing the ruffling of the heme in H-NOX (heme nitric oxide-oxygen reductase) causes a change in 
the redox potential of the heme. Redox potential of the WT H-NOX is about 420 mV. (all values are reported vs. 
SHE). Figure is reprinted with permission from Ref. 74. Copyright © 2010, American Chemical Society. 
The presence of electron donating or withdrawing groups on the FeS proteins and the overall 
charge of the cluster have been shown to influence E° of the FeS proteins. The less negative 
overall charge of the [2Fe-2S] cluster in Rieske proteins (0/-1) vs. ferredoxins (-2/-3) is 
suggested as one of the main contributors to higher E° of former27,76 (Figure 3.7). Slight changes 
in the structure of FeS clusters, such as differences in Fe-S-Cα-Cβ bond angles77-79 and distortions 
in the cuboidal structure of some 3Fe-4S centers can also cause E° changes.80  
 
Figure 3.7. Structure of (a) Rieske center in complex bc1 (PDB ID: 1BE3) and (b) a plant-type [2Fe-2S] ferredoxin 
(PDB ID: 3AV8).  As shown in the figure, while the clusters look very similar, the Rieske center has replaced two 
of its thiolate ligands with imidazolate. Values for redox potential are obtained from Ref.  81 and 82, respectively. 
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3.1.2.3. Secondary coordination sphere interactions 
While primary ligands are the major contributors to the overall range of E° of a given metal 
center, secondary coordination sphere (SCS) interactions can fine-tune the E° within proteins 
that share similar primary coordination spheres (PCS). A quick look at different classes of ET 
proteins can clarify the essential role of interactions beyond the PCS of metal ions in modulating 
the E° to match that of the redox partner to ensure efficient and specific ET and activity.27  
As an example, cupredoxins share the same geometry of Cu binding sites with two His and 
one Cys ligating to the Cu ion in a distorted tetrahedral geometry (Figure 3.8).27,83,84 Despite this 
similarity, their redox potentials span a range of over 500 mV.27,83,85-88 Similar changes in range of 
E° are observed in cases of 2Fe-2S ferredoxins, and cytochromes. The nature of these 
interactions and how they affect reduction potential are discussed in more detail in chapter four. 
 
Figure 3.8. (a) Overall structure of a cupredoxins (azurin, PDB ID: 4AZU). (b) Representative active site structure 
of cupredoxins. (c) Overall scheme of Greek key β-barrel fold of cupredoxins (adapted from [117]). (d) , (e) 
Representative UV-vis and EPR spectra of cupredoxins, respectively. (adapted from [21]) 
3.1.2.4. Longer range interactions 
While not as prominent as factors mentioned above, longer range interactions within proteins 
and the overall structural features of protein scaffolds in which metal ions are residing can also 
influence the E° of the metal center. Hydrophobic environments provided by protein around the 
metal will increase the reduction potential of metal centers by disfavoring higher redox states.27 
This desolvation is the reason that metal complexes in organic model systems usually have 
lower E° compared with those of proteins.30 Exclusion of solvent from the site will change the 
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entropy and enthalpy of a redox transition. Solvent exclusion and heme burial is thought to be 
among the chief factors in controlling redox potential of cytochromes,52,63,89-95 with an effect of up 
to 240 mV.63  
In addition, there have been several reports of cases in which a change far away from metal 
site influences the overall arrangement of primary and secondary ligands, causing a shift in 
redox potential. This structural change is considered as one of the ways binding to a redox 
partner can change E° and facilitate ET. Surface charge mutations in cytochrome b596 and CcP 
resulted in slight shifts in redox potential.97 Net surface charges have been proposed to be 
important in determining E° of HiPIPs.29,98,99   
3.1.3. Tuning E° using unnatural amino acids and non-native cofactors 
While native cofactors and amino acids are very effective for designing ET centers, the 
repertoire of redox active molecules can be further expanded by the introduction of unnatural 
amino acids (UAAs) or non-native cofactors. These molecules enable the deconvolution of 
features that contribute to ET rates.  
One successful example is the use of unnatural derivatives of Met in Az to study the role of 
hydrophobicity, specifically, in tuning the potential of the T1Cu center. Upon incorporation of a 
series of UAAs (shown in Figure 3.9), Lu and coworkers unambiguously demonstrated a linear 
relationship between hydrophobicity (logP) of the axial ligand and reduction potential of T1Cu 
center.100 
 
Figure 3.9. Unnatural Met derivatives that are incorporated into axial position of Az and their corresponding redox 
potentials. Figure is reprinted from Ref. 100. 
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Another example is the use of Tyr derivatives to probe ET. Tyr is a redox active amino acid 
that is shown to donate an electron and a proton during O2 reduction by CcO. This Tyr is 
covalently attached to an adjacent His, which is a Cu ligand in the active site CuB center. In 
order to study the features of this Tyr that are important for ET and proton transfer, Lu and 
coworkers used derivatives of Tyr to study the role and function of this amino acid in the 
reaction mechanism of a functional model of CcO in myoglobin (Mb) (Figure 3.10). Using these 
derivatives, they showed the importance of the His-Tyr crosslink in increasing the activity and 
turnover of the enzyme.101 They further confirmed the role of redox potential and pKa of the Tyr 
in the water production activity.102,103  
   
Figure 3.10. Redox active derivatives of Tyr used by Lu and coworkers to study water oxidation in mimics of CcO 
in Mb. 
In order to study the role of H-bonds from backbone amide group in HiPIPs, Low and Hill 
used chemical synthesis to introduce O instead of N in the backbone of Val42 and Ala57 in 
Rhodocyclus tenuis HiPIP protein.  They showed that removal of these H-bonds will result in a 
lower E° value as expected.104 
One class of nonnative cofactors that are widely used in design and study of ET proteins are 
modified porphyrins. Porphyrins with modified electron withdrawing groups were used to  
change the redox potential and hence ET rate in a Mb model of CcO and it was shown that an 
Tyr	   Metoxy-­‐Tyr	   imi-­‐Tyr	  
Chloro-­‐Tyr	   diFluoro-­‐Tyr	   triFluoro-­‐Tyr	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increase in ET rate corresponds to increase in activity105 (Figure 3.11). Similarly, addition of a 
diacetyl group to the heme in horse radish peroxidase resulted in an increase in E°.106  
 
Figure 3.11. Addition of electron withdrawing groups to heme results in increase in reduction potential of the heme 
and in O2 reduction activity in a Mb model of CcO. Figure adapted with permission from Ref. 105 Copyright © 2014, 
American Chemical Society. 
3.1.4. An unaddressed question: how nature does this? 
For millions of years, ET in biology has operated within the range of physiological E°ˊs, 
defined by the highest E°ˊ (~ +1 V vs. standard hydrogen electrode, SHE-all potentials 
mentioned in this study are vs. SHE) at which water is oxidized, and the lowest E°ˊ (~ -1V) at 
which protons are reduced to H2.27  Amazingly, nature has found a way to cover this wide range 
using a strikingly limited set of not only metal cofactors but also protein folds and metal center 
geometries, such as cupredoxins that cover 100 to 800 mV, cytochromes that cover -500 to 350 
mV and Fe-S proteins that cover -700 to 500 mV (Figure 1).27 Despite many years of research 
into these proteins and efforts to change the E°ˊ,107-111 how the E°ˊs can be tuned systematically in 
a wide range using the limited number of metal cofactors is still not well understood. An 
ultimate test of our understanding of this process is to design redox centers in a single protein, 
using a minimum number of metal cofactors and mutations that can cover the entire 2V range of 
physiological E°ˊ. Furthermore, there are very few water-soluble/stable, chemical redox agents 
within the physiological E°ˊ range. Even for those redox agents that can cover a wide range of 
E°ˊ in non-aqueous solution, combining different redox agents with different scaffolds or surface 
properties makes it difficult to carry out systematic studies of the effect of E°ˊ on ET or catalytic 
functions, as it is difficult to deconvolute different factors in the redox process. In this chapter, I 
report the design of the ET protein azurin to cover a range from +970 ±20 mV to ~ -954 ±50 
mV, by mutating only five residues and using two metal ions  
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3.2. Materials and methods 
3.2.1. Design of constructs and molecular dynamics simulation 
Before construction of HPAz, an in silico model of the protein was generated using VMD 
package.112 The model was then energy minimized (5000 steps, 2 fsec/step) and simulated for a 
total of 1 ns, at 310 K with NPT condition using the NAMD software package.113 The mutations 
were introduced into the Az gene containing a leader sequence to allow periplasmic expression 
in the pET-9a vector through QuickChange PCR (PfuUltraII, Agilent technologies) and 
confirmed by DNA sequencing at the CORE DNA sequencing facility (Urbana, IL). 
3.2.2. Protein expression and purification 
Expression and purification of HPAz was achieved through minor modifications of a 
previously reported method.114 The HPAz plasmid was expressed in E. coli using BL21 (DE3)* 
chemical competent cells (NEB) transformed with the gene of interest using the standard heat 
shock method, plated on LB agar plates containing 50 µg/mL of kanamycin and incubated at 
37°C overnight to produce single colonies. A single colony was then picked and inoculated in 50 
mL LB culture media with 50 µg/mL kanamycin at 37°C overnight. The above 50 mL starter 
culture was then transferred to a 2 L culture of 2xYT media [16 g/L bactotryptone (BD), 10 g/L 
yeast extract (BD) and 5 g/L NaCl (Fisher)] containing 50 mg/L kanamycin. The 2 L cultures 
were incubated with shaking at 25°C until an OD600~1.0-1.5 was reached. The cultures were 
then induced with 300 mg/L of IPTG (Gold Bio Technology Inc.) and incubation at 25°C was 
continued overnight. 
After expression, the cells were harvested by centrifugation and re-suspended in 1/8 the 
original culture volume of a recovery solution consisting of 200 g/L sucrose, 50 mM Tris buffer 
at pH 8.0 and 1 mM EDTA. The cells were recovered by shaking for 45 minutes at room 
temperature, and then re-harvested. The periplasmic membrane was ruptured by re-suspending 
the cells in a solution of 4 mM NaCl and 1 mM DTT and shaking the cells vigorously at 4°C for 
20 minutes. After centrifugation, the supernatant containing the Az variant was collected in a 
separate flask and further purified by adding 1/10 the volume of the supernatant of a 500 mM 
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sodium acetate solution at pH 4.0 to precipitate other components of the cells, which were then 
removed by centrifugation. 
The above supernatant containing the Az variant was then applied to SP-sepharose resin (GE 
Healthcare) by adding the resin directly to the above supernatant and shaking the suspension at 
4°C for at least 2 hours to allow the protein to bind to the resin. The mixture was then packed 
into a column and the Az variant was purified through a pH gradient from pH 4.1 to pH 6.4 
using 50 mM ammonium acetate buffer at the appropriate pH for both washing and eluting. The 
Az variant was further purified by passing the protein through a Q-sepharose (GE Healthcare) 
column and a Sephadex S-100 gel filtration column (GE healthcare), both equilibrated in 50 mM 
ammonium acetate buffer at pH 6.0. The identity of the protein after purification was verified by 
electrospray ionization mass spectrometry (ESI-MS) (calculated: 13974; observed: 13978 Da). 
Typical protein yields ranged from 100-200 mg of pure protein per liter of culture and purity was 
>98 % based on SDS-PAGE.  
Due to high affinity of the proteins for Cu, we used a slightly modified protocol for 
purification of samples for Ni addition. We treated the supernatant before SP column with 1mM 
EDTA to remove divalent cations. 1 mM EDTA was added to buffers as well. We then purified 
the protein on a size exclusion column that was previously washed with EDTA and then 
equilibrated with chelexed buffer. Chelexed buffer was used for running the column as well. 
Met121Glu mutant was purified using a different procedure, described previously.115 This is 
to ensure that the protein is purified in its apo form, since this protein has extremely high affinity 
for divalent metal ions and the procedure used for other variants is not effective to obtain metal-
free form of this protein. 
3.2.3. Copper and nickel reconstitution 
The Az variant was expressed and purified as apo (metal-free) protein. To reconstitute the 
copper into the apo-protein, sub-saturating equivalents of either CuSO4 or 5-10 mM 
Cu(CH3CN)4PF6 in acetonitrile was added to the protein solution with stirring in order to 
minimize the chance that free copper in solution would precipitate the protein.  
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Ni2+ addition to the proteins was performed following a previously reported protocol.116,117 
Briefly, a 50 µM solution of protein in 100 mM phosphate buffer pH 8.0 was prepared. 10 eq. 
NiCl2 was added to the solution and was stirred for two days at room temperature. As 
Met121Glu mutant was highly effective at binding to Ni2+, we found that one hour was enough 
to obtain saturation of the LMCT peak from Ni2+ binding. 
3.2.4. Mass spectrometry 
Electrospray ionization mass spectroscopy (ESI-MS) were obtained on a Quattro II (Waters) 
ESI mass spectrometer maintained by the School of Chemical Sciences Mass Spectrometry 
Laboratory (Urbana, IL). For checking the mass of copper free proteins, formic acid was used to 
ionize the protein upon injection. For observing metal bound proteins, the formic acid was 
omitted and a solution of the copper bound protein in 5 mM ammonium acetate buffer pH 5.0 
was injected as a continuous stream (5 µl/min) via syringe pump to build up sufficient signal to 
obtain an accurate mass. 
3.2.5. Cyclic voltammetry (CV)  
For CV on pyrolytic graphite electrodes (CH Instruments, Austin, TX), the electrode was 
first polished to a mirror finish and until no protein signal was visible. A 1 mM sample of either 
Cu(II)-1VAz or Cu(I)-1VAz (10 µL) in pH 6.35 ammonium acetate buffer (50 mM) was then 
added to the exposed carbon and immediately immersed in a solution of 50 mM ammonium 
acetate buffer at pH 5.0 and 500 mM NaCl. A scan from 0.6 V to 1.3 V vs. the standard 
hydrogen electrode, SHE, was then run at a scan rate of 0.1 V/sec. No signal was observed in 
different buffer solutions with carbon electrodes or below a scan rate of 0.1 V/sec. Using faster 
scan rate of 1V/sec increased the intensity of reductive peak significantly. The CV of Green-
Cu(II)HPAz was obtained in 10 mM sodium phosphate buffer at pH 7.0 supplemented with 100 
mM sodium formate. 
To obtain the potential of Ni-loaded variants, CV was run at 100 mM phosphate buffer at pH 
8.0 with 100 mM NaCl, with scan rate of 0.1 V/s. In addition to CV, differential pulse 
votammetry (DPV) was performed for Ni-loaded variants to check the accuracy of the peak 
positions. The DPV parameters are as follows: scan from 0.2 V to -1.2 V with increments of 
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0.004 V and amplitude of 0.05 V. Pulse width of o.o15 sec was applied with sampling width of 
0.005 sec and sampling period of 0.02 sec. A sensitivity of 5e-006 was used. 
Software SOAS and OriginPro9.0 were used for data process. Subtraction in SOAS was 
performed according to the manual. Subtractions in OriginPro were performed using the peak 
analysis tab. The presence of the peaks was confirmed by taking the first derivative of the 
voltammagram. 
3.2.6. Stopped-flow UV-vis absorption spectroscopy 
 Stopped-flow UV-vis spectra were collected on an Applied Photophysics Ltd 
(Leatherhead, UK) SX18.MV stopped-flow spectrometer equipped with a 256-element 
photodiode array detector. HPAz  was concentrated to 0.75 mM in an appropriate buffer and 0.5 
mM Cu(CH3CN)4PF6 was added by slow addition from a 50 mM stock of the salt in acetonitrile 
(the solution was sonicated to fully dissolve the Cu(I) salt before the experiment). Sub-saturating 
equivalents of Cu(I) were used to minimize the chance of free copper in solution to complicate 
interpretation of the results. Oxidant solutions were prepared in in the appropriate buffer at the 
appropriate concentrations to deliver the desired number of molar equivalents relative to the 
amount of Cu(I) in the protein solution upon mixing in the stopped flow chamber. Spectra were 
collected for up to 1000 seconds with 200 intervals spaced logarithmically with shorter intervals 
at the start of data collection. A series of chemical oxidants of varying redox potential were used 
to initially scan for oxidation of reduced HPAz, including (NH4)2Ce(NO3)6 (1.72 V),118 
Ce(IV)/EDTA (1.06 V),119 Na2IrCl6 (0.892 V),120 K2Mo(CN)8 (0.798 V),121 and K3Fe(CN)6 (0.424 
V vs. NHE).121 In general, oxidants with redox potentials around 0.9 V or higher were able to 
oxidize Cu(I)-HPAz to varying degrees while lower redox potential oxidants could not. 
(NH4)2Ce(NO3)6 and Ce(IV)/EDTA only recovered about 10 % of the expected absorbance 
assuming 100 % oxidation of the protein. Significant scatter was also seen with these titrants, 
which suggests protein precipitation. Na2IrCl6 was seen to yield approximately 20 % of the 
expected visible absorbance intensity based upon the amount of Cu(I) in solution with one molar 
equivalent of oxidant. As such, it was used for further spectrochemical titrations. For pH 
dependent studies of copper oxidation with Na2IrCl6 only acetate and phosphate-based buffers 
were used because Na2IrCl6 was seen to react with several other buffering molecules. Cu(II) 
	   61	  
incorporation was also monitored by stopped-flow by injecting a solution of apo-protein in 
buffer against a solution of CuSO4. 
Because of the instability of Cu(II)-HPAz, we can obtain its E°ˊ quantitatively using CV, as 
we can capture the state using a fast scan rate. While redox titrations using oxidants such as 
Na2IrCl6 can in principle obtain the E°ˊ, because of the bimolecular redox reaction in solution is 
much slower, the Cu(II)-HPAz, once generated, can decompose within the time scale of the 
redox reaction. Therefore we can estimate the E°ˊ only semi-quantitatively. Nonetheless, these 
redox titrations confirm the E°ˊ obtained from CV is in the correct range. 
3.2.7. Spectroscopic studies 
 Electronic absorption spectra in the UV-visible region (UV-vis) were collected on either 
an Agilent 8453 diode array (Agilent), a Carey 3E (Varian) or a Carey 5000 (Varian) UV-vis 
spectrometer. For the pH dependent studies, a buffer that is effective to maintain pH in a wide 
range (pH 4-11) without substantially altering the components in solution from sample to sample 
was used. This buffer (called UB buffer) contained 50 mM sodium acetate, 40 mM MES, 40 
mM MOPS, 40 mM Tris, 40 mM CAPS and 100 mM NaCl.  
Electron Paramagnetic Resonance (EPR) spectra were collected using an X-band Varian E-
122 spectrometer at the Illinois EPR Research Center (IERC). Samples were prepared typically 
at a final concentration of copper loaded protein of about 0.5-1 mM in the appropriate buffer and 
frozen as a glass with 20 % glycerol. Spectra were obtained in a temperature independent buffer 
at pH 7.0 (TIP7)122 as the effective pH of buffered solutions is known to change substantially 
when cooled to cryogenic temperatures, which can dramatically alter the observed spectra. 
Freeze quench EPR was performed on a syringe-RAM controller freeze/chemical quench 
apparatus from Update Instrument, Inc., Madison, WI. Protein sample was prepared in 50 mM 
phosphate buffer, pH 6.5 with addition of 0.1 M NaCl to decrease the temperature-induced pH 
changes after freezing. Glycerol was mixed with the protein sample to a final concentration of 
10% v/v. Concentrated protein sample loaded with Cu(I) was transferred to a 2 ml syringe and 
Na2IrCl6 to a 0.5 ml syringe at 4X the concentration of the protein. The samples were mixed 
with a ram speed of 1.6 cm/s using a reactor tube size of 6.4 with a calculated volume of 5.3 µL. 
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The displacement was set such that the reaction time is less than 20 msec and quenched by 
spraying into a pre-chilled EPR tube filled with iso-pentane cooled in an iso-pentane bath at -
120°C. Calculating the time from the initial mixing in the reaction chamber and adding the time 
required to freeze, a sample time of 20 msec was attained. The frozen sample was packed into a 
compressed layer in an EPR tube.  
Cryoreduction of the M121E-Ni sample was performed by Dr.  Stoyan A. Tashkov in nuclear 
radiation laboratory, UIUC. In brief the samplew were radiated by gamma-rays for three hours 
under liquid nitrogen temperature. 
Cu K-edge (8.9 keV) extended x-ray absorption fine structure (EXAFS) and x-ray absorption 
near edge (XANES) data were collected at the Stanford Synchrotron Radiation Lightsource 
operating at 3 GeV, with currents near 500 mA maintained by continuous top off. Samples were 
measured as aqueous glasses in 20% ethylene glycol at 10K.  All edges were measured on 
beamline 7-3, using a Si[220] monochromator. All data were collected in fluorescence mode 
using a high-count rate Canberra 30-element Ge array detector with maximal count rates per 
array element of <120 kHz. For each edge, four to six scans of buffer blank were averaged and 
subtracted for all protein samples in order to remove the Z-1 filter Kβ fluorescence and produce 
a flat pre-edge baseline. A Cu foil was placed between the first and second ionization chamber in 
order to provide energy calibration. Cu K-edges were collected using an Rh-coated mirror 
upstream with a 12.5 KeV energy cutoff to reject harmonics, and a nickel oxide filter and Soller 
slit inserted in front of the detector in order to reduce elastic scattering relative to the Cu Kα 
fluorescence.  
Data averaging, background subtraction, and normalization to the smoothly varying 
background atomic absorption were performed using EXAFSPAK123. For the experimental 
energy threshold energy (k=0), 8995 eV was selected. Spectral simulation was carried by least-
squares curve fitting, utilizing full curved wave calculations as formulated by the SRS library 
program EXCURVE 9.2124 as previously described.125 We refined the parameters of the fit as 
follows: E0, the photoelectron energy threshold, Ri the distance from the central metal atom (Cu, 
Se, or Ag) to atom i and 2σ2i the Debye-Waller (DW) term for atom i. Coordination numbers 
were fixed to those previously established from crystal structures whenever possible. The quality 
of the fits was determined using the least-squares fitting parameter, F, which is defined as:  
    F2 = (1/N) ∑ik6(χitheory – χiexperiment)2 
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and is hereafter referred to as the fit index or fit (FI).  
3.3. Results and discussion 
3.3.1. Protein design and purification 
The type 1 (T1) Cu center in wild type azurin (WTAz) resides in a Greek key β-barrel fold 
(Figure 3.12a) commonly found in cupredoxins, such as rusticyanin and laccase. The active site 
consists of a Cu(SCys)(NHis)2 core in a trigonal plane, common to all T1 Cu centers, with a 
thioether group from a Met residue (SMet) in the axial position (Figure 3.12b,c).27,85 This axial 
Met is found in most cupredoxins, except those with high E°’; rusticyanin and laccase contain a 
Leu residue at the axial position instead.27,85 We have previously shown that the E°ˊ of Az can be 
predictably tuned from 90 mV to 640 mV at pH 7, by tuning hydrogen bonding interactions and 
the hydrophobicity of residues near the copper binding site (Figure 3.12c).110 To our knowledge 
there is no report of a mononuclear cupredoxin with E°ˊs above or below this range.  
 
Figure 3.12. (a) Overall structure of Az. (b) Zoom-in of the metal binding site and the position of the residues 
mutated in this study. (c) WTAz active site structure, PDB ID: 4AZU, (d) Minimized structural model of HPAz, (e) 
Structure of M121E-Az, PDB ID: 4QLW, and (f) Minimized structural model of N47S/F114N/M121L-Az.  
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To tune the E°ˊ of the T1 Cu center in azurin to approach the highest E° under physiological 
conditions, we examined the T1 Cu centers in cupredoxins that exhibit extremely high E°ˊ, such 
as those in multi-copper laccase (E°ˊ = 790 mV at pH 6- The E°ˊ for a multi-nuclear ceruplasmin 
has not been observed, but has been hypothesized to be > 1V, beyond the physiological E°ˊ 
range),27,126 and found that these centers are highly desolvated and buried within the hydrophobic 
interior of the proteins.126 The area surrounding the Cu center is also typically filled with bulky, 
hydrophobic residues like Phe.126,127 Introducing such hydrophobic residues near the metal-
binding sites or desolvating the site in several metalloproteins has resulted in increased E°ˊ.27,128-
131  Based on these observations, we scanned the secondary coordination sphere of the T1 Cu 
center in Az for positions to introduce Phe residues, and found two such positions (Met44 and 
Gly116, see Figure 1b) that can be mutated to Phe with minimal structural perturbation (Figure 
3.12d).   
We combined the Met44Phe and Gly116Phe mutations with the 
Asn47Ser/Phe114Asn/Met121Leu mutations that had resulted in E°ˊ = 640  ±  1  mV at pH 7.0.110 
This quintuple variant of Az (Met44Phe/Asn47Ser/Phe114Asn/Gly116Phe/Met121Leu Az 
(Figure 3.12d), called HPAz hereafter) was constructed, expressed and purified to homogeneity 
as a metal-free apo protein using a procedure slightly modified from a previous study110 and ESI 
results showed the correct protein. Syringe-pump ESI showed only one copper is bound to the 
protein (figure 3.13) 
 
Figure 3.13. Syringe-pump ESI-MS of Cu(II)-HPAz (top) and Cu(I)-HPAz (bottom showing that one Cu is bound 
to the protein (MW= 14036 [13973 apo-HPAz+ 68 Cu]) 
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3.3.2. Cyclic voltammetry experiments   
After loading Cu(I) into the apo-HPAz, we employed cyclic voltammetry (CV) with a 
pyrolytic graphite “edge” plane electrode and observed a signal centered at 970 ±20 mV at pH 
5.0 in 50 mM ammonium acetate buffer at a scan rate of 100 mV/s(Figure 3.14). Increasing the 
scan rate did not produce significant changes in the current or peak separation while at lower 
scan rates the signal disappeared. The faradaic current from the CV is much lower than those of 
inorganic complexes, due to much slower diffusion rates, and similar to those of other 
metalloproteins reported in the literature.132-134 Attempts to obtain the potential in any other pH 
condition or buffer all failed. This failure maybe due to the low stability of the protein or 
impaired interaction with the electrode. 
 
Figure 3.14. Cyclic voltammagram showing the reversible redox couple of HPAz. The potential obtained at scan 
rate of 0.1 V/sec at pH 5.0 in 50 mM ammonium acetate buffer, obtained at scan rate of 0.1 V/sec (black line). The 
signal with the capacitative current subtracted is shown as an inset in the middle (red line). (Em= 0.97± 0.02 V vs. 
SHE). 
To ensure that the observed CV signal is from the Cu-HPAz variant, we performed several 
control experiments, including repeating the CV experiment under the same conditions in the 
absence of any protein (Blank), in the presence of apo-HPAz (Figure 3.15a), and HPAz loaded 
with redox inactive Zn2+ (Zn(II)-HPAz, Figure 3.15b). None of these control experiments 
exhibited a signal near 970 mV, which strongly suggests that the CV signal is from the 
Cu(I)/Cu(II) redox couple of Cu-HPAz, instead of any other components present in the solution.   
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Figure 3.15. Cyclic voltammagram showing (a) electrode without protein (Blank) or in the presence of apo-HPAz , 
(b) Blank or Zn(II)-HPAz, at pH 5.0 in 50 mM ammonium acetate buffer, obtained at scan rate of 0.1 V/sec (black 
line).  
Interestingly, the green Cu(II)HPAz displays a reductive peak around 650 mV vs. SHE at pH 
7.0 (see Figure 3.16). Consistent with this is that the green-HPAz, which has a relatively lower 
E°ˊ, is more stable than the blue HPAz. 
 
Figure 3.16. Cyclic voltammagram of Green-Cu(II)HPAz shows a weak reductive peak at 650 mV. CV performed in 
10 mM sodium phosphate buffer pH 7 supplemented with 100 mM sodium formate. The reductive peak is small but 
it is reproducible. The peaks close to 200 mV are present in the blank electrode as well and are a result of some 
oxidized functionalities on the electrode surface. 
3.3.3. Redox titration and stopped-flow experiments 
To provide additional support to the E° value determined by the CV, we probed the ability of 
Cu-HPAz to react with other redox agents that have different potentials with little success in 
finding one that oxidize the protein. Among those, ferricyanide (E°ˊ = 0.424 V, pH 7.0), which 
is known to rapidly oxidize Cu(I)-WTAz (E°ˊ = 0.31 V at pH 7),27,135 caused only minimal re-
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oxidation (~2%) of 0.2 mM Cu(I)-HPAz under the same condition within the first 1 s, even 
when in the presence of a 10-fold molar excess of the oxidant (see Figure 3.17). At time scales 
longer than 1 s, a slower process similar to previously reported ferricyanide-induced protein 
unfolding and subsequent reacting with Cu(I) was observed (Figure 3.17). The inability of 
ferricyanide to oxidize Cu(I)-HPAz suggests that the E°ˊ of the T1 Cu center in HPAz is at least 
higher than 0.42 V. 
 
 
Figure 3.17. Stopped-flow UV-vis kinetic of Cu(I)-HPAz oxidation by ferricyanide. Reaction of reduced HPAz with 
10 molar equivalents of ferricyanide for a) the 1st 20 s (black trace to red trace) and b) from 20 seconds to 1000 
seconds (red to blue).  
After trying several other oxidants of varying potentials to oxidize the HPAz, we found that 1 
equivalent of Na2IrCl6 (E°ˊ = 0.96 V at pH 5, Figure 3.18) was able to oxidize 0.2 mM Cu(I)-
HPAz at pH 5 with ~25 % loss of the Na2IrCl6 absorption bands (Figures 3.19 and 3.20). These 
results, together with the result obtained by replacing Cu with Ni on E°ˊ of the same protein 
(vide infra) indicate that the Cu-HPAz has an extremely high E°ˊ.  
  
Figure 3.18. Sample voltammagram of IrCl6. Spectrum taken in 50 mM NH4OAc buffer pH=5.0 + 500 mM NaCl. 
Em = 0.96 ± 0.0.  
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Figure 3.19. Stopped-flow UV-vis kinetics of oxidation of Cu(I)-HPAz by Na2IrCl6. (A) First 10 msec and (B) 10 
msec to 10 s oxidation of Cu(I)-HPAz by Na2IrCl6 monitored by stopped-flow UV-vis at pH 5.0 ammonium acetate 
buffer.  
 
Figure 3.20. 1:1 reaction of Cu(I)-HPAz and Na2IrCl6 resulted in ~25% loss of IrCl6 signal after 0.2 sec. The 
reaction was performed using stopped-flow. 0.2 sec was used as an end-point to measure the %loss of Na2IrCl6 for 
different reactions with a range of molar equivalent Na2IrCl6. 
To characterize the reaction between Cu(I)-HPAz and Na2IrCl6, we used stopped-flow UV-
Vis absorption spectroscopy (UV-Vis), aided by global spectral fit using the Specfit program 
(see Figure 3.21). Upon mixing 0.7 mM Cu(I)-HPAz with 1 equivalent of Na2IrCl6 at pH 6.5 in 
50 mM phosphate buffer and 0.1 mM NaCl, the absorption bands at 420, 485 and 600 nm due to 
Na2IrCl6 (red line) rapidly decayed, while new absorbance bands at 404 and 610 nm (blue line), 
typical of a T1 Cu(II) center136-139, grew in (Figure 3.21a,b). This species (henceforth referred to 
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as “Blue Cu(II)-HPAz”) reached a maximum at ~ 7 msec and then decreased (Figure 3.21a). As 
the Blue Cu(II)-HPAz started to decrease, a new species displaying absorption bands at 400 and 
607 nm (green line, Figure 3.21a,b) concurrently increased in intensity with time (Figure 3.21c). 
 
Figure 3.21. Stopped-flow UV-vis spectra of oxidation of 0.7 mM Cu(I)-HPAz by 1 eq Na2IrCl6 at pH 6.5 in 50 mM 
phosphate buffer and 100 mM NaCl. (a) Spectral changes in first 10 s of reaction; (b) Simulated spectra of 
individual species as determined by the Specfit program. (c) Time-dependent transitions of Na2IrCl6, Blue Cu(II)-
HPAz and Green Cu(II)-HPAz, as simulated by the Specfit program. 
The final spectrum is identical to that observed after direct addition of CuSO4 to apo-HPAz 
(Figure 3.22), suggesting that it is the final product of the oxidation and the stable form of 
Cu(II)-HPAz (henceforth called “Green Cu(II)-HPAz”). Because the decay of Na2IrCl6 signal is 
concomitant with formation of Blue Cu(II)-HPAz, and the decay of Blue Cu(II)-HPAz results in 
growth of Green Cu(II)-HPAz, we used a global spectral fit to confirm the following kinetic 
process and obtained corresponding rate constants:  
 
 
 
Figure 3.22. Comparison of final species after IrCl6 oxidation of Cu(I)-HPAz and addition of Cu(II) to apo-HPAz. 
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In order to investigate the integrity of the protein, we re-reduced the green Cu(II)-HPAz and 
then re-oxidize it. The UV-vis spectrum of the resulting protein is almost identical to that of the 
starting protein (Figure 3.23), suggesting that there is little damage to the protein from such as 
redox process and thus making it possible to use the protein as a redox agent. 
 
Figure 3.23. Oxidation and reduction studies of the Green-Cu(II)HPAz. The apo-protein loaded with Cu(I) and then 
oxidized by Na2IrCl6 (the red line) shows similar features to Cu(II)-HPAz at resting state (the black line). The 
protein can go back to the resting state after being reduced by ascorbate and then being oxidized back by Na2IrCl6 
(the blue line). 
3.3.4. Characterizing the intermediates of oxidation reaction 
To further probe the nature of the products of the Na2IrCl6 oxidation found from the above 
study, we employed rapid freeze quench electron paramagnetic resonance (EPR) spectroscopy 
under the same conditions as those used in the stopped-flow UV-Vis study. The minimal 
achievable time of our freeze quench apparatus was 20 msec, which is slightly slower than the 
time necessary to form the maximal Blue Cu(II)-HPAz intermediate observed in the stopped-
flow UV-Vis (7 msec). At 20 msec after addition of Na2IrCl6 to Cu(I)-HPAz, we observed an 
EPR spectrum (Figure 3.24, top) that can be best simulated as a mixture consisting of 60% T1Cu 
(gz = 2.230 and Az = 65.19 cm-1), 39% type 2 (T2) Cu (gz = 2.309 and Az = 144.81 cm-1) and 
1% radical (gz = 1.992) (Table 3.1). The percentage values for the individual species observed in 
EPR are consistent with those obtained from stopped flow UV-Vis study (Figure 3.21c): at 20 
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msec in the stopped flow experiment, 69 % Blue Cu(II)-HPAz and 26 % Green Cu(II)-HPAz 
were formed.  
 
Figure 3.24. EPR spectra of Na2IrCl6 oxidation of Cu(I)-HPAz. The top spectra shows freeze-quenched after 20 
msec of the reaction and the bottom spectra is the final product of the reaction. The broad feature at less than g = 2.0 
in the 20 msec sample is due to packing of the tube during the freeze quench process. Black line: experimental 
spectra; Dotted red line: simulated spectra.  
Table 3.1. EPR simulation parameters of 20 msec freeze quenched sample. 
Species % gx, gy, gz Ax, Ay, Az (10-4 cm-1) 
Final species (T2 Cu like) 3
9 
2.009, 2.079, 2.230 0.14, 11.46, 144.81 
T1 Cu like 6
0  
2.021, 2.069, 2.309 23.04, 25.23, 65.19 
Free-radical like 1 2.011, 2.003, 1.992 0.00, 0.00, 0.00 
At longer time scales, the percentage of the T1 Cu species decreased while that of the T2 Cu 
species increased. The final EPR spectrum is identical to that of addition of Cu(II) to apo-HPAz 
(Figure 3.24, bottom, Figure 3.25, and table 3.2). Based on the similar kinetic behavior between 
the UV-Vis and EPR studies, we assigned the Blue Cu(II)-HPAz to a T1 Cu center, and the 
Green Cu(II)-HPAz to a T2 Cu center.  
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Figure 3.25. EPR spectrum of Cu(II)-HPAz. Sample is at 50 mM phosphate pH6.5 with 100 mM NaCl, recorded at 
30 °K. 
Table 3.2. Simulation paramters of EPR spectrum of the final product of Cu-HPAz oxidation at 50 mM phosphate 
pH6.5 with 100 mM NaCl, recorded at 30 °K. 
Species % gx, gy, gz Ax, Ay, Az ( 10-4 cm-1) 
Final species (T2 like) 74 2.009, 2.079, 2.230 0.14, 11.46, 144.81 
T1 like 26 2.021, 2.069, 2.309 23.04, 25.23, 65.19 
We have been, thus far, unable to crystalize the Cu(I) or Cu(II) form of the HPAz. 
Consequently, extended X-Ray absorption fine structure (EXAFS) was employed to obtain 
structural information. The spectra of the Cu(I)-HPAz and Cu(II)-HPAz species show a clear 
difference in their edges when overlaid, with the reduced HPAz exhibiting a strong feature at 
8983.2 eV (Figure 3.26) that implicates Cu(I)-HPAz as a two-coordinate species, particularly 
when compared to the edge obtained for other biologically relevant sites, most notably that of the 
Cys to Ala mutant of Bacillus subtilis Sco.140  
2.8 2.4 2.0 1.6 1.2
g value
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Figure 3.26. EXAFS and XANES analyses of different HpAz variants. Fourier transform and EXAFS (inset) for (a) 
Cu(I)-HPAz at phosphate buffer pH 6.5, (b) Cu(I)-HPAz at phosphate buffer pH 8, and (c) Cu(II)-HPAz at 
phosphate buffer pH 6.5. Experimental data are shown as solid black lines and simulation are shown as solid red 
lines. Parameters used to fit data were shown in Table 1. (c) Normalized edge spectra for (a) (red line) and (c) (black 
line).  
The EXAFS spectrum of Cu(I)-HPAz (in Figure 3.26) was best simulated as one SCys at 2.17 
Å, and one multiple scattering NHis at 1.92 Å (Table 3.3). The short Cu(I)-SCys and Cu-N 
distances are typical of 2-coordinate Cu(I) species.140  In contrast, the EXAFS spectrum of 
Cu(II)-HPAz (Figure 3.26) required the addition of a second NHis at 1.98 Å, and the SCys–Cu 
bond was lengthened to 2.21 Å. This Cu(II)-SCys distance is significantly longer than that of 
Cu(II)-WTAz (2.17 Å), but similar to other thiolate-containing T2 Cu proteins such as 
nitrosocyanin141 and Met121Hcy azurin.125  
Table 3.3. EXAFS fitting parameters. 
Sample/fit F Cu—S Cu—N(His) Cu—S(Met) E0 
  N R(Å) DW(Å2) N R(Å2) DW(Å) N R(Å2) DW(Å)  
Cu(I)-WTAz 0.0003
9 
1 2.19 0.002 2 1.97 0.010 1 2.68 0.003 -0.231 
A	   B	   C	  
D	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Table 3.3 cont.            
Cu(I)-HPAz 0.0002
2 
1 2.17 0.004 1 1.92 0.010    -0.387 
Cu(II)-WTAz 0.0005
1 
1 2.17 0.003 2 1.93 0.008 1 2.70 0.006 -2.346 
Cu(II)-HPAz 0.0005
6 
1 2.23 0.010 2 1.98 0.005    -2.905 
Interestingly, we observed that the EXAFS of Cu(I)-HPAz in phosphate buffer at pH 8 
(Figure 3.26, Table 3.4) showed an increase in the His contribution to approximately 1.5. This 
change can be readily observed by comparing the intensity of the His peak in the Fourier 
transformed spectrum of Cu(I)-HPAz  with that of Cu(I)-HPAz at pH 6.5 (Table 3.4). These 
results suggest that stronger binding of His ligand to the Cu center at high pH, due to 
deprotonation of the His ligand.  
Table 3.4. EXAFS parameters of Cu(I)-HPAz in phosphate buffer pH 8: 
Sample/fit F Cu—S Cu—N(His) E0 
  N R(Å) DW(Å2) N R(Å2) DW(Å)  
Cu(I)-HPAz 0.23 1 2.17 0.003 1.3 1.93 0.003 -0.591 
Putting these spectroscopic results together, we propose a scheme in which Cu(I)-HPAz 
exists as a bi-dentate copper center, with His117 no longer interacting with the copper, as it is the 
most solvent accessible copper ligand (Scheme 3.1). This result may also explain why the Cu-
HPAz showed such a high E°ˊ, because HPAz enforces a coordination sphere that is preferred by 
Cu(I). Upon oxidation by Na2IrCl6, the colorless Cu(I)-HPAz was rapidly oxidized, within the 
first 7 msec, to a blue species that exhibited UV-vis (Figure 3.21) and EPR (Figure 3.24) spectra 
that were are typical of a T1 Cu(II) center. To complete the T1 Cu(II) coordination sphere,  the 
His117 rapidly bound to the Cu(II), as indicated by the combined stopped-flow, EPR and 
EXAFS data, however, because this Cu(II)-HPAz with E°ˊ of ~ 1V is so oxidizing, it became 
unstable under physiological conditions and changed its coordination sphere into a more stable 
green species whose UV-vis (Figure 3.22) and EPR (Figure 3.26) are typical of a T2 Cu(II) 
center.  
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Scheme 3.1. Proposed mechanism for the oxidation of Cu(I)-HPAz with IrCl6. 
Although the CV results are obtained at pH 5.0, whereas other characterization are performed 
at pH 6.5, the similarity between intermediates observed upon reaction of Cu(I)-HPAz with 
Na2IrCl6 at pH 6.5 (Figure 3.21) and 5.0 (Figure 3.19) suggests that the scheme proposed applies 
to pH 5.0 as well.  
3.3.5. Ni substitution in azurin variants and characterization of them 
After tuning the T1Cu center in Az to reach the highest possible E°ˊ under physiological 
conditions (~ 1V), we explored the next challenge, which is to design azurin to reach the lowest 
E°ˊ under physiological conditions (~ -1V). To achieve this goal, we replaced the Cu ion in 
azurin with other physiologically available metal ions. Azurin, like other cupredoxins, has been 
shown to be amenable to metal substitutions with minimal perturbation of either the overall 
structure or the metal-binding site.27,142 Among the transition metals previously used, the T1Cu in 
WTAz has been replaced with Ni(II);116,117,143 the Ni(II)/Ni(I) redox pair has been shown to have 
much lower potential than the Cu(II)/Cu(I) pair within the same ligand set.144 Therefore, we 
added Ni(II) to apo-HPAz. Successful incorporation of Ni(II) into HPAz was first confirmed by 
UV-vis, and was similar in features to those of Ni(II)-WTAz143 (Figure 3.27).  
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Figure 3.27. Representative UV-vis spectra of Ni-HPAz and Ni-M121E 
The CV of this protein indicated an E°ˊ of 50 mV in pH 8.0 phosphate buffer (see Figure 
3.28), which is ~ 900 mV lower than that of Cu(II)/Cu(I)-HPAz.  Encouraged by the result, we 
added Ni(II) to an apo-azurin variant (Met121Glu-Az) whose Cu(II)/Cu(I) redox couple is at a 
low E°ˊ (184 mV at pH 8.0).108 The E°ˊ of Ni(II)-M121EAz was observed to be -945 mV in pH 
8.0 phosphate buffer, which is close to the lowest E°ˊ possible under physiological conditions.  
 
Figure3.28. Representative cyclic voltammagram Ni-Az variants. (a) Ni-Met121Glu and (b) Ni-WTAz, obtained at 
100 mM phosphate buffer at pH 8.0 with 100 mM NaCl, at scan rate of 0.1 V/s. The red trace is after subtracting the 
capacitative current. As shown in the figure only a reductive peak is observable. The peak shown with * in 
Met121Glu spectra is observed in the blank as well. The values for Ni-loaded Az variants are based on the reductive 
peak position, as the Ni+ state is not stable. 
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Interestingly, replacing Cu ion with Ni ion in multiple variants of Az nearly always resulted 
in the lowering of E°ˊ by ~1000 mV, making the E°ˊ additive and predictable. In agreement with 
this trend, the E°ˊ of Ni-HPAz, measured at 50 mV, is similarly 900 mV below that of Cu-
HPAz, providing additional support for the high E°ˊ of Cu-HPAz.  
To confirm that the Ni(II)-Az variants indeed are going through the Ni(II)/Ni(I) transition, I 
radiated an EPR sample of Ni(II)-Met121Glu under liquid nitrogen temperature. The irradiation 
of the 20% glycerol in the sample by gamma-rays generated free electrons which then reduced 
the Ni(II)-Met121Glu. I hoped that since the sample is frozen, the Ni(I)-Met121Glu can be 
captured and as shown in figure 3.29, that is exactly what happened. The huge signal at g ~ 2 is 
due to free electrons. 
 
 
Figure 3.29. EPR of Ni-M121E after cryoreduction shows features of Ni(I). (power 20db, modulation 4, 15 K) 
3.4. Summary and conclusion 
In summary, by mutating only five residues in the secondary coordination sphere of the 
mononuclear T1 Cu center in Az and using two metal ions (Cu and Ni), we have achieved fine-
tuning of a single protein, Az, whose potentials can expand the entire range of physiological E°ˊ, 
from ~ +970 ±20 mV to ~ -954 ±50 mV. Before this work, the highest observed E°ˊ for a natural 
mononuclear metalloprotein is that of the T1 Cu center in rusticyanin (670 mV at pH7),145,146 
while the highest observed E°ˊ for a multi-nuclear metalloprotein is that of the T1 Cu center next 
to the tri-nuclear Cu cluster in laccase (E°ˊ = 790 mV at pH6).126,147 The positive charge from the 
other Cu ions in the multi-copper cluster is known to play a role in raising the E°ˊ of the T1 Cu 
2.8 2.7 2.6 2.5 2.4 2.3 2.2 2.1
g value
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center in laccase over that of mononuclear cupredoxins such as rusticyanin.127 The E°ˊ of 970 
mV represents the highest E°ˊ observed under physiological conditions, and approaches the 
theoretical limit of 1V, before water itself is oxidized. We achieved this goal by tuning hydrogen 
bonding networks near the Cu center (Asn47Ser and Phe114Asn), adding a hydrophobic residue 
in the axial position to the Cu center (Met121Leu) and desolvating the Cu center by adding Phe 
residues to surround it (Met44Phe and Gly116Phe). This result is remarkable, particularly when 
we consider that it has been accomplished on a mononuclear site without the aid of other 
positively charged metal ions nearby, as observed in the trinuclear copper center in laccase; such 
an E°ˊ exceeds the highest E°’ of a natural mononuclear cupredoxin (rusticyanin) by ~ 300 mV. 
The spectroscopic studies indicate that the Cu(II)-HPAz displays an unusual geometric 
parameter from those of Az derivatives that has lower or more normal E°ˊ. This is not 
unexpected for protein with such a high E°ˊ that is close to the physiological E°ˊlimit at which 
H2O can be oxidized. To capture and study metal complexes with very high or low E°ˊ, very low 
temperature and non-aqueous solution were often employed to stabilize the unusual states. It is 
remarkable that such an unusually high E°ˊ can be captured in a protein at room temperature and 
under physiological condition. Furthermore, by replacing the Cu ion in the above azurin mutants 
with Ni ion, we can tune the E°ˊ to as low as -954 mV at pH 8.0, and anywhere in between the 
two extreme E°ˊs, by different combinations of these mutations and the metal ions. 
In order to cover the entire range of physiological E°ˊ, nature must use at least three different 
classes of proteins and metal ions (Figure 3.12). The ability to cover the entire physiological 
range of E°ˊ, and even surpasses the observed E°ˊ range for all ET proteins combined, using two 
metal ions and mutating only five residues in a single protein scaffold (Figure 3.12) is a 
testimony of how much we now understand the structural features responsible for tuning E°ˊ of 
metalloproteins. Given the wide range of potentials attainable from a single protein possessing 
the same overall fold and surface properties, the azurin variants reported in this study may 
enable scientists and engineers to take advantage of these water-soluble redox agents for 
biochemical and biotechnological applications such as solar energy transfer and other alternative 
energy conversions. Since tuning the potentials of many inorganic, bioinorganic and 
organometallic catalysts can result in catalysts with different oxidation states with dramatically 
different catalytic efficiency for different substrates,148 the knowledge gained from this study 
may also allow others to use the same principle to tune redox properties of numerous catalysts 
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for even wider applications, such as small molecule activation and synthesis of important 
intermediates or products for pharmaceutical applications. 
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CHAPTER 4 
 
ROLE OF RESIDUE 114 IN TUNING REDUCTION POTENTIAL OF AZURIN 
* Portions of this chapter are going to be in a manuscript to be submitted as “The effect of hydrogen-bonding residues at position 
114 on the redox properties of cupredoxins azurin” (Marshall N.M.*, Hosseinadeh P.*, Petrik I.D., Robinson H., Gao Y-G., 
Nilges M.J., Lu Y.). Marshall N.M. performed EPR and UV-vis and designed the mutants. Petrik I.D. helped in confirming 
refinements. 
* Portions of the introduction are from a review submitted to Biophys. Biochim. Acta as “Designed and fine-tuning redox 
potentials of metalloproteins involved in electron transfer in biology” (Hosseinzadeh P., Lu Y.) 
 
4.1. Introduction 
A significant portion of biological processes are involved with providing vital energy sources 
such as ATP, and controlling the flow of energy through living systems. These bioenergetics 
processes, the most important of which are photosynthesis and respiration, require electron 
transfer (ET) between different redox partners.  Metalloproteins are one of the most widely used 
ET centers in biology. They can be classified into three major classes: cupredoxins, which 
include type 1 copper (T1Cu) proteins and CuA centers,1-10 cytochromes,10-17 and iron-sulfur (FeS) 
proteins.10,18-24 Each class of ET proteins transfer electrons between different redox partners which 
possess different reduction potentials (E°) (Figure 4.1). Therefore, the ET centers need to adjust 
their E° in a way that matches those of their redox partners. Cupredoxins usually function at the 
high end of the E°, while FeS proteins are mostly involved in ET reactions possessing relatively 
low E°.10 The E°’s of FeS proteins overlap significantly with those of cytochromes that often 
have intermediate E° among the three classes of ET proteins. How reduction potential is tuned in 
a wide range within each class of proteins despite sharing similar metal geometries and protein 
scaffolds is a question that remained to be fully understood 
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Figure 4.1. Reduction potential range of metal centers in electron transfer metalloprotein. Adapted from ref. 10 
 
Although metal ions and their primary ligands are the main contributors to the E°, these 
factors are highly evolved and optimized in natural ET proteins to ensure the lowest 
reorganization energy required for the rapid transfer of electrons. Such factors usually remain 
unchanged in different classes of ET proteins to avoid the need to re-optimize the sites, so 
accordingly most changes are exerted through SCS modifications. In this section, we will go 
through the ways by which nature tunes the ET proteins without changing the primary ligands.  
4.1.1. Role of axial interactions 
Axial interactions can have a great effect on the E° of the metal center. They are among the 
strongest SCS interactions and are usually closer to the metal center than the rest. Their effects 
can usually be directly transferred to the metal site. Several homology studies between proteins 
with the same metal center have sparked interest in investigating the role of the axial residue, 
showing a correlation between the nature of this ligand and the redox potential of the metal 
center. These observations further encouraged researchers to replace axial residues in several 
metalloproteins with other natural and unnatural amino acids. 
Hydrophobicity of the axial residue has been shown to modify the metal center potential in 
different proteins. The more hydrophobic it is, the higher the E° of the site (Figure 4.2). 
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Cupredoxins are the best demonstration of such an effect. While a Met is present in the majority 
of cupredoxins, there is a Gln in stellacyanin, which has a very low E° (190 mV).10 A Leu or Phe 
is found in laccase and ceruloplasmin, cupredoxins that are known to be in the  higher extremes 
of the reduction potentials (790 mV for laccase).10 Replacement of the axial residue in several 
cupredoxins has confirmed that the hydrophobicity of this residue is directly related to E° 
values.25-27  
 
   
Figure 4.2. Role of hydrophobicity of the axial ligand in redox potential of cupredoxins. Moving from more 
hydrophobic to more hydrophilic (a to c), the redox potential will decrease 4,26,28. Cu ion is shown as a purple ball, 
the primary ligands are shown in cyan and the axial ligand is shown in black stick and balls.  
The presence of a carbonyl oxygen in azurin in a distal site of Cu is proposed to lower the 
redox potential of the site by stabilizing the Cu(II) form through increased electron density at the 
site.7,29  
4.1.2. Role of hydrogen bonding interactions 
Despite the important role of the axial residue, it is not the sole contributor to E° fine-tuning 
as evidenced by cytochromes with similar primary and axial ligands, yet display a variety of E° 
values. There are known cases of cupredoxins with the same Met axial residues yet significantly 
different potentials, and FeS proteins with a range of E° values despite sharing similar Cys and 
inorganic S ligands.10 In both these cases a prominent factor in tuning the E° is the hydrogen-
bonding (H-bonding) network around the metal center. H-bonding interactions can lock the 
ligands in the proper position required for the redox activity, however, this is not the only role 
they play. H-bonding to primary ligands can alter their chemical properties resulting in altered  
reduction potentials.  
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H-bonding to the Cys ligand of cupredoxin is shown to decrease the electron-donating 
features of this residue. Removal of just one of these H-bond interactions from the backbone 
amide of Phe114 residue through a Phe114Pro mutation in azurin resulted in a decrease of 100 
mV in the E°.30,31 Asn to Ser mutation removes a H-bond between loops and has been shown to 
cause a 131 mV increase in E° in azurin,32 while changing Ser to Asn in rusticyanin decreases E° 
by 77 mV.33 Decreasing the electron density on the Cu site by adding an H-bond to distal 
carbonyl of Gly45 through Phe114Asn mutation resulted in an increase in E° of azurin.34 
Another example can be found in the case of peroxidases. Heme b is found both in 
peroxidases and Mb, and both proteins have a His residue as their proximal ligand. However, 
peroxidases have significantly lower E°, as is required for their activity. This lowering of E° is 
mainly attributed to the presence of an Asp residue that H-bonds to a metal coordinated His 
ligand (Figure 4.3). This strong H-bond can partially deprotonate His, giving more imidazolate 
character to it.35,36 Electrostatic stabilization of the positive charges in Fe(III) will lower the 
E°.37,38 Removal of this bond will increase the reduction potential, drastically decreasing 
peroxidase activity. The presence of such H-bonds are indeed important, but they also require 
proper orientation to fully convey their role. Interestingly, strengthening the H-bond to the 
proximal His ligand of cytochrome c resulted in a 100 mV decrease in redox potential.39 
Disruption of H-bonds from Tyr to the Met axial ligand in yeast iso-1 cytochrome c resulted in a 
decrease of up to 56 mV in E°. This change in the E° was attributed to the increase in electron 
density on Met, stabilizing Fe(III) state.40,41 
 
Figure 4.3. Comparison of the heme binding pocket of Mb and CcP.  CcP has an Asp ligand that H-bonds to its 
proximal His and lowers the redox potential (potentials from Ref.  42 and 43, respectively) 
Mb	  (E° = 50 mV) 
PDB ID: 1MBN	  
CcP	  (E° = -190 mV) 
PDB ID: 2CYP	  
2.93	  Å	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H-bonding from backbone amides of SCS residues to FeS cluster ligands are shown to be an 
important feature in determining E° of FeS proteins.44,45 More NHamide…S H-bonds increase the 
E° by decreasing electron density on the sulfur ligand, thereby selectively stabilizing the reduced 
state. While ferredoxins have 11 conserved H-bonds, only 8 are observed in HiPIP proteins. This 
difference results in two distinct oxidation states of the cluster ([4Fe-4S]1+/2+ for ferredoxins and 
[4Fe-4S]2+/3+ for HiPIPs).44,46-49 Altering these H-bonds by replacing them with Pro residues 
resulted in a decrease in E°.50,51 In Rieske proteins, several H-bonding interactions to Cys ligands 
are present from either main chain nitrogens or conserved residues such as Tyr or Ser. 
Mutagenesis studies have shown the importance of these H-bonds in maintaining high to Cys 
ligands of the Rieske center.50,52. Interestingly, Rieske-type proteins have significantly lower E° 
values (between -150 to -100 mV)50,51,53 than Rieske proteins (-100 to +490 mV)50 despite their 
similarities in their primary ligands (Figure 4.4). This lower E° is partially attributed to lack of 
the H-bonds from conserved Tyr and Ser residues to the Cys ligands of FeS cluster.52 
 
 
Figure 4.4. Comparison of H-bonding network between a Rieske-type protein (naphthalene dioxygenase-NDO) and 
a Rieske protein (water soluble fragment of complex bc1- ISF). The figure is reprinted with permission from Ref. 50. 
 
4.1.3. Role of hydrophobicity and solvent exposure 
In general, placing the metal center in a more hydrophobic environment and less exposure to 
water will result in an increase in E° due to greater destabilization of higher oxidation states 
compared with lower ones. The Cu sites in laccase and ceruloplasmin are surrounded by 
hydrophobic residues.28 Placing Phe at several positions in SCS of Cu site in Az resulted in an 
overall increase in redox potential.54 Increased hydrophobicity around the heme pocket is also 
shown to increase the redox potential in various heme proteins.55-58 The most significant example 
of such hydrophobicity effect is seen in the case of HiPIPs and [4Fe-4S] ferredoxins. While the 
NDO	  (E° = ~-100 mV) 
PDB ID: 2NDO	  
ISF	  (E° = ~300 mV) 
PDB ID: 1REI	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cluster is very similar between the two, the cluster’s buried location resulted in a much higher E° 
in HiPIPs47,59,60 (Figures 4.5). Furthermore, the covalency of Fe-S bond can be altered by 
hydration, hence influencing the redox potential.61  
 
 
 
Figure 4.5. The [4Fe-4S] cluster is more buried in HiPIPS (PDB ID: 1HRR ) vs. ferredoxins (PDB ID: 1DFD). One 
of the ligands in ferredoxin is completely exposed to water. 
4.1.4. Role of the net charge of the protein 
While controversial in some cases, a net charge in the SCS of a metal center can influence 
the E°. Presence of a negative charge, or even a negative dipole, can stabilize higher oxidation 
states and decrease the E°. Precise positioning of Gln and the interaction of its dipole with heme 
in cytochromes c6 and c6a has been shown to raise the potential by 100 mV.62 Mutation of Tyr to 
HiPIP	  [4Fe-­‐4S]	  
PDB	  ID:	  1HRR	  
Ferredoxin	  [4Fe-­‐4S]	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a Lys in cytochrome c resulted in 117 mV increase in the reduction potential, due to 
neutralization of negative charges in propionates by the positively charges Lys, resulting in less 
negative heme ring and hence destabilizing higher oxidation state of Fe.63 Placement of polar or 
negative residues close to heme in Mb reduced the reduction potential by up to 200 mV.64 
Replacement of Leu by Glu in a de novo designed heme protein lowers the E° by 40 mV while 
introducing a Gln increased it from -156 to -104 mV.57 Positive charges, on the other hand, will 
increase the E° by destabilizing these higher oxidation states. The presence of net positive amide 
dipoles is suggested to account for the differences between redox potentials of HiPIPs and 
ferredoxins.59,65,66 
4.1.5. Role of the aromatic interactions and pi stacking 
Although to a much lesser extent, aromatic interactions and π-stacking are known to 
influence the redox potential of certain metal centers. The majority of observed effects resulting 
from mutagenesis of aromatic residues are on the stability, rather than directly on the E° of the 
site.67-70 However, there are cases in which an aromatic residue is shown to play a role in 
determining the E° of a metalloprotein, mostly through π–interactions. Effects due to increased 
hydrophobicity or H-bonding have been already discussed. Aromatic π-interactions between Tyr 
and proximal His in tetraheme cytochrome c3 results in a 34-45 mV decrease in E°.71 An 
aromatic residue is present in cyt b6f that is in contact with heme f at position four. In algea 
cytochromes, there is a Trp present in this position, while a Phe in seen in cyanobacteria. 
Swapping these residues can result in a 70mV difference between the E° of the two proteins.72 
Another example is the Phe in cytochrome c3 that is shown to be in contact with heme I, and is 
suggested to lower its E° through π-π interactions with porphyrin π system.73 
4.1.6. Other factors in the secondary coordination sphere 
The overall composition of SCS ligands and the length of the loop between ligands have also 
been shown to be important in determining the E° of the metalloprotein. An interesting example 
of such effects is seen in a series of loop-directed mutagenesis studies performed on blue copper 
proteins, in which the ligand loop of different cupredoxins were swapped with one another.74-77 
The E° of the chimeric proteins were in between those of the loop donor and acceptor. A loop 
from a lower E° protein would decrease the E° of the acceptor and vice versa.75-78 
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4.1.7. Blue copper protein azurin as a platform for tuning reduction potential 
Azurin (Az) from Pseudomonas aeruginosa is one of the most well studied blue copper 
proteins. Several studies have been performed in order to understand the underlying role of 
different residues in determining the redox potential of Az and the ET rates in this protein.79-91 
Table 4.1 provides one of the studies in which E° of several Az variants were investigated under 
different pH conditions.26 As shown in the table, replacement of the axial Met with hydrophobic 
ligands resulted in an increase in E° while addition of polar or charged ligands decreased it. 
Table 4.1. Reduction potential of different Az variants. Reprinted from ref. 26. Copyright © 2005, John Wiley and 
Sons under license number 3636610216032. 
Protein pH 
4 5 6 7 8 
Wild-type  346 333 310 293 
His35Lys  344 337 317 296 
Met44Phe 434 428 412 384 373 
Gly45Ala  333 314 300 292 
Asn47Asp    333  
Trp48Leu  352 345 323 306 
Trp48Met  352 340 312 299 
Lys85Glu  340 335 321 299 
Ser89Gly 354 339 312 294 288 
Glu91Gln  352 340 314 298 
Phe114Ala  377 372 358 343 
Phe114Val  346 340 324 314 
Met121Ala    373  
Met121Asn    348  
Met121Asp   333 319 287 
Met121Glu     184 
Met121End    205  
Met121His    310  
Met121Ile    448  
Met121Leu   433 412 392 
Met121Leu+Asn47Leu    510  
Met121Lys    318  
Met121Val    445  
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In order to understand the role of different factors in SCS of T1Cu sites and their interplay in 
determining the E°, Marshall et al. used Az to incorporate several mutations in the SCS. As a 
result several variants were obtained that could span a range of ~700 mV in redox potential, 
never before reported in the cupredoxin superfamily (Figure 4.6).34 With only 3 mutations 
(Asn47Ser/Phe114Ans/Met121Leu) it was deomonstrated that the E° can increase beyond any 
reported E° values of mononuclear T1Cu sites. The mutant with the lowest E°, 
Phe114Pro/Met121Gln, had a redox potential very close to 0 at pH=9, never reported before in 
any natural cupredoxins or their variants.34 The authors further demonstrated that the effects of 
these specific mutations are additive in nature.34 Replacement of the Met axial ligand with a 
more hydrophobic residue is accompanied with an increase in E°, while placing a more polar 
Gln residue at the same position decreased the redox potential, as explained in section 5.1. An 
Asn47Ser mutation also resulted in an increase in the reduction potential due to strengthening 
the H-bonds to a Cys ligand and rigidifying the site. The role of Phe114 is more complicated. 
Mutation of this residue to a Pro slightly disrupted the site, removing a H-bond to the Cys 
ligand, and hence decreased the E°. Mutation of Phe114 to Asn introduced an H-bond to 
backbone carbonyl of Gly45, and increased E°.34 
 
Figure 4.6. SCS mutants of azurin span a range of reduction potential never reported before. The effect of these 
mutations is additive. Adapted from 34 
A more in depth study on some of these mutants, Phe114Pro, Phe114Asn, and Asn47Ser, 
was performed to understand the underlying reason for their observed effects on E°.92 Based on 
the experimental data that was obtained, Hadt et al. performed density functional theory (DFT) 
calculations on the mutants, and showed that the effects could be divided into covalent and 
nonlocal electrostatic contributions (Figure 4.7a).92 The covalent component arises from the 
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changes in metal-ligand covalency, which can in turn influence the molecular orbitals. This 
component can be measured using S K-edge x-ray absorption spectroscopy studies. Active H-
bonds (Figure 4.7b) within 5 Å of the metal site and carbonyl dipoles with a specific orientation 
towards the site, are the main SCS contributors to the covalent component. Nonlocal 
electrostatic interactions are another contributor to the changes observed in redox potential 
through affecting the enthalpy of the reaction. The effect of active H-bonds is additive. On the 
other hand, the effect of dipoles can be additive or oppose on other. The combination of these 
effects contribute to the fine-tuning of E° in azurin.92  
 
Figure 4.7. (a) Contribution of different factors in determining the E° in azurin mutants. (b) Active vs. passive H-
bond. Reprinted with permission from 92. Copyright © 2012, American Chemical Society. 
4.1.8. Goals of the study: 
Previously, we reported that the redox potential of Az could be altered over the entirety of 
this range by altering intraprotein hydrogen bonding and hydrophobic interactions near the 
copper binding site. Along the path towards finding which interactions could be changed to give 
the desired effects to the redox potential, we noticed several interesting interactions, or trends 
that always resulted in a change in redox potential. Chief among these is the effect of adding 
hydrogen bonding groups at position 114 in Az. 
Phe114 in Az is directly adjacent to the copper binding site and across from the backbone 
carbonyl oxygen of Gly45 that has been proposed to have a strong ionic interaction with the 
copper in Az. Position 114 was initially investigated for its effects on redox potential because 
the similarly positioned amino acid in another cupredoxin, rusticyanin, was known to be crucial 
for maintaining the high reduction potential (Em) of that copper site. Furthermore, it was known 
that one of the copper sites in the protein ceruloplasmin that has an estimated Em of higher than 1 
a	   b	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V naturally has an Asn residue at this position. This Asn in ceruloplasmin hydrogen bonds to the 
aforementioned carbonyl oxygen in that protein, forming a hydrogen bonding bridge between 
the copper ligand containing loops of ceruloplasmin.  
Initial computer aided modeling of potential hydrogen bonding residues at position 114 
showed that residues the size of Gln or Glu were too long to remain close to the copper binding 
site. We therefore were limited to shorter hydrogen bonding residues like Asn, Asp and Ser. 
Here we report the redox potentials of Phe114Asn, Phe114Asp and Phe114Ser Az, the spectral 
characteristics of each variant and the crystal structures of each. The changes in redox potential 
of Phe114Xxx Az variants are correlated to subtle but significant structural changes near the 
copper binding site.  
4.2. Materials and methods 
4.2.1. Protein expression and purification 
The proteins were expressed using our previously reported method of azurin purification. In 
brief, the BL21 (DE3) cells that were transformed by the plasmids were grown in 5ml LB media 
for 8 hours at 37 C. 1ml of the starter culture will then be used to inoculate 2L of 2xYT media. 
The proteins are then extracted from the periplasm using osmotic shock procedure. 
Reconstitution of the apo proteins with copper, the variants were purified using a 5 mL HiTrap 
HP Q-sepharose column (GE Healthcare, Piscataway, NJ, USA) equilibrated in 50 mM 
ammonium acetate buffer at pH 6.0 on an AKTA basic FPLC system (GE Healthcare, 
Piscataway, NJ, USA). The electrospray mass spectrometry (ESI-MS) confirms that the 
molecular weights of the variants match those predicted from calculations, within the 
experimental errors (Phe114Asn: calculated 13192.72; Phe114Asp: calculated 13913.72; and 
Phe114Ser Az: calculated 13885.71.  
4.2.2. Spectroscopic characterization of Az variants  
UV-visible spectra of Az and its variants were collected on a Varian Cary 5000 UV-visible 
spectrometer in TIP7 buffer.93 Electron paramagnetic resonance spectra were collected on Varian 
E-line 12” Century Series X-Band CW spectrometer at 30 °K in the same buffer. The parameters 
for each EPR spectrum were determined by simulation with the Simpower 6 program.94,95 
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Extinction coefficients were determined by spin counting using EPR spectroscopy, in which 
several CuSO4 standards in the concentration range from 0.125 mM to 2.0 mM were prepared in 
deionized water. The EPR spectra of the samples were then collected and the total area of the 
integrated EPR absorption spectra were plotted vs. [Cu2+] to build a standard curve. The protein 
samples were then exchanged into the TIP7 buffer and concentrated to ~0.5 mM. The UV-vis 
spectra were obtained and then EPR of the same samples were collected. The total area of EPR 
signal in the protein samples was then used to determine the [Cu2+] in each sample, which was, 
in turn, used to calculate the extinction coefficient of the LMCT band of the protein via Beer’s 
Law.  
4.2.3. Cyclic voltammetry  
Redox potential values of Az variants were measured via cyclic voltammetry (CV) as thin 
films on pyrolytic graphite edge (PGE) electrodes, assembled according to previous procedures,96 
with a platinum wire as an auxiliary electrode and a Ag/AgCl electrode as a reference electrode. 
Protein solution (typically 5 µL of 2 mM) was applied to the graphite and allowed to incubate at 
4°C for 10 minutes. The working electrode, auxiliary wire and reference electrode were then 
immersed in a mixed buffer solution consisting of 50 mM ammonium acetate, 40 mM MOPS, 40 
mM MES, 40 mM Tris, 40 mM CAPS and 100 mM NaCl at either pH 4.0 or 7.0. The potential 
range was then scanned at a rate of 0.2 V/s, typically with a total of 6 scans (3 in each direction). 
No dependence of the Em upon the scan rate was observed in the range from 0.01 to 1 V/s, as is 
typical for Az and most Az variants.97 Redox potential values were calculated by averaging the 
positions of the oxidation and reduction waves. Peak separations were typically less than 0.1 V 
indicating the reversibility of the redox cycle for each variant. The values obtained were then 
corrected to be reported vs. the standard hydrogen electrode (SHE) by adding 210 mV to the 
observed Em. The correction factor was determined by testing the redox potential of ferrocene 
with the reference electrode used. 
4.2.4. Protein crystallization and diffraction  
The holo, copper bound version of Phe114Ser was crystallized by hanging drop vapor 
diffusion from a mixture of protein (6 mM) in pH 6.0 ammonium acetate mixed 1:1 with a 
solution of 50 mM ammonium acetate buffer, 260 mM CaCl2, 280 mM LiNO3 and 30 % w/w 
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polyethylene glycol (PEG) M.W. = 8000 Da. Crystals typically formed after about 1 month time 
at 4°C and the highest quality crystals formed after as much as 6 months.  
The holo, copper bound form of Phe114Asp was crystallized using hanging drop vapor 
diffusion method from a 1:1 mixture of 1mM protein in pH 6.0 ammonium acetate with a 
solution of 100 mM Tris buffer at pH 8.0, 100 mM LiNO3, 10 mM CuSO4 and 25% w/w PEG 
M.W. =10000 Da. Rectangular-shape crystals were formed in about a mount of incubating the 
drop against the described solution at 4°C and were mounted after 2 months incubation using 
100 mM Tris buffer at pH 8.0, 100 mM LiNO3, 10 mM CuSO4 and 50% PEG M.W.=400 Da as 
cryoprotectant.  
The holo, copper bound form of Phe114Asn was crystallized using hanging drop vapor 
diffusion method from a 1:1 mixture of 2mM protein in pH 6.0 ammonium acetate with a 
solution of 100 mM Tris buffer at pH 8.0, 100 mM LiNO3, and 30% w/w PEG M.W. =10000 
Da. Rectangular-shape crystals were formed in about a mount of incubating the drop against the 
described solution at 4°C and were mounted after 2 months incubation using 100 mM Tris buffer 
at pH 8.0, 100 mM LiNO3, and 50% PEG M.W.=400 Da as cryoprotectant.  
Diffraction patterns were collected at Brookhaven National Laboratory (Upton, NY, USA). 
The data for Phe114Asn and Phe114Asp was refined and solved using PHENIX program version 
1.8.4. 
4.3. Results and discussion  
4.3.1. Electronic Absorption (UV-vis) and Electron Paramagnetic Resonance (EPR) 
Spectroscopic studies    
As shown in Figure 4.8A, all three Az variants display a strong absorption band around 625 
nm (Table 4.2), similar to that in WT Az. This absorption band has been assigned to Cys sulfur 
to Cu(II) charge transfer, typical of the cupredoxin family. Similarly, the three Az variants also 
show axial EPR spectra with narrow hyperfine coupling constants, again very similar to that of 
WT Az and typical of other T1 Cu proteins.  The only significant change to the EPR signals is 
that Phe114Ser has a slightly smaller gz value as compared to the other variants (table 4.2), 
which may indicate some slight effect to the Cu-S interaction.  The similarity in UV-vis and 
EPR characteristics of the investigated Az variants indicates minimal perturbation of the copper 
binding site from the mutations.87,89,98-100 
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Figure 4.8. A) UV-visible spectra and B) EPR for (−) F114D Az, (−) F114N Az, (−) F114S Az, and (−) WT Az. 
In all cases, when a hydrogen bond donor was added to Az at position 114, very little change 
to the UV-vis and EPR parameters were seen. Even when added to other mutations, these 
hydrogen bond altering mutations generally had little effect on these spectroscopic signatures. 
This retention of the spectroscopic signatures suggests that Phe114Asn, Phe114Asp and 
Phe114Ser alone have only subtle effects on the geometry of the copper binding site,87,89,98-100 at 
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least as far as can be observed with UV-vis and EPR. The exception to this is the 
Asn47Ser/Phe114Asp/Met121Leu variant, which was observed to be green in color, as opposed 
to blue. Combining Phe114Asp with other mutations was clearly destabilize, which is not 
surprising as it introduces a negatively charged residue to a highly hydrophobic region of the 
protein. Significant decrease in bond length between Cu ligands and Cu is observed in 
Phe114Ser structure. 
Table 4.2. Spectroscopic parameters for Az variants from this study. 
Variant λmax (nm),  
ε (M-1cm-1) 
gx gy gz Ax (cm-1) Ay (cm-1) Az (cm-1) 
WT 625, 6487  2.028 2.055 2.262 9 9 50 
F114N 621, 5829 2.030 2.058 2.252 8 8 57 
F114D 622, 6150 2.027 2.054 2.264 9 9 47 
F114S 621, 5900 2.028 2.052 2.245 8 8 48 
 
4.3.2. Reduction potentials of Az variants   
While the spectroscopic properties of each Az variant studied here vary little from protein to 
protein, the Em values were observed to vary by a wide range. Table 4.3 gives the observed Em 
values for each Az variant in this study. The values obtained for WT Az at each pH are close to 
previously reported values, indicating that our method of measurement is consistent with 
previous studies. Figure 4.9 shows representative CV for all variants. Of the previously 
unreported residue 114 variants of Az, Phe114Asp has the identical effect to the Em as compared 
to Phe114Asn at pH 4.0. The inflation of the Em in Phe114Asp is, however, lessened slightly at 
pH 7.0. Phe114Ser also increases the Em of Az at each pH, although to a lesser degree than 
Phe114Asn or Phe114Asp.  
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Figure 4.9. CV of A) WT, B) Phe114Asn, C) Phe114Asp and D) Phe114Ser Az 
In previous publications, others and we have shown that the effect of individual mutations in 
Az can be additive in regards to Em.26,34,54 We had previously shown that Phe114Asn, Asn47Ser 
and Met121Leu can be combined to raise the Em of Az beyond the upper range of Em values 
known for mononuclear cupredoxins.34 We decided to investigate whether Phe114Ser and 
Phe114Asp mutations also show such additive effects when combined with Asn47Ser and 
Met121Leu. Table 2 gives a summary of the Em values of the individual mutations and shows 
the additive effect when mutations are combined. In the case of both Phe114Asp and Phe114Ser, 
a similar total increase in Em upon combination of mutations was seen. Both 
Asn47Ser/Phe114Asp/Met121Leu Az and Asn47Ser/Phe114Ser/Met121Leu Az also have 
similar, although slightly lower, Em values as compared to Asn47Ser/Phe114Asn/Met121Leu 
Az. As is denoted in the table, the Asn47Ser/Phe114Asp/Met121Leu variant was exceptionally 
unstable and exhibited multiple species in the potential range scanned. 
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Table 4.3. Observed Em values for different Az variants studied in this paper. 
Variant 
Redox Potential at 
pH 4.0 
(mV vs. SHE) 
Deviation 
from WT 
(mV) 
Redox Potential at 
pH 7.0 
(mV vs. SHE) 
Deviation 
from WT 
(mV) 
WT 359 ± 8 - 286 ± 8 - 
F114N 446 ± 7 +87 376 ± 4 +90 
F114D 446 ± 17 +87 364 ± 8 +78 
F114S 414 ± 7 +55 331 ± 3 +45 
N47S 462 ± 3 +103 385 ± 4 +99 
M121L 420 ± 12 +61 388 ± 5 +102 
N47S/F114N/M121L 707 ± 3 +348 641 ± 9 +355 
N47S/F114D/M121L* 668 ± 14 +309 - - 
N47S/F114S/M121L 665 ± 7 +306 608 ± 2 +322 
* This combination of mutations was seen to result is significant changes to the visible spectrum of the protein with strong 
absorbance around 400 nm indicating significant perturbation of the copper binding site. The visible spectrum was also seen to be 
pH dependent in both cases. 
4.3.3. Structural studies of the mutants 
Table 4.4 gives a list of relevant atom-to-atom distances seen in the crystal structure of 
Phe114Ser/Asn/Asp Az. For comparison, several distances from previously reported WT 
structure are also shown.  
Table 4.4. Selected crystallographically observed bond lengths and the change in the length from the WT protein. 
Variant	  (PDB	  Code	  if	  
deposited,	  resolution	  Å)	  
Atoms	  of	  
Interest	  
Molecule	  in	  the	  
Asymmetric	  
Unit	  
Distance	  (Å)	   Average	  
Distance	  (Å)	  
Deviation	  
from	  WT	  
Distance	  (Å)	  
WT	  (4AZU,30	  1.90)	   SCys112-­‐Cu	   A	   2.27	   2.24	   -­‐	  
B	   2.27	  
C	   2.24	  
D	   2.17	  
NδHis46-­‐Cu	   A	   1.99	   2.08	   -­‐	  
B	   2.06	  
C	   2.13	  
D	   2.12	  
NδHis117-­‐Cu	   A	   2.11	   2.01	   -­‐	  
B	   1.98	  
C	   1.96	  
D	   2.00	  
SMet121-­‐Cu	   A	   3.18	   3.15	   -­‐	  
B	   3.16	  
C	   3.21	  
D	   3.05	  
OGly45-­‐Cu	   A	   2.84	   2.97	   -­‐	  
B	   2.95	  
C	   3.05	  
D	   3.03	  
B	   3.60	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F114S	  (2.39)	   SCys112-­‐Cu	   A	   2.38	   2.39	   +0.15	  
B	   2.54	  
C	   2.33	  
D	   2.32	  
NδHis46-­‐Cu	   A	   2.09	   2.10	   +0.02	  
B	   2.08	  
C	   2.24	  
D	   2.01	  
NδHis117-­‐Cu	   A	   2.12	   2.36	   +0.35	  
B	   2.20	  
C	   2.63	  
D	   2.49	  
SMet121-­‐Cu	   A	   3.19	   2.87	   -­‐0.28	  
B	   2.84	  
C	   2.66	  
D	   2.80	  
OGly45-­‐Cu	   A	   2.86	   3.03	   +0.06	  
B	   2.75	  
C	   3.29	  
D	   3.20	  
OγSer114-­‐OGly45	   A	   2.50	   2.80	   -­‐	  
B	   2.72	  
C	   3.27	  
D	   2.72	  
F114N	  (1.95)	   SCys112-­‐Cu	   A	   2.19	   2.26	   +0.02	  
B	   2.29	  
C	   2.33	  
D	   2.23	  
	   NδHis46-­‐Cu	   A	   2.06	   2.05	   -­‐0.03	  
B	   2.02	  
C	   2.04	  
D	   2.09	  
NδHis117-­‐Cu	   A	   2.07	   2.10	   +0.09	  
B	   2.05	  
C	   2.16	  
D	   2.11	  
SMet121-­‐Cu	   A	   3.10	   3.07	   +0.02	  
B	   3.15	  
C	   2.86	  
D	   3.15	  
OGly45-­‐Cu	   A	   3.23	   3.21	   +0.24	  
B	   3.16	  
C	   3.28	  
D	   3.18	  
NδAsn114-­‐OGly45	   A	   2.70	   2.79	   -­‐	  
B	   2.78	  
C	   2.91	  
D	   2.77	  
F114D	  (2.20)	   SCys112-­‐Cu	   A	   2.26	   2.22	   -­‐0.02	  
B	   2.18	  
	   NδHis46-­‐Cu	   A	   2.10	   2.09	   +0.01	  
	   	   B	   2.09	   	   	  
	   NδHis117-­‐Cu	   A	   2.19	   2.15	   +0.14	  
	   	   B	   2.01	   	   	  
	   SMet121-­‐Cu	   A	   2.83	   2.93	   -­‐0.22	  
	   	   B	   3.04	   	   	  
	   OGly45-­‐Cu	   A	   2.96	   2.99	   +0.02	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Of the distances shown above, most are within the error of atom positions as determined by 
calculation of the average uncertainty in the position of atoms using the resolution of each 
structure, the refinement parameters and the empirical methods published by Freeman.101 
However, there are several significant changes in the structure of these variants. In the structure 
of Phe114Asn and Phe114Asp, the NδHis117-Cu distance is longer by 0.09 and 0.14 Å, 
respectively. Also in the structure of Phe114Asp, the SMet121-Cu distance was seen to be shorter 
than average by 0.22 Å. In the Phe114Ser and Phe114Asn structure, the average distance 
between hydrogen bond donors from Ser or Asn and the carbonyl OGly45 is 3.07 and 2.27 Å, 
respectively, which is sufficiently short to be considered a hydrogen bond. The same distance on 
Phe114Asp is longer, 3.36 Å, suggesting a weaker hydrogen bond if present. Also, a significant 
elongation of OGly45-Cu distance is observed in Phe114Asn. The overall structures and important 
distances are shown in figure 4.10. 
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B	  
	  
3.02	  
	   	  
	   OδAsp114-­‐OGly45	   A	   3.53	   3.36	   -­‐	  
	   	   B	   3.19	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Figure 4.10. Comparison of the crystal structures of A) WT Az and C) Phe114Ser Az showing the hydrogen bonds 
formed to Gly45 upon mutation. In all panels nitrogen atoms are shown in blue, sulfur atoms in yellow and copper 
is shown in green. To differentiate between structures, the backbone in Panel A is shown in blue with carbon atoms 
in cyan, while the backbone and carbon atoms are orange in panel B and green in panel C. Average atom-to-atom 
distances are shown as dashed lines with the average distance listed for each interaction. 
4.3.4. Structural effects of F114S 
Table 4.5 shows the crystallographic parameters for the Phe114Ser Az variant. The slight 
decrease in gz in Phe114Ser (table 4.2) can be explained by observed decrease in Cys-Cu 
distance in crystal structure (table 4.5). 
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Table 4.5. Crystallographic parameters for F114S-Az. 
Crystal	  Data	   F114S	  
Space	  Group	   P1211	  
Unit	  Cell	  
a	  (Å)	  
b	  (Å)	  
c	  (Å)	  
α  (o) 
β 	  (o)	  
γ  (o) 
	  
49.771	  
83.155	  
63.237	  
90.00	  
108.93	  
90.00	  
Data	  collection	  
statistics	  
	  
Wavelength	  (Å)	   1.1	  
Resolution	  (Å)	   2.39	  
Number	  of	  unique	  
reflections	  
19118	  
Completeness	  (%)	   98.52	  
Refinement	  
statistics	  
	  
Resolution	  (Å)	   10.0	  -­‐	  2.39	  
R-­‐all	  (%)	   30.26	  
R-­‐work	  (%)	   22.39	  
RMS	  Bond	  lengths	  
(Å)	  
0.009	  
RMS	  Bond	  angles	  
(°)	  
1.25	  
Metal	  Ion	   4	  
No.	  of	  water	  
molecules	  
82	  
 
The structure of Phe114Ser Az clearly shows that the desired hydrogen bond does form, 
which can be directly correlated to the increase in Em of this variant as well (Figure 4.10D and 
Table 2). However, the crystal structure also shows that the hydrogen bond between Ser114 and 
Gly45 is fluxional to some extent. In two of four molecules in the asymmetric unit, the oxygen-
oxygen distance is about 3 Å or less, which can be considered a strong hydrogen bond. In the 
other 2 molecules, this distance is between 3 Å and 3.5 Å, indicating a weaker interaction. Given 
the resolution of the structure, the average Cu-OGly45 distance for all the molecules in the 
asymmetric unit was effectively unchanged. The inherently weaker nature of the hydrogen bond 
between Ser and OGly45 can explain the fact that OGly45-Cu distance is almost unchanged in 
Phe114Ser structure while it significantly increases in Phe114Asn structure in which a strong 
hydrogen bond is formed between Nδ of Asn114 and OGly45. 
Similar to other variants discussed, elongation of NδHis117-Cu distance is also observed for 
Phe114Ser. Interestingly, Phe114Ser also shows a significant increase in SCys112-Cu distance in 
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the structure. Such movement of the Cu ligands away from the Cu site results in a more electron 
deficient site, destabilizing Cu(II) state and increasing the Em. 
In this same structure of Phe114Ser Az, it is also seen that the methyl group on the end of 
Met121 has significantly more conformational freedom. The increase conformational freedom of 
Met121 observed in the crystal structure was also apparent in the EXAFS data of F114N Az 
where a large DW factor was seen. This structural effect is likely also due to the destabilization 
of the loop containing Asn114 and His117, as Met121 is also a part of this loop. In these 
structures, the axial Met came closer to the Cu site. This lower distance can be justified by the 
movement of two of the Cu ligands away from the Cu site and the need to compensate for the 
charges to hold the Cu in place. This compensation of electron deficiency on the site by the Met 
residue in Phe114Ser variant can explain the lower increase in Em in this protein compared to 
Phe114Asp and Phe114Asn variants. 
4.3.5. Structural effects of F114N 
Table 4.6 shows the structural parameters for Phe114Asn mutant. Phe114Asn was designed 
to form a hydrogen bond directly to the backbone carbonyl of Gly45 in order to mimic the 
aforementioned hydrogen bonding interaction seen in ceruloplasmin. Analysis of the crystal 
structure shows that this hydrogen bond is indeed forming between the Nδ of Asn and the O of 
Gly45, with an average distance of 2.79 Å. Formation of this hydrogen bond resulted in a 
concomitant elongation of OGly45-Cu distance probably due to the carbonyl atom being pulled by 
Nδ of Asn114 (figure 4.10A,C). this in turn will remove the electron density donated to the Cu, 
hence increasing the redox potential (table 4.3). 
Table 4.6. Crystallographic parameters for F114N-Az. 
Crystal Data F114N 
Space Group P1211 
Unit Cell 
a (Å) 
b (Å) 
c (Å) 
α (o) 
β (o) 
γ (o) 
 
61.24 
49.29 
80.38 
90.00 
108.437 
90.00 
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Table 4.6 cont. 
 
Another observed effect is the elongation of NδHis117-Cu distance (figure 3A,C). This 
structural effect is likely also due to the destabilization of the loop containing Asn114 and 
His117. Weakening the NδHis-Cu bond in Az has been previously shown to result in a higher Em 
both experimentally and computationally.82,102-105 When His117 was mutated to a Gly residue, 
thereby completely removing the ligand all together, the Em of Az increased by 300 mV.102 Upon 
addition of exogenous imidazole, the Em returned to nearly the WT value.102 However, it is 
unclear if the dramatic changes seen in the previous study are due to the absence of the His 
ligand, or the possible binding of other exogenous ligands to the copper, such as water or 
chloride, when the His ligand is not present.  
As further proof of the importance of NδHis-Cu length in tuning the Em of cupredoxins, a 
recent computational study showed that the crystallographic NδHis-Cu length can be correlated to 
the electron affinity of the copper site in several cupredoxins when the rest of the ligand set is 
the same. This effect also correlates to the Em of the proteins, with higher Em cupredoxins 
exhibiting longer NδHis-Cu distances on average. Weakening the NδHis-Cu interaction in 
Data collection 
statistics 
Wavelength (Å) 1.1 
Resolution (Å) 1.95 
Number of 
unique 
reflections 
33388 
Completeness 
(%) 
99.53 
Refinement 
statistics 
 
Resolution (Å) 41.39-1.95 
R-all (%) 24.8 
R-work (%) 20.5 
RMS Bond 
lengths (Å) 
0.007 
RMS Bond 
angles (°) 
1.083 
Metal Ion 4 
No. of water 
molecules 
374 
	   107	  
cupredoxins removes the strong σ-donating His from the coordination sphere of the copper, 
resulting in a more electron deficient metal and, in turn, preferentially stabilizing the Cu(I) state. 
Thus, the significant lengthening of this bond seen in the Phe114Asn structure can explain the 
increase in Em. 
Another observed effect is a slight change in the orientation of His117 residue compared with 
that of WT and other variants studied (figure 3). Increased conformational freedom for His117, 
as the Phe114Asn mutation also removes steric bulk from the vicinity of His117 allows His117 
to twist towards residue 114, away from its position in WT Az (Figure 3A,C). Even if the 
distance between the Cu and the N of His117 is not lengthened, the rotation of the imidazole 
ring away from the position in WT will affect the orbital overlap between the Cu and His117 
and, thereby, the redox potential of the site. A similar structural effect was seen in the previously 
reported Phe114Ala variant, along with a concomitant increase in redox potential of the copper 
site.106 
4.3.6. Structural effects of F114D 
Table 4.7. shows structural parameters for Phe114Asp. While it was initially expected that 
Phe114Asp would lower the redox potential of Az due to stabilization of the Cu(II) state by 
adding a full negative charge in close proximity to the copper binding site,107 experimental results 
show that this mutation actually causes an identical increase in the Em as compared to 
Phe114Asn at pH 4.0. As these residues, Asn and Asp, are isostructural to one another, they will 
have similar capacities to hydrogen bond and presumably cause similar structural perturbations 
at pH 4.0.  
Table 4.7. Crystallographic parameters for F114D-Az. 
Crystal Data F114D 
Space Group P212121 
Unit Cell 
a (Å) 
b (Å) 
c (Å) 
α (o) 
β (o) 
γ (o) 
 
48.109 
56.606 
83.638 
90.00 
90.00 
90.00 
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At pH 7.0, Phe114Asp has less of an inflating effect, which is likely due to deprotonation of 
the side chain of the Asp residue. Upon deprotonation, the capacity of Asp to donate a hydrogen 
bond is lost, which suggests that the hydrogen bonding effects of the side chain are actually 
more important than both the loss of steric bulk at position 114 and the introduction of ionic 
interactions. This   
The structure of Phe114Asp, prepared at pH 8.0, shows the possibility of a weak hydrogen 
bond, if any, between Asp and OGly45 (figure 4.10B). This observation is consistent with the 
dampening of the increased in Em at pH 7.0 (table 4.2) due to the probable deprotonation of Asp. 
Interestingly, the crystal structure of Phe114Asp shows two deviations from the WT structure 
(figure 3A,B) that work in opposite directions, both resulted from the increased flexibility of the 
loop containing residues 114, 117 and 121, and removal of the steric hindrence from Phe114. On 
one hand significant elongation of the NδHis-Cu distance results in an increase in Em for reasons 
similar to those explained for Phe114Asn.  On the other hand, SMet-Cu distance in Phe114Asp is 
shorter than other Az variants. A stronger SMet-Cu interaction can decrease the Em.  
Data collection 
statistics 
Wavelength (Å) 1.1 
Resolution (Å) 2.39 
Number of 
unique 
reflections 
11973 
Completeness 
(%) 
99.35 
Refinement 
statistics 
 
Resolution (Å) 46.88-2.20 
R-all (%) 24.7 
R-work (%) 19.0 
RMS Bond 
lengths (Å) 
0.008 
RMS Bond 
angles (°) 
1.074 
Metal Ion 4 
No. of water 
molecules 
137 
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4.4. Summary and conclusion 
In general, addition of hydrogen bond donors at position 114 produced a large effect on Em 
(+50 to +100 mV at pH 4.0) with little apparent disruption to the copper binding site based on 
EPR and UV-vis. Although all the hydrogen bond donating residues introduced at this position 
were initially designed to hydrogen bond directly to the carbonyl oxygen of Gly45 to mimic a 
similar interaction found in ceruloplasmin, crystal structures of these variants show that the 
relative length of the residue at this position determines the exact molecular effect of the 
mutation. Structural analysis of variants that contain an Asn or Asp residue at position 114 
shows that this mutation destabilizes the loop of Az that contains both of the copper ligands 
His117 and Met121. This destabilization weakens the interactions between the copper and these 
ligands, which raises redox potential. Moreover, the strong hydrogen bond formed between Asn 
and OGly45 moves this carbonyl away from the Cu site. Due to the structural similarity between 
Asn and Asp, it is likely that the F114D mutation has a similar effect. The key to these mutations 
is that, while the ligand-metal interactions are weakened, the destabilization is not large enough 
to completely abolish ligand binding. In this way, the copper site maintains most of the features 
of WT Az, but exhibits a higher redox potential.   
A hydrogen bond to Gly45 via Phe114Asn or Phe114Ser mutation is observed. It is difficult 
to determine whether the effect of withdrawing electron density from the copper-oxygen 
interaction by forcing a hydrogen bond to form has the greatest effect on Em, or, if adding a 
hydrogen bond in this way, between the two ligand containing loops in Az, causes some other 
effect, such as rigidifying other hydrogen bonds to Cys11226,33,108-111 or having a similar 
destabilizing effect as the Phe114Asn mutation. It is, however, exceptionally clear that the 
identity of the amino acid at position 114 in Az has a strong influence on the redox tuning of Az 
and that adding hydrogen bond donors at this position can be used to raise the Em, although 
through different mechanisms. 
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CHAPTER 5 
 
INVESTIGATING MARCUS INVERTED REGION IN A NON-DERIVATIZED 
PROTEIN SYSTEM USING A SERIES OF AZURIN VARIANTS 
* Portions of this chapter are from the manuscript published in J. Phys. Chem. Let. “Long-range electron transferred in 
engineered Azurins exhibits Marcus inverted region behavior” (Farver O., Hosseinzadeh P., Marshall N.M., Wherland S., Lu Y., 
Pecht I.). Farver O., Wherland S., and Pecht I. performed the electron transfer studies and generated the related figures. 
 
5.1. Introduction 
5.1.1. Marcus theory of ET 
Marcus theory of electron transfer was first developed by Rudolph Marcus to describe ET 
rates in a non-adiabatic system in which electrons are transferred between two molecules 
without any perturbation of the structures or reorganization of ligands, i.e. outer-sphere ET.1 The 
main assumption behind the theory is that such ET reaction happens through reorganization of 
solvent molecules that are shielding the two redox centers. During ET, the two reactants more or 
less keep their individuality. Hence, the electron can jump as a whole. Since the rate of electron 
jump is faster than the reorganization of the solvent molecules, the nuclear positions of solvent 
molecules remain constant before and after the reaction (Frank-Condon principle). Therefore, 
the electron jump is only possible when the energy of ET system doesn’t change during the 
jump. A visual representation of what stated above is provided in Figure 5.1a. As shown in the 
figure, electron transfer can happen only and only when the energy diagrams of the system of 
two reactants before and after ET overlap. The basic equation of Marcus theory is shown in 
equation 5.1: 
 𝑘!" =    !!ℏ   |𝐻!"|! !!!"!!! exp   −   (!!!!°)!!!!!!                          Eq. 5.1 
 
where kET is the rate of electron transfer, HAB is the electron coupling constant. The higher 
HAB, the higher the coupling between the two systems, hence higher probability of electron 
jumps. λ is the reorganization energy, a term that is an indicative of changes in the system before 
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and after ET event. The smaller the λ, the lower the rearrangement of molecules between 
molecules of solvent in the system during ET. ∆G° is the driving force of the reaction.1 
One counterintuitive prediction of Marcus equation is that by moving towards more negative 
free energies, which is known to increase the reaction rates, after a certain point, which is called 
reorganization energy, the rate of ET would decrease. This regime is also known as Marcus 
inverted region (Figure 5.1b).  Later, unambiguous experimental results confirmed the presence 
of Marcus inverted region in several organic and inorganic small molecules,2,3 and derivatized4,5 
and non-derivatized protein systems.6 Although the equation predicts a hyperbolic shape for the 
rate, the rates at inverted region usually reach a plateau due to generation of electronically 
excited products.7 
Marcus theory has been widely used to explain ET processes in biology including 
photosynthesis, charge separation, some types of chemiluminescence and corrosion.7 
 
  
Figure 5.1. (a) Schematic representation of energy diagrams of the ET system before and after ET (figure from 
Wikipedia). (b) Effects of changes in rate based on changes in driving force and visual representation of Marcus 
inverted region (Adapted from 7). 
5.1.2. Ways to measure ET rates 
Direct measurement of ET rates in metalloprotiens is of prime importance for understanding 
the kinetics of the process and obtaining the experimental values for ET. There are several ways 
to measure intermolecular and intramolecular rate constants of ET. We will briefly give some 
examples of such ways without going into details since it is not within the scope of this review.  
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A very common classic way of measuring the rates of intermolecular ET (i.e. between two 
molecules) is through using stopped-flow kinetics and monitoring the accumulation or decay of 
species using UV-vis. This method is particularly useful for heme-containing proteins as they 
have very strong soret band that is distinct between reduced and oxidized forms and has been 
widely used to study ET rates in heme proteins.8 The data will then fit into rate equations, most 
of the times first order or second order rate equations, and rate constants will be deduced. 
Pulse radiolysis is another very common technique to measure ET rates. In this technique, a 
single pulse of high-energy radiation will be delivered to sample. The pulse should be powerful 
enough to generate sufficient amount of reactive intermediates that can be detected by some 
means such as UV-vis, EPR, or fluorescent. Fast electrons with 2-15 MeV energy are a common 
source of such pulses. A high-energy irradiation will be applied to the protein sample and will 
generate both oxidizing (OH− ) and reducing (H ) reactive species. Based on the molecules in 
the solution, these reactive species will later generate some reactive intermediates in the proteins 
that can transfer electrons to the metal center. For biological studies, reactions are performed in 
formate buffer, interaction of which with OH−  anion radical will result in a powerful reducing 
agent, CO2−  anion radical.9,10 As an example, CO2−  anion radicals have been used to later 
generate disulfide anion radicals in Azurin. Electrons will then transfer from this anion radical 
(decay can be tracked by monitoring 410 nm peak, ε410=10,000 M-1cm-1) to the reduced metal 
center and the production of oxidized metal will be monitored at the right wavelength. At any 
given temperature, kET is:6,11,12 
 𝑘!" = 𝑘 𝑟 𝑣  𝑒𝑥𝑝 − !!!"                                                                 Eq. 5.2 
  
where k(r) is the electronic transmission coefficient at a distance r between two reactants, v is 
the nuclear frequency factor, and Ea is the activation free energy. 
Flash photolysis is another way of measuring ET rates in biological samples. This technique 
is very similar to pulse radiolysis, but with a lower energy. In flash photolysis, samples are 
irradiated with highly focused laser beams. Upon irradiation, a chemical reaction would happen 
that cause a certain molecule in the sample to go to an excited state. This molecule will then 
transfer electrons to the metal site and the rates can be measured by fitting the curves obtained 
from monitoring the formation of final products or decay of initial reactive species. One example 
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of molecules that can get excited by laser is flavin cofactor.13 The most commonly used so-called 
photosensitive molecule is probably trisbipyridine Ru(II) ([Ru(bpy)3]2+ hereafter).  Upon 
irradiation, Ru(bpy)3 will go to the [Ru(bpy)3]2+* excited state. This molecule can either accept 
or donate an electron. In the presence of sacrificial oxidants in the solution such as 
peroxodisulfate or chloropentamine cobalt chloride, [Ru(bpy)3]2+* will transfer an electron and 
turn into [Ru(bpy)3]3+, which is a strong oxidant. Conversely, [Ru(bpy)3]2+* can be a reductant 
and donates electrons directly. In order for the process to be catalytic, presence of sacrificial 
reductants such as EDTA4- or triethanolamine is required. ([Ru(bpy)3]2+ have been widely used 
by multiple groups to study ET rates in several proteins such as Az, Mb, and cytochrome c.14-21 
Cyclic voltammetry (CV) is another way to obtain ET rate constants. While CV is mostly 
known for its ability to measure reduction potential, ET rates can be deduced using the peak 
separation at different scan rate and applying Marcus theory.22-25 The common way of modeling 
the rate is to fit the data by Butler-Volmer equation: 
 𝑘!"!" =   𝑘! exp(!!"# !!!°!" )                                                         Eq. 5.3 
 𝑘!"#!" =   𝑘! exp((!!!)!" !!!°!" )                                                    Eq. 5.4 
 
Where E is the applied potential, E° is the formal reduction potential of the couple, n is the 
number of transferred electrons, α is the transfer coefficient showing the degree of symmetry of 
the rate constant for oxidation and reduction and k0 is the rate at zero overpotential. 
5.1.3. Long-range ET 
Perhaps the most intriguing feature of ET in biology is the fact that in many biological 
systems electrons can transfer over long distances. In order to explain long-range ET in 
respiratory chain, it was proposed initially that electrons move in energy bands, like what is 
observed in semiconductors 26. It is now clear that long-range ET in biology is achieved through 
two main mechanisms, electron tunneling, mostly, and electron hopping.7,27,28 A thermally 
activated model of tunneling was first postulated by Hopfield29  and was then experimentally 
proved by Gray and coworkers using Ru modified cytochrome c.30 Later several studies were 
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performed on understanding the electron tunneling and rules governing it. In general, electron 
tunneling is distant-dependent as the coupling constant (HAB) decrease exponentially with 
distance. Figure 5.2 shows the dependence of tunneling time with distance in several media. 
 
  
Figure 5.2. (a) and (b) show how the tunneling time increase rapidly by increase in the distance between electron 
donor and acceptor. (a) shows a comparison between different media and (b) shows a more detailed results in 
different protein systems. (c) shows the contour diagram of dependence of rates to distance. Figures are adapted 
with permission from Ref. 28 
Electrons can tunnel effectively up to a distance of 2.5 nm in proteins due to their small 
mass.28,31,32 For transfers after this range, multiple electronic tunneling steps are required, a 
process called hopping. In order for hopping to be efficient, the sites should be arranged in a 
favorable manner with low reorganization energies, i.e. the free energy changes of endergonic 
reactions between intermediates steps being less than 0.2 eV.28 Multiple electron tunneling steps 
happen through redox active cofactors, including metal centers and also amino acids. In general, 
covalent bonds are preferred to van der Waals interactions (through-bond vs. through-space) and 
aromatic residues are preferred over non-aromatic residues. Interestingly, a sequence analysis of 
different classes of proteins in databank showed that the frequency of aromatic residues in 
oxidoreductases (enzymes performing reactions that require ET) is significantly higher than 
others and above the average 7.  
5.1.4. Previous studies on Marcus inverted region-the need for a protein-only system 
It was not until 1984 when Miller, Calcaterra and Closs provided the first experimental 
observation of the Marcus inverted region, three decades after Marcus coined it. They measured 
the intramolecular ET rates anions of bifunctional steroids (Figure 5.3) and showed that in 2-
methyltetrahydrophuran (MTHF) solution, inverted region can be observed at 296 K.2 
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Figure 5.3. Inverted region can be observed in intramolecular ET rates between anions of bifunctional steroids in 
MTHF solution, measured at 296 K. Figure from ref. 2 
Later, more and more experiments described the observation of the inverted region in 
different systems. Gray and coworkers reported the observation of a Gaussian free-energy 
dependence in photoinduced ET rates in a series of synthetic electron donor-acceptors, as 
predicted by Marcus theory.3 In these series, the electron donors were excited Iridium dimers and 
the acceptors were N-alkylpyridinium groups covalently linked to the phosphinite ligands of Ir2. 
A series of studies later showed that Marcus inverted region can be observed in derivatized 
protein systems as well. A classic example of such observation is reported by Millett and 
coworkers.4 They measured the rates of ET in a cytochrome b5 system that was labeled by 
Ruthenium(II) polypyridine complexes. 
While several reports are available in which the Marcus inverted region is observed in a 
synthetic or derivatized protein systems, reports of observation of such system in protein-only 
systems are rare. We only found two examples of such observation. The first is reported by 
Gunner and Dutton in the reaction center from Rhodobacter spheroids.33 They measured the ET 
rates from bacteriopheophytin to different quinones in a series of temperatures and in some they 
observed the inverted region and Gaussian dependence of the rates to the free energy. It is worth 
noting that while the study was performed in a native protein, the rates of ET were between two 
cofactors. The other example was recently provided by Boussac et. Al.34 They studied the kinetics 
of charge recombination in the Tyr-qunione radical pair in photosystem II of 
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Thermosynechococcus elongates in cryogenic temperatures using EPR and showed that this 
recombination occurred in Marcus inverted region. 
In this chapter I report our studies to demonstrate Marcus inverted region in a non-
derivatzied protein system. This study is built upon our previous investigation of the 
intramolecular ET rates in a series of azurin variants with different reduction potentials.12 In that 
paper we observed lower reorganization energy in our variants compared to the WT-Az, which 
was contributed to a more flexible Cu binding site. We also observed a plateau in the free energy 
dependence plot of the rates. These observations gave us hope that we are close to reach the 
Marcus inverted region and we should be able to observe that region by using variants with 
higher reduction potential. Indeed, we observed, for the first time, the Marcus inverted region 
within a system consisting of only protein at room temperature. 
5.2. Materials and methods 
5.2.1. Preparation, purification and characterization of azurin (Az) mutants 
The Az mutants were constructed, expressed and purified following the previously reported 
protocols.12,16,35 Correct mutations were verified by DNA sequencing. To ensure higher purity, a 
gel filtration chromatography step was added to the last step of the purification process. Such a 
protocol resulted in a low yield for N47S/F114S/M121L Az. To obtain this protein with a higher 
yield, the procedure of induction and growth of cells were revised as follows: Two litres of 2xYT 
media was inoculated by 50 ml of an overnight starter culture and grew to optical density (OD) = 
0.6 at 25 °C. Expression was then induced at 25 °C by addition of 1mM IPTG and expression 
continued overnight. The identity of proteins were again confirmed by electrospray ionization 
(ESI) mass spectrometry using ZMD (Waters) ESI mass spectrometer at the School of Chemical 
Sciences Mass Spectrometry Laboratory (Urbana, IL). To check the mass of copper-free proteins, 
formic acid was used to ionize the protein upon injection. 
5.2.2. Electrochemical measurements 
Redox potentials of the proteins were measured on a CH instruments electrochemical analyzer 
equipped with Chi620a software, using a previously reported protein film voltammetry 
technique.12,35-37 All the measurements were performed in 10 mM sodium phosphate buffer at pH 
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7 with 100 mM sodium formate in order to reproduce the conditions employed in the pulse 
radiolysis experiments. To increase the electrochemical signal for some of the mutants, a 
dodecyldimethyl ammonium bromide (DDAB)-coated electrode was used to collect the CV 
results in protein solutions as reported before.38 
5.2.3. Spectroscopic analysis 
UV-vis spectra were collected on an Agilent 8453 diode array spectrometer. The buffer used 
for these studies was 50 mM ammonium acetate at pH 6.35. EPR spectra were collected using an 
X-band Varian E-122 spectrometer at the Illinois EPR Research Center. Most of the samples 
were prepared by exchanging the protein into TIP7 buffer since the effective pH of this buffer is 
known to remain about the same at cryogenic temperatures as that at room temperature.39 50 mM 
potassium phosphate buffer at pH 6.5 with 100 mM NaCl was used to obtain the data for 
N47S/F114S/M121L mutant. The spectra were simulated using the Simpow program.40,41 The 
observed spectral parameters for all the Az mutants in this study are in good agreement with 
reported values for type 1 copper, electron transfer proteins. 
5.2.4. Kinetic measurements  
The pulse radiolysis experiments were carried out using the Varian V-7715 linear accelerator 
at the Hebrew University in Jerusalem. 5 MeV pulses of accelerated electrons at pulse lengths in 
the range from 0.4 to 1.0 µs were applied. All kinetic measurements were carried out 
anaerobically in N2O saturated solutions contained in a 1 cm quartz cuvette using three light 
passes which results in an overall optical path-length of 3 cm. A 150 W xenon lamp produced the 
analysing light beam. In order to avoid photochemistry and light scattering, an optical filter with 
a cut-off at 385 nm was used. The data acquisition system consisted of a Tektronix 390 A/D 
digitizer connected to a PC. The temperature range employed in the kinetic studies, from 4 to 45 
oC, was controlled by a thermostat, and continuously monitored by a thermocouple attached to 
the cuvette holder. The protein concentration was varied between 75 and 200 µM. All reactions 
were performed under pseudo-first order conditions, with typically a 10-fold excess of oxidized 
protein over reductant. The concentration of Cu(II) was monitored at 600 - 635 nm (ε625 ~ 5,000 
M−1 cm−1) while formation and decay of the RSS*R− radical were followed at 410 nm 
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(ε410 = 10,000 M−1 cm−1). Data collection was performed in aqueous solutions containing 0.10 M 
in sodium formate and 10 mM sodium phosphate at pH 7.0, deaerated and saturated with N2O by 
bubbling directly in the cuvette. Afterwards, an appropriate small volume of concentrated protein 
stock solution was added to the cuvette, and N2O bubbling was continued for another 5-10 
minutes before starting the kinetic measurements. Each individual kinetic measurement was 
repeated at least three times at each temperature. Spectra of the samples were taken prior, during, 
and after the kinetic measurements to monitor the state of the protein throughout the kinetic 
measurements. Two reaction phases were observed following the introduction of a pulse into the 
solutions when monitored by absorption changes at either 410 nm (disulfide radical) or at ~625 
nm [Cu(II)]. The first step is the bimolecular reduction of disulfide (monitored at 410nm) and 
Cu(II) (at ~625nm) by the CO2− radicals, followed by the second phase shown to be the 
intramolecular (RSS•R− to  Cu(II)) ET which is the process of interest (cf. reaction scheme and 
Fig. 2). All the kinetic traces were analysed by fitting to a sum of exponentials using a non-linear 
least squares program written in MATLAB® (The MathWorks, Natick, MA) 
5.2.5. Molecular dynamics simulations 
Molecular dynamics were performed using VMD and NAMD software.42,43 The structure of 
mutants was modelled based on PDBs reported in Table S2. PSF files were generated using the 
PSFGEN suite in VMD. Proteins were solvated in a water box with a size 15 Å, and the overall 
structure was neutralized by 0.1 M NaCl. Molecular dynamics simulations were performed using 
1000 or 2000 steps of minimization followed by 1 ns of equilibration (2 fs/step) in a PVT format. 
5.3. Results and discussion 
5.3.1. Mutant design and reduction potentials 
In order to enable a quantitative examination of the relationship between the ET driving force 
and the rate constant in a protein-only system without any ancillary foreign donor or acceptor, 
we have now expanded this series and prepared several other mutants (F114N, 
N47S/F114S/M121L, and M44F/N47S/F114N/G116F) with higher potentials than that of WT Az 
(Figure 5.4 and Table 5.1).    
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Figure 5.4. Schematic presentation of Az and the designed mutants. Calculated paths (see below) of electron transfer 
from the disulfide to Cu are illustrated by the red arrows. The mutated residues are shown in black stick and ball. 
The green mutations cause increase in reduction potential while the red ones decrease it. 
Table 5.1. Rate constants, activation parameters of the intramolecular ET reactions, and the potentials of the copper 
site.  
 
*Data from Ref.12. **This study.  
5.3.2. Kinetic measurements of the electron transfer rates 
Kinetic measurements of the intramolecular ET in these nine different Az mutants, including 
three previously unreported ones with reduction potentials from 0.39 to 0.61 V vs. NHE have 
 
Azurin Mutant 
 
kET (s−1) 
at 298 K 
 
E° 
(mV) 
 
ΔH‡  
(kJ/mol) 
 
ΔS‡ 
(J/K·mol) 
1. F114P/M121Q* 81 ± 11 122 ± 6 36.6 ± 7.5 -86 ± 14 
2. F114P* 191 ± 26 220 ± 18 ~29 -106 
3. F114N** 198 ± 14 381 ± 8 29.9 ± 0.2 -101 ± 1 
4. N47S/F114N* 387 ± 59 499 ± 3 33.7 ± 2.5 -82 ± 4 
5. N47S/M121L* 355 ± 51 503 ± 5 44.0 ± 2.1 -48 ± 1 
6. F114N/M121L* 287 ± 34 513 ± 4 ~ 39 ~ -66 
7. M44F/N47S/ 
F114N/G116F** 
220 ± 13 588 ± 20 26.8 ± 2.3 -110 ± 7 
8. N47S/F114S/ 
M121L** 
44 ± 5 604 ± 14 30.4 ± 4.3 -110 ± 12 
9. N47S/F114N/ 
M121L* 
78 ± 12 614 ± 11 41.7 ± 5.9 -71 ± 8 
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been investigated. Pulse radiolytically produced CO2- radicals reduce both the disulfide bridge 
(Cys3-Cys26) and the Cu(II) site in Az with similar, essentially diffusion controlled rate 
constants (k1 ≈ 109 M-1s-1), (Figure 2). Since an excess of protein is employed over the reducing 
CO2− radicals, only a fraction of either disulfide or Cu(II) is reduced, allowing for the disulfide 
radical produced (RSS•R−) to transfer an electron to the Cu(II) center in a second, slower and 
concentration independent, intramolecular ET process (Figure 5.5):  
                                            kET 
                                     Az[Cu(II)RSS•R−] → Az[Cu(I)RSSR] 
 
Figure 5.5. (A). Time resolved absorption changes at 410 nm of the F114N azurin mutant, monitoring formation and 
decay of the RSS•R− radical ions. (B) Time resolved absorption changes (625 nm) of the F114N Az mutant 
monitoring reduction of Cu(II). The protein concentration was 93 µM in an N2O saturated solution; temperature 25 
oC. All other technical details are described in the Experimental methods section. 
 
The rate constants, kET at 25oC, were determined by monitoring both the oxidation of the 
radical (410 nm, Figure 5.5A) and reduction of Cu(II) (600-635 nm, depending on the mutant’s 
absorption maximum). The kET values and calculated activation parameters are presented in 
Table 1 together with earlier results. 
Calculations of ET pathways between the RSS•R− radical ion and Cu(II) in these mutants 
showed that the same two pathways are operating in them and in the WT. Neither pathway 
involves the mutated residues. 
Time/s	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The semi-classical Marcus theory for ET reactions between spatially fixed and oriented 
donors and acceptors provides a framework for analysis of rate constants in the non-adiabatic 
regime, Eq. 5.5:44 
                                     Eq 5.5 
where 
                                    Eq 5.6 
In Eq. 5.5, κ(r) is the transmission coefficient at a separation distance, r, while ν is the 
frequency of nuclear motions. (In the non-adiabatic regime, κ(r)ν is independent of this 
frequency). R and T are the gas constant and temperature (in K) respectively. ΔG* and ΔG0 (cf. 
Eq. 5.6) are the activation free energy and standard free energy of reaction, respectively, and 
λTOT is the total reorganization free energies of both the ET donor and acceptor. When the driving 
force of the reaction equals the total reorganization energy, the rate constant reaches a maximum 
value, kMAX. Since κ(r)ν decays exponentially with the separation distance, we can calculate kMAX 
by Eq. 5.7 below:       
 
                       Eq. 5.7 
 
where kB and h, respectively are Boltzmann’s and Planck’s constants, r is the donor-acceptor 
separation distance and r0 is the value of r for direct (van der Waals) contact; the generally 
accepted value for r0 is 0.3 nm. The timetable for activationless electron tunneling in β-sheet 
proteins of Gray et al. provides a decay constant of β = 10 nm-1.45 
Attempts to experimentally determine the reduction potential for the formation of the RSS•R− 
radical in azurin have failed so far. Since the cystine is partly solvent exposed, we have been 
using a value of -0.41 V vs. NHE, determined from hybrid disulfide between a nitroaromatic and 
a protein cysteine thiol.46 It is noteworthy that any change in the value for the reduction potential 
of the disulfide primarily adds or subtracts a constant from the abscissa values of the plot in 
Figure 5.5, and thus the reorganization energy by the same value.  
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The activation free energies, ΔG* of the ET reactions in each mutant can be calculated from 
the activation parameters presented in Table 5.1. However, the experimentally determined 
activation entropy, ΔS‡, includes a contribution from the electronic coupling:44 
       Eq. 5.8 
  
where the symbols have already been defined above. 
5.3.3. Investigating the Marcus plot in azurin variants 
 Figure 5.6 shows a plot of the ET rate constants, kET, vs. driving force, for the nine Az 
mutants fitted to the theoretical curve calculated using Eqs. 5.5 and 5.6 above. A non-linear least 
squares analysis of the data yields a value of kMAX = 249(+56/-44) s-1 and a reorganization free 
energy of λTOT = 0.78(+0.04/-0.04) eV. The broken lines result from using the method of support 
planes,47 the limit of each parameter that produces a 10% change in chi squared while the other 
parameter is allowed to optimize. The two broken lines represent the limits of kMAX. In this 
analysis, kMAX is the pre-exponential term in Eq. 5.5, treated as a constant, and is consistent with 
a kMAX = 286 s-1 calculated directly from Eq. 5.7.  
 
Figure 5.6.  The Marcus plot of log(kET) of intramolecular ET in the Az mutants as function of  the driving force. 
The fitted line is calculated using kMAX = 249 (+56/-44) s-1 and λTOT = 0.78 (+0.04/-0.04 eV. The points are labelled 
1 – 9, as in Tables 1 & 2. WT Az is the open circle symbol.   
Also, the reorganization free energies of the individual mutants were calculated 
independently using the experimental activation parameters, ΔH‡ and ΔS‡. Using β(r-r0) = 23.8 
(cf. Eq. 3) we obtain Rβ (r- r0) = 198 JK-1mol-1 (or 2.05 meV K-1). We then calculate ΔG* using 
Δ Δ ΔS S R S R r r≠ = + = − −* *ln( / ) ( )κν β1013 0
‡	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the activation enthalpy and the corrected activation entropy values. Finally, the reorganization 
free energy, λcalc is calculated from Eq. 2. The results are presented in Table 5.2. 
Table 5.2. Reorganization free energies, λcalc. for the Az mutants. 
 
*Data from (Ref.12). **This study. 
As illustrated in Figure 5.6, the experimentally determined rate constant values of the 
intramolecular ET in the Az mutants fit the theoretical parabola calculated using Marcus theory 
in the above plot of the ET rate constants vs. their driving force reasonably well, considering the 
redox potential range of mutants studied and the requirement of kMAX and λTOT being constant for 
the entire set of examined mutants. The reorganization energy includes contributions from both 
the T1 Cu site and the disulfide-radical ion. From previous pulse radiolysis studies, we have 
calculated a λSS = 1.2 eV48,49 which yields a λCu = 0.4 eV, a significantly lower value than that 
(λCu = 0.82 eV) previously determined for WT Pseudomonas aeruginosa Az.49,50 In a previous 
study, we have attributed such lowering of the reorganization energy to increased flexibility of 
the T1 copper center caused by changes in non-covalent interactions such as hydrogen bonding 
and hydrophobicity in the secondary coordination sphere of the T1 copper site.12 It has been 
shown before that changing hydrogen bonds and collective perturbation of the protein dynamics 
 
       Azurin Mutant 
-ΔG0  
(eV) 
ΔG*  
(eV) 
λcalc.  
(eV) 
1. F114P/M121Q* 0.532  
± 0.006 
0.033  
± 0.007 
 
0.87 
2. F114P* 0.630  
± 0.023 
 
~0.016  0.87 
3. F114N** 0.791  ± 0.008 
0.009 
± 0.001 
 
0.98 
4. N47S/F114N* 0.909  
± 0.003 
-0.009  
± 0.001 
 
0.91 
5. N47S/M121L* 0.913  
± 0.005 
-0.007  
± 0.006 
 
0.91 
6. 114N/M121L*  0.923  
± 0.004  
~ -0.003 0.92 
7. M44F/N47S/F114S/G116F** 0.998  ± 0.020 
0.006 
± 0.001 
 
0.85 
8. N47S/F114S/M121L** 1.014  ± 0.014 
0.043  
± 0.005 
 
0.67 
9. N47S/F114N/M121L* 1.024  
± 0.011 
0.040  
± 0.006 
0.69 
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can affect the λ values.51 The deviations from the fit line at the highest driving force would, if 
attributed only to variation in the reorganization energy, correspond to a variation of up to 0.25 
eV from the average or fit value.    
5.3.4. Discussion 
The exponential decay constant, β (cf. Eqs. 5.7 and 5.8) is another important parameter 
determining the ET rates. Differences in β would affect both the ET rates and activation entropies 
even when a common ET pathway is operating. These differences may be due to subtle changes 
in the electronic coupling between the copper ion and its ligands, particularly upon slight 
differences in the covalency of the Cu2+−S(Cys) bond. Calculations of the Fermi contact term 
presented in table 5.3 show only small differences in the anisotropic covalency, suggesting that 
the mutations have only a minor effect on the total electronic coupling along the ET pathway 
(Figure 5.7).  
 
Figure 5.7.  Major residues along the ET pathway in azurin (WT-Az, PDB ID: 4AZU) 
Table 5.3. EPR parameters of the Az mutants and calculated Fermi contact terms. The EPR spectra were measured 
under conditions identical to those of the ET measurements.  
 
gx gy gz Ax /cm-1 Ay/cm-1 Az/cm-1 Fermi contact term 
WT 2.028 2.055 2.262 8.5 x10-4 8.6 x10-4 5.3 x10-3 0.414 
F114P/M121Q 2.03 2.054 2.257 7.9 x10-4 7.9 x10-4 4.5 x10-3 0.389 
F114P 2.028 2.049 2.205 7.0 x10-4 7.0 x10-4 6.5 x10-3 0.386 
Cys3	  
Thr30	  
Val31	  
Trp48	  
Val49	   Phe111	  
Cys112	   Copper	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Furthermore, the electronic coupling between electron donor and acceptor does not change 
significantly as a result of the mutations (an average β = 10.0 +/- 0.2 nm-1) and is unlikely to 
cause the observed steep decrease in rate constants in mutants with the highest driving force 
illustrated in Figure 5.6. Comparing mutants 7 and 8, the five-fold decrease in rate constant 
would require an unlikely change in the decay constant, β, from 10.0 to 10.7. However, minor 
changes in the electronic coupling could be responsible for the scatter of the points in Figure 5.5 
(beside experimental errors). Examination of the distances in the ET pathways of the different 
mutants using their crystal structure or molecular dynamics (MD) simulations showed minor 
differences that do not correlate with the observed rate constants (Table 5.4).  
Table 5.4.  Calculated distances between major residues along the ET pathways in azurin mutants (based on either 
crystal structures when available or molecular dynamic (MD) simulation models) 
Mutant Cys3 (O) –Thr 30 
(N) 
Val 31 (CG1) –Trp 48 
(CD2) 
Val 49 (O)—
Phe111(N) 
WT-Az (4AZU) 3.06 3.83 2.88 
F114P/M121Q (3IN0) 3.15 4.09 2.83 
F114P (2GHZ) 2.98 3.91 2.91 
F114N# 3.00 3.88 3.00 
N47S/F114N (3JTB) 3.20 3.89 3.01 
N47S/M121L (3JT2) 3.05 3.93 2.96 
F114N/M121L* 3.04 4.06 3.16 
M44F/N47S/F114N/G116F* 3.43 3.83 3.17 
N47S/F114S/M121L* 3.08 4.05 3.01 
N47S/F11N/M121L* 3.20 3.94 2.99 
# data from unpublished x-ray structure 
* from MD models 
 
 
 
Table 5.3 cont.        
N47S/F114N 2.028 2.056 2.28 8.9x10-4 8.9x10-4 5.0x10-3 0.424 
N47S/M121L 2.026 2.062 2.298 9.6x10-4 9.6x10-4 3.9x10-3 0.415 
F114N/M121L 2.028 2.057 2.263 8.7x10-4 8.7x10-4 5.3x10-3 0.415 
N47S/F114N/M121L 2.021 2.058 2.31 9.2 x10-4 9.2 x10-4 4.2 x10-3 0.433 
F114N 2.057 2.028 2.248 8.45x10-4 8.45x10-4 5.92x10-3 0.400 
M44F/N47S/F114N/G116F 2.054 2.03 2.258 7.78 x10-4 7.78 x10-4 6.18x10-3 0.410 
N47S/F114S/M121L 2.047 2.025 2.234 14.05x10-4 14.05x10-4 6.31x10-3 0.383 
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5.4. Summary and conclusion 
Taken together the present results provide rare34 and compelling evidence that, in this set of 
Az mutants, the Marcus inverted region has been reached at driving forces greater than ~0.8 eV 
(Figure 5.6). However, the ET rates observed for mutants with the highest driving force lie 
considerably below the calculated curve. Marcus theory in its semi-classical form attributes the 
inverted region to an increasing activation energy in the exponential term of the rate equation, 
but nuclear tunneling may cause a decrease in the pre-exponential factor leading to the 
considerably lower rates observed.52 
These mutants reach the “inverted region” in the internal ET process, since they possess a 
lower reorganization energy than most other Az mutants. When the reorganization energy is 
higher, as in the case of WT Az (cf. Figure 5.6), even greater driving force would be required to 
reach the “inverted region”, a rather difficult task to fulfill with modifications of the copper 
environment. Moreover, the inverted region could be achieved in this system because both ET 
products, Cu(I) and disulfide, have closed shells and their electronic excited states are too high to 
be populated after the long range ET. The inverted region in a bimolecular ET reaction with 
closed shell products has indeed been demonstrated before.53 The present results provide the first 
demonstration of the Marcus inverted region in a non-derivatized protein-only system. It has 
been hypothesized that the dramatically different ET rates in the photosynthetic reaction center 
are due to the lower reorganization free energy and large activation barrier for the reverse 
processes that result from the inverted region.1 The inverted region, therefore, allows for the 
charge separation required for unidirectional ET through that system and is critical for efficient 
energy conversion processes. 
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CHAPTER 6 
 
ATTEMPTS TO DESIGN A HIGH-THROUGHPUT SCREENING PLATFORM TO 
OBTAIN AZURIN VARIANTS WITH DESIRED POTENTIAL 
 
6.1. Introduction: 
Three chapters of this thesis were dedicated to rationally tuning the reduction potential of the 
protein azurin, understanding the factors that contribute to the reduction potential, and 
application of such systematically tuned protein variants. While the rational design approach has 
been very successful in achieving a protein that spans the entire 2V range of biological reduction 
potentials and a great deal is learnt by studying the detailed spectroscopic and crystallographic 
features of those mutants, some issues still remain. Proteins at the high extreme are usually not 
very stable. Moreover, the Ni-Az variants (see chapter 3) are not stable at their desired reducing 
state, the Ni(I) state. 
Proven to be a powerful method regarding primary and secondary sphere interactions,1-3 
rational design is not promising beyond that regime. It is usually very difficult to predict the 
effect of mutations far from the active site and there are always unexpected interactions that can 
be transferred via protein motions or more complicated networks of interactions. In addition, 
stabilizing mutations are very difficult to be designed and predicted rationally. Directed 
evolution is the method of choice in such cases. In this method random mutations are introduced 
to proteins and the created library is then screened for desired activity to select the best mutants 
and the library generation and selection process continues until no further enhancement is 
observed.4-19 
Oxidized azurin has a strong absorption at 625 nm due to ligand to metal charge transfer, 
while reduced form lacks this absorption.20-23 This change is obvious in vitro; however, such it is 
very hard to detect absorption changes under physiological conditions due to strong background. 
Fluorescent signal usually has the advantage of low background and bio-compatibility.  The idea 
is to couple oxidation-reduction process to a change in fluorescence so that we can use flow-
cytometry to sort our library of mutants.24 Paramagnetic quenching of a nearby fluorophore 
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(either a protein or a small molecule) by Cu(II) can be restored upon reduction of the Cu(II), 
providing a  means to distinguish lower potential variants from higher potential ones.  
In this chapter, I will describe several attempts to design and test this system. Due to the 
variety of techniques tested, I broke down the chapter first by the approach used. Then, I further 
sub-categorized each section into a brief introduction, materials and methods, and results. An 
overall summary and future direction is presented at the end of this chapter. 
6.2. Conjugation to Alexa-fluor 688 dye 
6.2.1. Introduction 
Alexa dyes are a class of fluorophores available through several companies with a range of 
emissions and different modalities for conjugation. We chose Alexa fluor 610 (Figure 6.1) which 
has an emission close to Cu(II) absorption in azurin to enhance the efficiency of quenching. This 
dye is conjugated via a maleimide labeling conjugation. In order to attach the dye, Yang Yu 
designed N42C-Az variant, which has a Cys close to the Cu binding site.  
 
Figure 6.1. Spectra of emission of different Alexa Fluor dyes. Adapted from life technologies website/ 
6.2.2. Materials and methods 
Alexa Fluor dye was purchased from Fluka Analytical. The labeling was performed first 
according to the manual as follows. The protein was exchanged using PD-10 columns into 50 
mM Tris-HCl buffer pH= 7.0. The reduction of disulfides was skipped, as the Cys42 is surface 
exposed and not linked to any other Cys resideus. A 10-20 mM stock of the dye was prepared in 
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DMSO. As a control, a 20 mM stock of maleimide was used. 10-20 moles excess of the dye was 
added dropwise to the stirring solution of the protein and was stirred for two hours at room 
temperature (or overnight at 4 C). Instead of adding thiols to stop the reaction, we passed the 
protein down a PD-10 column to remove unreacted dye and to exchange the protein to the buffer 
required for mass spectroscopy. To optimize the condition, different concentrations of protein 
was used (less than 50 µM, between 50-100 µM and more than 100 µM). We also tested 
different ratios of maleimide to protein (20, 250, 1000). To label with the dye, we used 200 µl of 
180 µM protein and added about 5 molar excess dye and stir overnight at 4C. We also tried using 
both fresh dye and the dye that came out of the PD-10 and was not reacting in order to save the 
dye. 
Expression	   and	   purification	   of	   N42C-­‐Az	   variant	   was	   performed	   as	   described	  
previously.1	   In	  brief	   the	  cells	  are	  subjected	  to	  osmotic	  shock	  to	  release	  the	  protein	   from	  
periplasmic	   space.	   A	   precipitation	   step	   via	   acidifying	   the	   culture	   is	   used	   to	   precipitate	  
other	  proteins.	  The	  apo-­‐protein	   is	  purified	  via	   a	   cation	  exchange	  SP-­‐sepharose	   column.	  
After	  addition	  of	  Cu,	  the	  holo-­‐protein	   is	  separated	  from	  the	  apo-­‐protein	  using	  an	  anion	  
exchange	   Q-­‐sepharose	   column.	   The	   protein	   content	   was	   confirmed	   using	   a	   QuatroII-­‐
waters	  electrospray	  ionization	  mass	  spectroscopy	  machine	  (ESI-­‐MS)	  
MALDI mass spectroscopy was performed by the university mass-spec facility.  
Fluorescent studies were performed on a HORIBA Jobin Yvon Fuoromax-P using an 
excitation of 610 nm, scanning from 600-750 nm with slit opening of 2 nm. 
6.2.3. Results and discussion 
 6.2.3.1. Protein purification 
N42C-Az protein was purified with comparable yields to the WT-Az. The mass obtained by 
ESI (13931 ± 5) was very close to the estimated mass (13934.3) as shown in figure 6.2. 
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Figure 6.2. ESI mass spectrum of N42C-Az. 
 6.2.3.2. Maleimide labeling 
Upon reaction with maleimide (control) using the Fluka Analytical protocol (described in the 
materials section), no significant maleimide labeling (expected mass around 14904) was 
observed by ESI-MS as shown in figure 6.3. 
 
Figure 6.3. ESI of initial attempts of maleimide labeling of N42C. 
MALDI mass spectroscopy showed about 40% labeling with maleimide and an enhancement 
of the labeling efficiency upon addition of more protein. The labeling for overnight at 4 C didn’t 
increase the efficiency. Labeling efficiency was greatly enhanced using increased maleimide to 
protein ratio as shown in figure 6.4.  
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Figure 6.4. Increasing maleimide labeling results in an enhanced labeling efficiency. 
N42C-Az labeled with Alexa came out of PD-10 column as a pink band with UV-vis features 
of both Alexa and Cu(II)-Az (see figure 6.5). MALDI results also confirmed the labeling (figure 
6.5b). We noticed that labeling with fresh or old dye did not affect the yield as observed by 
MALDI (data for the old one is not shown but is similar to the one in figure 6.5). 
 
Figure 6.5. UV-vis of labeled N42C with Alexa is shown on the left. The right figure shows MALDI result of the 
same sample. 
6.2.3.3. Fluorescence studies 
In contrast to labeling studies, fluorescent studies were very successful. As shown in figure 
6.6, we observed significantly better quenching of the emission with our labeled dye compared to 
the control in which free azurin was added to the Alexa Fluor sample. The emission signal was 
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restored upon quenching of the Cu(II) by addition of ascorbate (75% increase in intensity in 
labels compared to only 8% in the control). 
 
Figure 6.6. Fluorescent studies on the Alexa-N42C-Az show efficient quenching and later restoration of the 
fluorescent upon reduction of Cu. 
Fluorescent studies on the reactions treated with cell culture showed no fluorescent signals. 
6.3. Fusion to mCherry 
6.3.1. Introduction 
The discovery of fluorescent proteins opened new avenues in the field of protein science and 
especially in vivo studies of protein dynamics and localization	  25-27 as evident by dedication of the 
Nobel prize in Chemistry, 2008, for the discovery of GFP.28 One big advantage of using 
fluorescent proteins compared to conjugation techniques is the ability to genetically encode them 
and hence avoiding the post-purification processes. To take advantage of these properties, Yang 
Yu and I decided to design a series of constructs in which mCherry is fused to azurin (mCh-Az) 
and to use that system for our directed evolution set up. 
6.3.2. Materials and methods 
Some of the proteins used in this study were designed by Yang Yu. Detailed information of 
those constructs is not provided in here and readers are referred to Yang’s thesis or his progress 
reports. 
6.3.2.1. Preparation of fragments for Yeast display vector 
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Yeast display was performed with the help of Tong Si from Huimin Zhao lab, using a 
method previously reported29 and then later developed by their group.30 The experimental details 
of the technique are provided here. 
PRS416 vector was used as the yeast display vector. Azurin fragment was inserted between 
V5 and GS linkers that connect α-hemmaglutinin gene to TEF. To design vectors, adjacent 
fragments had 40 nucleotides overhang with each other so that we could use yeast homologous 
recombination system. Primers are listed below: 
PRS423-seq-f: 5'-gtgctgcaaggcgattaag (primer to get TEF) 
V5-Az-r: 5'-gcatctgatcattaccctggatatcaacggagcattcagccgtagaatcgagaccgagg (primer to get TEF with 
overlapping region of Azurin) 
V5-Az-f: 5'-ggtaagcctatccctaaccctctcctcggtctcgattctacggctgaatgctccgttgatatcc (primer to get Azurin with 
overlapping region of V5) 
GS-Az-f: 5'-ggtcactccgcactgatgaaaggtaccctgactctgaaagagggtggaggcggtagtggcgg (primer to get Azurin 
with overlapping region to GS) 
GS-Az-r: 5'-gcttttggcgctaacctccaccgccactaccgcctccaccctctttcagagtcagggtacc (primer to get GS with 
overlapping region to Azurin) 
ADH2t-Seq-r: 5'-caattaatgtgagttacctc (primer to get Gs from vector) 
Gal10 was extracted from yeast genomic DNA using following primers: (genomic DNA of yeast was 
isolated using zymolase kit from Huimin Zhao lab) 
Gal10-r: 5'- GTA GAA TCG AGA CCG AGG AGA GGG TTA GGG ATA GGC TTA CCA CCT GCA GCT AAT GCG 
GAG GAT GCT GCG AAT AAA ACT GCA GTA AAA ATT GAA GGA AAT CTC ATT TTC AAA AAT TCT TAC TTT 
TTT TTT GGA TGG ACG C 
Gal10-f: 5'- CCC AGT CAC GAC GTT GTA AAA CGA CGG CCA GTG AGC GCG CGT AAT ACG GTC AAT ATA GCA 
ATG AGC AGT TAA GCG 
Forward primer for mCherry-Azurin construct, since the reverse is the same: 
Mch-Az-f: 5'- TCC GCA TTA GCT GCA GGT GGT AAG CCT ATC CCT AAC CCT CTC CTC GGT CTC GAT TCT 
ACG GCT GAA TGC TTT CCC GGG ATG GTG AGC AAG GGC GAG GAG G  
To make the construct polymerase chain reaction (PCR) was performed on each of the 
fragments. Source for TEF and Aga was PRS416 plasmid and Azurin was purified from the 
stock plasmid in pET9a vector. PCR reaction was performed as follow: an initial cycle of 
denaturation at 95 for 1 min, followed by 34 cycles of 30 sec denaturation at 95, annealing for 
30 sec at 53 and elongation at 72 for 40 sec. the final product was finally elongated for 2 min at 
72. For most genes Phusion polymerase from NEB was used except for mCherry containing 
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genes and Aga that worked better with Platinum Taq from Invitrogen. PCR products were then 
loaded onto a 1% agarose gel and ran for 20 min at 127 V. Fragments then gel extracted using 
Qiagen minimprep gel extraction kit according to the user guide. 
PRS416 fragment was prepared by double digestion of the vector with BamHI and EcoRI, 
based on NEB protocol. The fragment then gel extracted as described previously. 
6.3.2.2. Yeast recombination 
To generate the construct using yeast homologous recombination system, the fragments 
should first be uptaken by yeast. Yeast competent cells were prepared as follows for one shot 
transformation: a single colony of yeast strain (EYB100 or CPNK) was grown in 2-3 ml yPAD 
media overnight at 30. Inoculate 5 ml (times number of shots) yPAD media with overnight 
culture to get OD~ 0.7. Let grow for 3-4 hours. Centrifuge 5 minutes at 4000 rpm using 
Eppendorf centrifuge. The pellet was then resuspended in 25 mL water and centrifuged again. 
Cells resuspended in 1ml of 0.1 M LiNO3 and centrifuged again. Finally cells were resuspended 
in 100 μL (per shot) of 0.1 M LiNO3. For transformation, 240 μL filtered 30% PEG was gently 
added to the top of cell containing vials. After that 50 μL of preheated salmon sperm DNA (5 
min at 100), 36 μL 1M LiNO3 and 200 ng of each fragment were added respectively. The 
concentrations of fragments were calculated based on 260 absorption using HP diod array 
spectrometer. Cells were then placed in 42 water bath for 40 minutes. After this heat shock 
period, 1 mL SC-Ura media was added to cells and 50 μl is plated on SC-Ura plates. The plates 
are incubated at 30 for 2 days. To validate colonies, they are grown in 5 mL SC-Ura for 2 days 
and plasmids are extracted by zymoprep yeast plasmid extraction kit based on manual. All 
constructs are validated by sequencing at ACGT Inc. 
yPAD media: (600 mL) 
0.6 gr Difco yeast extract 
12.0 gr Difco peptone 
12.0 gr glucose 
60 mg adenine hemisulfate 
(+10 gr bacto agar for solid media) 
 
SC-Ura: (600ml) 
	   141	  
1.0 gr difco yeast nitrogen base 
3.0 gr ammonium sulfate 
12.0 gr dextrose 
0.5 gr SC-Ura 
60 mg Adenine hemisulfate 
(+10 gr bacto agar for solid media) 
 
6.3.2.3. Construction of bacterial surface display 
The pAPEX vector for bacterial surface display was a kind gift from Dr. George Georgiou 
lab, University of Texas, Austin. The vector was constructed as described before.31 The vector 
sequence is shown below. Regions with yellow highlight and red text are the SfiI restriction sites. 
        1 ACCCGCCACC ATCGAATGGC GCAAAACCTT TCGCGGTATG GCATGATAGC GCCCGGAAGA 
       61 GAGTCAATTC AGGGTGGTGA ATGTGAAACC AGTAACGTTA TACGATGTCG CAGAGTATGC 
      121 CGGTGTCTCT TATCAGACCG TTTCCCGCGT GGTGAACCAG GCCAGCCACG TTTCTGCGAA 
      181 AACGCGGGAA AAAGTGGAAG CGGCGATGGC GGAGCTGAAT TACATTCCCA ACCGCGTGGC 
      241 ACAACAACTG GCGGGCAAAC AGTCGTTGCT GATTGGCGTT GCCACCTCCA GTCTGGCCCT 
      301 GCACGCGCCG TCGCAAATTG TCGCGGCGAT TAAATCTCGC GCCGATCAAC TGGGTGCCAG 
      361 CGTGGTGGTG TCGATGGTAG AACGAAGCGG CGTCGAAGCC TGTAAAGCGG CGGTGCACAA 
      421 TCTTCTCGCG CAACGCGTCA GTGGGCTGAT CATTAACTAT CCGCTGGATG ACCAGGATGC 
      481 CATTGCTGTG GAAGCTGCCT GCACTAATGT TCCGGCGTTA TTTCTTGATG TCTCTGACCA 
      541 GACACCCATC AACAGTATTA TTTTCTCCCA TGAAGACGGT ACGCGACTGG GCGTGGAGCA 
      601 TCTGGTCGCA TTGGGTCACC AGCAAATCGC GCTGTTAGCG GGCCCATTAA GTTCTGTCTC 
      661 GGCGCGTCTG CGTCTGGCTG GCTGGCATAA ATATCTCACT CGCAATCAAA TTCAGCCGAT 
      721 AGCGGAACGG GAAGGCGACT GGAGTGCCAT GTCCGGTTTT CAACAAACCA TGCAAATGCT 
      781 GAATGAGGGC ATCGTTCCCA CTGCGATGCT GGTTGCCAAC GATCAGATGG CGCTGGGCGC 
      841 AATGCGCGCC ATTACCGAGT CCGGGCTGCG CGTTGGTGCG GACATCTCGG TAGTGGGATA 
      901 CGACGATACC GAAGACAGCT CATGTTATAT CCCGCCGTTA ACCACCATCA AACAGGATTT 
      961 TCGCCTGCTG GGGCAAACCA GCGTGGACCG CTTGCTGCAA CTCTCTCAGG GCCAGGCGGT 
     1021 GAAGGGCAAT CAGCTGTTGC CCGTCTCACT GGTGAAAAGA AAAACCACCC TGGCGCCCAA 
     1081 TACGCAAACC GCCTCTCCCC GCGCGTTGGC CGATTCATTA ATGCAGCTGG CACGACAGGT 
     1141 TTCCCGACTG GAAAGCGGGC AGTGAGCGGT ACCCGATAAA AGCGGCTTCC TGACAGGAGG 
     1201 CCGTTTTGTT TTGCAGCCCA CCTCAACGCA ATTAATGTGA GTTAGCTCAC TCATTAGGCA 
     1261 CCCCAGGCTT TACACTTTAT GCTTCCGGCT CGTATGTTGT GTGGAATTGT GAGCGGATAA 
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     1321 CAATTTCACA CAGGAAACAG CTATGACCAT GATTACGAAT TTCTAGAGAA GGAGATATAC 
     1381 ATATGAAACT GACAACACAT CATCTACGGA CAGGGGCCGC ATTATTGCTG GCCGGAATTC 
     1441 TGCTGGCAGG TTGCGACCAG AGTAGCAGCG AGGCCCAGCC GGCCATGGCG GATCCTTGCT 
     1501 ATTTACCGCG GCTTTTTATT GAGCTTGAAA GATAAATAAA ATAGATAGGT TTTATTTGAA 
     1561 ACTAAATCTT CTTTATCGTA AAAAATGCCC TCTTGGGTTA TCAAGAGGGT CATTATATTT 
     1621 CGCGGAATAA CATCATTTGG TGACGAAATA ACTAAGCACT TGTCTCCTGT TTACTCCCCT 
     1681 GAGCTTGAGG GGTTAACATG AAGGTCATCG ATAGCAGGAT AATAATACAG TAAAACGCTA 
     1741 AACCAATAAT CCAAATCCAG CCATCCCAAA TTGGTAGTGA ATGATTATAA ATAACAGTAA 
     1801 ACAGTAATGG GCCAATAACA CCGGTTGCAT TGGTAAGGCT CACCAATAAT CCCTGTAAAG 
     1861 CACCTTGCTC ATGACTCTTT GTTTGGATAG ACATCACTCC CTGTAATGCA GGTAAAGCGA 
     1921 TCCCACCACC AGCCAATAAA ATTAAAACAG GGAAATCTAA CCAACCTTCA GATATAAACG 
     1981 CTAAAAAGGC AAATGCACTA CTATCTGCAA TAAATTCGAG CAGTACTGCC GTTTTTTCGC 
     2041 CCCATTTAGT GGCTATTCTT CCTGCCACAA AGGCTTGGAA TACTGAGTGT AAAAGACCAA 
     2101 GACCCGCTAA TGAAAAGCCA ACCATCATGC TATTCCATCC AAAACGATTT TCGGTAAATA 
     2161 GCACCCACAC CGTTGCGGGA ATTTGGCCTA TCAATTGCGC TGAAAAATAA ATAATCAACA 
     2221 AAATGGGCAT CGTTTTAAAT AAAGTGATGT ATACCGAATT CGATTGCGTC TCAACCCCTA 
     2281 CTTCGGTATC TGTATTATCA CGTGTATTTT TGGTTTCACG GAACCAAAAC ATAACCACAA 
     2341 GGAAAGTGAC AATATTTAGC AACGCAGCGA TAAAAAAGGG ACTATGCGGT GAAATCTCTC 
     2401 CTGCAAAACC ACCAATAATA GGCCCCGCTA TTAAACCAAG CCCAAAACTT GCCCCTAACC 
     2461 AACCGAACCA CTTCACGCGT TGAGAAGCTG AGGTGGTATC GGCAATGACC GATGCCGCGA 
     2521 CAGCCCCAGT AGCTCCTGTG ATCCCTGAAA GCAAACGGCC TAAATACAGC ATCCAAAGCG 
     2581 CACTTGAAAA AGCCAGCAAT AAGTAATCCA GCGATGCGCC TATTAATGAC AACAACAGCA 
     2641 CTGGGCGCCG ACCAAATCGG TCAGACATTT TTCCAAGCCA AGGAGCAAAG ATAACCTGCA 
     2701 TTAACGCATA AAGTGCAAGC AATACGCCAA AGTGGTTAGC GATATCTTCC GAAGCAATAA 
     2761 ATTCACGTAA TAACGTTGGC AAGACTGGCA TGATAAGGCC AATCCCCATG GCATCGAGTA 
     2821 ACGTAATTAC CAATGCGATC TTTGTCGAAC TATTCATTTC ACTTTTCTCT ATCACTGATA 
     2881 GGGAGTGGTA AAATAACTCT ATCAATGATA GAGTGTCAAC AAAAATTAGG AATTAATGAT 
     2941 GTCTAGATTA GATAAAAGTA AAGTGATTAA CAGCGCATTA GAGCTGCTTA ATGAGGTCGG 
     3001 AATCGAAGGT TTAACAACCC GTAAACTCGC CCAGAAGCTA GGTGTAGAGC AGCCTACATT 
     3061 GTATTGGCAT GTAAAAAATA AGCGGGCTTT GCTCGACGCC TTAGCCATTG AGATGTTAGA 
     3121 TAGGCACCAT ACTCACTTTT GCCCTTTAGA AGGGGAAAGC TGGCAAGATT TTTTACGTAA 
     3181 TAACGCTAAA AGTTTTAGAT GTGCTTTACT AAGTCATCGC GATGGAGCAA AAGTACATTT 
     3241 AGGTACACGG CCTACAGAAA AACAGTATGA AACTCTCGAA AATCAATTAG CCTTTTTATG 
     3301 CCAACAAGGT TTTTCACTAG AGAATGCATT ATATGCACTC AGCGCTGTGG GGCATTTTAC 
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     3361 TTTAGGTTGC GTATTGGAAG ATCAAGAGCA TCAAGTCGCT AAAGAAGAAA GGGAAACACC 
     3421 TACTACTGAT AGTATGCCGC CATTATTACG ACAAGCTATC GAATTATTTG ATCACCAAGG 
     3481 TGCAGAGCCA GCCTTCTTAT TCGGCCTTGA ATTGATCATA TGCGGATTAG AAAAACAACT 
     3541 TAAATGTGAA AGTGGGTCTT AAAAGCCCCA TCGGCCTCGG GGGCCGAATT CGCGGCCGCA 
     3601 GTCGACCATC ATCATCACCA TCACGGGGCC GCAGAACAAA AACTCATCTC AGAAGAGGAT 
     3661 CTGAATGGGC GCGCCGCATA GTGATATCGC AAGCTTGACC TGTGAAGTGA AAAATGGCGC 
     3721 ACATTGTGCG ACATTTTTTT TGTCTGCCGT TTACCGCTAC TGCGTCACGG ATCCCCACGC 
     3781 GCCCTGTAGC GGCGCATTAA GCGCGGCGGG TGTGGTGGTT ACGCGCAGCG TGACCGCTAC 
     3841 ACTTGCCAGC GCCCTAGCGC CCGCTCCTTT CGCTTTCTTC CCTTCCTTTC TCGCCACGTT 
     3901 CGCCGGCTTT CCCCGTCAAG CTCTAAATCG GGGCATCCCT TTAGGGTTCC GATTTAGTGC 
     3961 TTTACGGCAC CTCGACCCCA AAAAACTTGA TTAGGGTGAT GGTTCACGTA GTGGGCCATC 
     4021 GCCCTGATAG ACGGTTTTTC GCCCTTTGAC GTTGGAGTCC ACGTTCTTTA ATAGTGGACT 
     4081 CTTGTTCCAA ACTGGAACAA CACTCAACCC TATCTCGGTC TATTCTTTTG ATTTATAAGG 
     4141 GATTTTGCCG ATTTCGGCCT ATTGGTTAAA AAATGAGCTG ATTTAACAAA AATTTAACGC 
     4201 GAATTTTAAC AAAATATTAA CGTTTACAAT TTCAGGTGGC ACTTTTCGGG GAAATGTGCG 
     4261 CGGAACCCCT ATTTGTTTAT TTTTCTAAAT ACATTCAAAT ATGTATCCGC TCATGTCGAG 
     4321 ACGTTGGGTG AGGTTCCAAC TTTCACCATA ATGAAATAAG ATCACTACCG GGCGTATTTT 
     4381 TTGAGTTATC GAGATTTTCA GGAGCTAAGG AAGCTAAAAT GGAGAAAAAA ATCACTGGAT 
     4441 ATACCACCGT TGATATATCC CAATGGCATC GTAAAGAACA TTTTGAGGCA TTTCAGTCAG 
     4501 TTGCTCAATG TACCTATAAC CAGACCGTTC AGCTGGATAT TACGGCCTTT TTAAAGACCG 
     4561 TAAAGAAAAA TAAGCACAAG TTTTATCCGG CCTTTATTCA CATTCTTGCC CGCCTGATGA 
     4621 ATGCTCATCC GGAGTTCCGT ATGGCAATGA AAGACGGTGA GCTGGTGATA TGGGATAGTG 
     4681 TTCACCCTTG TTACACCGTT TTCCATGAGC AAACTGAAAC GTTTTCATCG CTCTGGAGTG 
     4741 AATACCACGA CGATTTCCGG CAGTTTCTAC ACATATATTC GCAAGATGTG GCGTGTTACG 
     4801 GTGAAAACCT GGCCTATTTC CCTAAAGGGT TTATTGAGAA TATGTTTTTC GTCTCAGCCA 
     4861 ATCCCTGGGT GAGTTTCACC AGTTTTGATT TAAACGTGGC CAATATGGAC AACTTCTTCG 
     4921 CCCCCGTTTT CACCATGGGC AAATATTATA CGCAAGGCGA CAAGGTGCTG ATGCCGCTGG 
     4981 CGATTCAGGT TCATCATGCC GTCTGTGATG GCTTCCATGT CGGCAGAATG CTTAATGAAT 
     5041 TACAACAGTA CTGCGATGAG TGGCAGGGCG GGGCGTAATT TTTTTAAGGC AGTTATTGGT 
     5101 GCCCTTAAAC GCCTGGTGCT ACGCCTGAAT AAGTGATAAT AAGCGGATGA ATGGCAGAAA 
     5161 TTCGAAAGCA AATTCGACCC GGTCGTCGGT TCAGGGCAGG GTCGTTAAAT AGCCGCTTAT 
     5221 GTCTATTGCT GGTTTACCGG TTTATTGACT ACCGGAAGCA GTGTGACCGT GTGCTTCTCA 
     5281 AATGCCTGAG GCCAGTTTGC TCAGGCTCTC CCCGTGGAGG TAATAATTGC TCGACATGAC 
     5341 CAAAATCCCT TAACGTGAGT TTTCGTTCCA CTGAGCGTCA GACCCCGTAG AAAAGATCAA 
	   144	  
     5401 AGGATCTTCT TGAGATCCTT TTTTTCTGCG CGTAATCTGC TGCTTGCAAA CAAAAAAACC 
     5461 ACCGCTACCA GCGGTGGTTT GTTTGCCGGA TCAAGAGCTA CCAACTCTTT TTCCGAAGGT 
     5521 AACTGGCTTC AGCAGAGCGC AGATACCAAA TACTGTCCTT CTAGTGTAGC CGTAGTTAGG 
     5581 CCACCACTTC AAGAACTCTG TAGCACCGCC TACATACCTC GCTCTGCTAA TCCTGTTACC 
     5641 AGTGGCTGCT GCCAGTGGCG ATAAGTCGTG TCTTACCGGG TTGGACTCAA GACGATAGTT 
     5701 ACCGGATAAG GCGCAGCGGT CGGGCTGAAC GGGGGGTTCG TGCACACAGC CCAGCTTGGA 
     5761 GCGAACGACC TACACCGAAC TGAGATACCT ACAGCGTGAG CTATGAGAAA GCGCCACGCT 
     5821 TCCCGAAGGG AGAAAGGCGG ACAGGTATCC GGTAAGCGGC AGGGTCGGAA CAGGAGAGCG 
     5881 CACGAGGGAG CTTCCAGGGG GAAACGCCTG GTATCTTTAT AGTCCTGTCG GGTTTCGCCA 
     5941 CCTCTGACTT GAGCGTCGAT TTTTGTGATG CTCGTCAGGG GGGCGGAGCC TATGGAAAAA 
     6001 CGCCAGCAAC GCGGCCTTTT TACGGTTCCT GGCCTTTTGC TGGCCTTTTG CTCACATG 
// 
The vector was a periplasmic anchor vector with chloramphenicol (CM) resistance, so I had to 
make my own CM plates: 200 ml LB and 15 g/L bacto agar were mixed and autoclaved. After 
cooling down the autoclaved media and before pouring the plates, a final concentration of 34 
µg/ml was added. 
The SfiI enzyme is an enzyme that generates non-compatible ends so one can use it to directly 
insert fragments without being worried about the vector self-ligation. The designed primers to 
incorporate fragments into vector: 
pAPEX-rev 5'- GGC CGG CTG GGC CTC GCT GCT ACT CTG GTC GC 
pAPEX-for 5'- GGC CTC GGG GGC CGA ATT CGC GGC CGC 
Az-APEX-for 5'- GCA GCG AGG CCC AGC CGG CCG CTG AAT GCT CCG TTG ATA TCC 
Az-APEX-rev 5'- CGC GAA TTC GGC CCC CGA GGC CCT ATT TCA GAG TCA GGG TAC CTT TCA TCA 
G 
mCh-APEX-for 5'- GCA GCG AGG CCC AGC CGG CCA TGG TGA GCA AGG GCG AGG AGG 
mCh-APEX-rev 5'- CGC GAA TTC GGC CCC CGA GGC CTT ACT ACT TGT ACA GCT CGT CCA TGC C 
mCh-APEX-long-f 5'- GGC AGG TTG CGA CCA GAG TAG CAG CGA GGC CCA GCC GGC CAT GGT GAG 
CAA GGG CGA GGA GG 
mCh-APEX-long-r 5'- GGT GAT GAT GAT GGT CGA CTG CGG CCG CGA ATT CGG CCC CCG AGG CCC TTG 
TAC AGC TCG TCC ATG CCG CC 
To obtain mCh-Az fragment, I used mCh-APEX-for and Az-APEX-rev. to obtain mCh, I had 
to use the mCh-APEX-long pair. I obtained the fragments using PCR. The PCR of the vector 
wasn’t successful, so I digested it using SfiI enzyme. The construct preparation was formed 
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using Gibson assembly kit from NEB. The constructs were confirmed through sequencing by 
ACGT-inc Company. 
The surface expression was performed similar to what reported by Georgiou’s group with 
slight modifications.31 The plasmid was transformed into TOP10 cells to enable arabinose 
induction. The cells were induced when they reached O.D. 0.6 by addition of 0.5-1% Ara and 
then let expressed overnight at 30 C. Purification is similar to azurin, but I keep the cells after 
osmatic shock. To incorporate Cu in vivo, I tried adding 1mM Cu together with arabinose. 
6.3.2.4. Construction of mCherry fusion to circularly permutated proteins 
Yang Yu designed two versions of circularly permutated azurin (cp-Az1/2) and I designed 
primers to get the pET28-cpAz-mCh construct. The primer sequences are shown below: 
CP-­‐Az1-­‐EcoRI-­‐f:	  5’-­‐GCGGATCCGATGGAGTTCAACACCAA	  
CP-­‐Az1-­‐SacI-­‐r:	  5’-­‐CGAGCTCCTGATCATTACCCTGGATA	  
CP-­‐Az2-­‐EcoRI-­‐f:	  5’-­‐GCGGATCCGATGGGCGTTATGGGTC	  
CP-­‐Az2-­‐SacI-­‐r:	  5’-­‐CGAGCTCCTTCGGCAGGTTACCTGG	  
mCh-­‐SacI-­‐f:	  5’-­‐CGAGCTCATGGTGAGCAAGGGCG	  
mCh-­‐NotI-­‐r:	  5’-­‐	  ATAAGAATGCGGCCGCTTACTACTTG	  
	  
I built the constructs in two ways. In the first method, I ran PCR and obtained the fragments 
as shown above. I PCR-purified the fragments and confirm them by running them on 1% agarose 
gel, 120 V, 20 min. I then digested both the fragments and the pET28b vector with the proper 
restriction enzyme, PCR-purified them following the protocol provided by Qiagen kit and set the 
ligation reaction using Roche quick ligation kit. The final constructs were confirmed through 
sequencing by DNA-inc, UIUC.  
In the other method, to obtain the cpAz1/2-mCh fragment, I performed an overlap extension 
PCR. In this method I first run few PCR cycles to obtain small fragments of cp-Az and mCh. I 
then used those fragments and the forward primer from cpAz and the reverse primer from mCh 
to extend the cp-Az-mCh fragment. After obtaining that fragment and confirming that by running 
on a gel, I performed the digestion and ligation as explained above. 
6.3.2.5. Protein purification 
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Plasmids were transformed into BL21(DE3) competent cells. Single colonies were picked and 
inoculated into start culture of 5 mL LB with corresponding antibiotics. After 8 hours, start 
culture was inoculated 1:1000 into large LB culture with corresponding antibiotics. It was shaken 
at 37 °C overnight. IPTG was added to final concentration of 0.3 mM and culture was inducted 
for 4 hours before harvesting. Cells were harvested by centrifuge at 8000 rpm for 10 min. Pellet 
was resolubilized in 25mM HEPES, 250 mM NaCl, pH 7 and sonicated for 6 min at 70 W. After 
sonication, cells were centrifuged for 30 min at 13000rpm to separate supernatant and pellet. 
Proteins without His-tag(mCherry-linker-Azurin) were exchanged to 50mM Tris, pH9, then 
loaded on HiTrap Q column(GE healthcare), desired protein were eluted with salt gradient and 
with 590nm absorbance monitored on AKTA. 
Proteins with His-tag were loaded on a Ni-NTA(NEB) column. Following washing with 
10mM imidazole, protein was eluted by 500mM imidazole or an imidazole gradient. Protein 
identity and purity were verified by SDS-PAGE. 
To purify the proteins without His-tag, the purification protocol for GFP was adopted.  
Briefly, after sonication of cells, ammonium sulfate is added to the supernatant to reach 40% 
ammonium sulfate in total. This will precipitate most proteins. After stirring for an hour at 4 C, 
the protein is subjected to centrifugation. The supernatant contains the proteins. To pellet the 
protein, ammonium sulfate is added to the protein solution to reach a final of 80%. After 
centrifugation, the pellet is dissolved in lysis buffer and is dialyzed against 20 mM HEPES 
buffer at pH 7.5. The protein will then be loaded onto a size exclusion column. 
To purify mCh-Az in membrane form, I adapted a protocol from Gennis lab. After 4 hours of 
induction with 0.5 % arabinose at 37 C, I harvested the cells and resuspended them in 200 mM 
potassium phosphate buffer, pH 7.5. I then sonicated the cells for 3 times using Misonix 
ultrasonic liquid processor. The process time was 6:00 min with 6 s pulses on and 12 s pulses off 
and amplitude of 70. I then used the ultracentrifuge instrument. The vacuum was first turned on 
until the instrument was cooled down to 4 C. Cells were then poured ultracentrifuge tubes and 
carefully adjusted for weight. The vacuum was stopped and the protein samples were placed in 
ultracentrifuge. After sealing the door, the vacuum was turned on again. When the pressure was 
below 200 I started the centrifugation at 40000 rpm for four hours. The pellet had the membrane 
proteins. It was then resuspended in buffer with 1% DDM (a detergent). I first resuspended the 
cells in the buffer and then added DDM dropwise while stirring. I stirred for three hours at 4 C. 
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Cells were then centrifuged in the ultracentrifuge for one hour at 40000 rpm (or half an hour at 
42000). All other purification steps should be performed with buffers that contain 0.5% DDM. 
6.3.2.6. Fluorescence spectrometry 
Fluorescent studies were performed on a HORIBA Jobin Yvon Fuoromax-P using an 
excitation wavelength of 590 nm, a scan range from 600-750 nm, slit width of 1.5 nm in 
excitation and 2 nm at emission, integration time of 0.01 s with 0.5 nm increments. About 200µL 
of 0.1mM protein was used for fluorescence measurement. CuSO4 or ascorbate acid were added 
into protein solution in cuvette and mixed by vortex. Every spectrum was taken in triplicate. The 
concentration of the proteins when fused to mCherry was estimated based on mCh absorption 
(ɛ590 = 41000) and for azurin variants using ɛ280 = 9000 M-1cm-1. For cpAz-mCh studies, 
excitation at 587 was used with slit opening of 3 and 3 nm. 
6.3.2.7. Spectroscopies 
Electronic absorption was taken on an HP diode array spectrometer or a Cary 5000 
spectrometer. X-band EPR spectra were collected on a Varian E-122 spectrometer at the Illinois 
EPR Research Center (IERC). Proteins were exchanged to TIP7 buffer32 by a short Sephadex G-
25 column and 25% of glycerol was added. The samples were run at ∼30 K using liquid He and 
an Air Products Helitran cryostat with 20% glycerol. Magnetic fields were calibrated with a 
Varian NMR gaussmeter, and the frequencies were measured with an EIP frequency counter. 
6.3.2.8. Flow cytometry analysis 
To make sure the protein is displayed on the surface of yeast, flow cytometry studies was 
performed. Cells were first grown on 2 ml media at 30 overnight. The density of cells was 
checked by measuring absorption at 600 nm. A volume of OD=0.1(initial OD=x, volume to be 
added=X/0.1) was added to v-shape 96 well plates (highest density that instrument can handle). 
Centrifuge the pellet for 2 min at 4000 rpm. Cells were resuspended in 200 µl PBS-BSA 5% and 
then centrifuged again. Supernatant was taken out using vacuum and this washing step was 
repeated at least for 3 more times. Then 25 ml of 1x antibody (antiV5-mouse antibody) was 
added to the wells and incubated 1 hour at 4. 190 µl PBS-BSA was added and centrifuged and 
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the supernatant was removed by vacuum. This washing step was repeated one more time. 25 µl 
of 1x second antibody which is biotin-anti mouse was added to pellet and incubated 1 hour at 4. 
Cells were washed twice with 190 µl PBS-BSA.25 µl of third tag, streptavidin-PE, was added 
next and plate was incubated for 40 minutes at 4 covered with aluminum foil. Plates were 
washed three times with 190 µl PBS-BSA and if washing is good, one should see pink color in 
plates. Pellets were resuspended in 280 µl PBS-BSAand were transferred to flow cytometry 
tubes and analyzed by flow cytometry instrument as suggested by operator on PE channel.  
To perform flow cytometry on bacterial display variant, I resuspended the pellet after osmatic 
shock in PBS buffer and used those to run the flow cytometry. I used to use an old program using 
PE-A and perCy5 dyes before but then I realized it is wrong and I changed it with the help of 
Barbara Pilas in flow-cytometry lab. The SCS threshold was set to 1000 due to small size of the 
cells and cells were run at low rate. We also changed the instrument so that I can get yellow laser 
for better results.I used Forresta flow cytometer in MNTL and used PE-Texas Red to excite my 
samples. The instrument also has a photomultiplier tube that enhances the signal. The method 
was written by Barbara. 
PBS buffer was prepared as follows: 
8 gr NaCl, 0.2 gr KCl, 1.44 gr Na2HPO4, 0.24 gr KH2PO4  in 20 ml water 
 6.3.2.9. Construction of domain insertion variants 
I used Gibson assembly to build these constructs. The general design is vector_mCh-
part1_cpAz_mCh-part2_vector. I designed to types of primers: primers to PCR the vector and 
primers to add NdeI and XhoI to mCh to insert mCh into vector if the vector PCR didn’t work. 
Below are the sequences of the primers. The constructs were confirmed through sequencing by 
ACGT-inc. 
mCh-pET28b-NdeI-f 5'- GGG AAT TCC ATA TGG TGA GCA AGG GCG AGG AGG ATA AC 
mCh-pET28b-XhoI-r 5'-  GGC GCT CGA GTT ACT ACT TGT ACA GCT CGT CCA TGC CGC C 
pET28b-mCh-gr-2 5'- GGC GGC ATG GAC GAG CTG TAC AAG CAC CAC CAC CAC CAC 
CAC TGA GAT CCG GCT GCT AAC AAA GCC C 
pET28b-mCh-gf 5'-GGC GGC ATG GAC GAG CTG TAC AAG CAC CAC CAC CAC CAC 
CAC TGA 
mCh-pET28b-gf-2 5'- CCC CTC TAG AAA TAA TTT TGT TTA ACT TTA AGA AGG AGA 
TAT ACC ATG GTG AGC AAG GGC GAG GAG GAT AAC 
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mCh-pET28b-gr-2 5'- GGG CTT TGT TAG CAG CCG GAT CTC AGT GGT GGT GGT GGT 
GGT GCT TGT ACA GCT CGT CCA TGC CGC C 
mCh189-190_r 5'- CTT GGC CTT GTA GGT GGT CTT GAC C 
mCh189-190_f 5'- AAG CCC GTG CAG CTG CCC 
mCh193-194_r 5'- CTG CAC GGG CTT CTT GGC CTT G 
mCh193-194_f 5'- CTG CCC GGC GCC TAC AAC G 
cpAz1_mCh189-190_linker_f 5'- GGT CAA GAC CAC CTA CAA GGC CAA GTC GGG CGG CTC CAT 
GGA GTT CAA CAC CAA CGC C 
cpAz1_mCh189-190_linker_r 5'- GGG CAG CTG CAC GGG CTT GGA GCC GCC CGA CTG ATC ATT 
ACC CTG GAT ATC AAC GG 
cpAz1_mCh193-194_linker_f 5'- CAA GGC CAA GAA GCC CGT GCA GTC GGG CGG CTC CAT GGA 
GTT CAA CAC CAA CGC C 
cpAz1_mCh193-194_linker_r 5'- CGT TGT AGG CGC CGG GCA G GGA GCC GCC CGA CTG ATC ATT 
ACC CTG GAT ATC AAC GG 
cpAz2_mCh189-190_linker_f 5'- GGT CAA GAC CAC CTA CAA GGC CAA GTC GGG CGG CTC CAT 
GGG CGT TAT GGG TCA CAA CTG GG 
cpAz2_mCh189-190_linker_r 5'- GGG CAG CTG CAC GGG CTT GGA GCC GCC CGA CTT CGG CAG 
GTT ACC TGG GTG AG 
cpAz2_mCh193-194_linker_f 5'- CAA GGC CAA GAA GCC CGT GCA GTC GGG CGG CTC CAT GGG 
CGT TAT GGG TCA CAA CTG GG 
cpAz2_mCh193-194_linker_r 5'- CGT TGT AGG CGC CGG GCA G GGA GCC GCC CGA CTT CGG CAG 
GTT ACC TGG GTG AG 
 
6.3.3. Results and discussion 
6.3.3.1. Construction of Azurin-mCherry fusion protein 
We used overlap extension PCR to fuse Azurin to mCherry and put the fragment into 
pET22b vector using standard digestion and ligation protocol. Azurin and mCherry attached to 
each other via different types of linkers and also without linker and the constructs were validated 
by sequencing.  
6.3.3.2. Fluorescence analysis of Azurin-mCherry fusion proteins 
Since all the fusion proteins have His tag, they were purified according to Ni-NTA protocol 
by passing through a Nickel column. The quenching efficiency of each protein was assessed by 
measuring mCherry fluorescence using a fluorometer. Results are shown in figure 1. Construct 
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mCherry-SGGS-azurin gave the best quenching over other constructs (~30% at 1Eq of Cu2+, 
Figure 6.7, generated by Yang Yu) 
 
Figure 6.7. Results of Fluorescent quenching upon Cu addition in different mCh-Az variants. 
6.3.3.3. Yeast surface display of Azurin-mCherry 
We chose the commonly used method of α-agglutinin fusion for displaying the fusion protein 
on the surface of the yeast.29,30 To evaluate the method, we started to display azurin alone first. 
The construct was made using homologous recombination of yeast, by a method called DNA 
Assembler.33 Although sequencing has confirmed the proper placement of Azurin gene inside the 
vector, we couldn’t see protein expression using antibodies against a-agglutinin and TEF (figure 
6.8). 
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Figure 6.8. Aschematic representation of the vector for yeast display of Az generated by Tong Si from Huimin Zhao 
lab using Vector-NTI program. 
 The expression failed in multiple trials, so we hypothesized that Azurin cannot be folded 
properly inside yeast, which prevents its display on surface. To circumvent this problem, we 
repeated the experiment with Azurin-mCherry fusion based on the fact that mCherry has a very 
stable fold that can mediate azurin folding. However, we couldn’t see any expression.  To 
overcome the obstacle, we put Azurin-mCherry gene in front of inducible Gal10 promoter 
because it has higher expression levels than the constitutive promoter we were using. The 
expression failed again for this construct. We tested the expression using flow cytometry (data 
not shown but is presented in page 140 of PH notebook III). 
6.3.3.4. Bacterial surface display of Azurin-mCherry and flow cytometry 
Since azurin could not be displayed on the surface of yeast, we decided to change our display 
system from yeast to bacteria. We adapted the anchored periplasmic expression (APEx) method 
reported by George Georgiou group (figure 6.9). Visual inspection of the mCh color confirmed 
that the majority of the protein is expressed on cell surface. This observation was confirmed by 
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running the cells on flow cytometry and observing a shift in cell population compared to Az-
pAPEX control that has no fluorescent.31  
 
Figure 6.9. Overall scheme of bacterial surface display, adapted from ref .31 
Using the old method, I could only see aggregates of cell and a small signal due to the laser 
not exciting the mCh at right wavelength. Using the machine with yellow laser and the new set 
up, I obtained clear results showing that cells expressed the fluorescent protein (figure 6.10). 
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Figure 6.10. Flow cytometry of cells expressing mCh, mCh-Az, or Az on surface. The left figure is shown the result 
upon excitation with yellow laser. Results from excitation with an improper laser are shown on the right. 
The Cu quenching experiments resulted in inconsistent outputs. Sometimes Cu seemed to 
quench the fluorescent and sometimes not and even when it quenched, according to Barbara 
Pilas, it was not enough to sort the cells. Since the Cu was effective at quenching mCh alone, 
unfolding of Az on the surface was one of the possible scenarios that came into mind (figure 
6.11). 
 
Figure 6.11. Flow cytometry results of Cu quenching. 
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In order to test the possibility, I purified the mCh-Az in its membrane-bound form. Presence 
of a pink color in final supernatant is another indicator of the protein being membrane-associated 
as designed. Attempts to incorporate Cu into the protein was not successful, which is an 
indicator of improper Cu incorporation due to maybe wrong folding (figure 6.12). 
 
Figure 6.12. UV-vis of membranous Az and mCh-Az protein, before and after Cu incorporation. The peak at 700 nm 
corresponds to free-Cu(II) absorption. The peak around 580 is due to mCherry. 
 6.3.3.5. In vitro studies of cpAz variants 
The cpAz-mCh variants were designed with the hope that having the mCh closer to the Cu 
site (now at terminals) would increase the quenching efficiency (figure 6.13, generated by Yang 
Yu). The protein was expressed in decent yield and the ESI showed mass values (43042 ± 5) 
close to the expected mass (43194). However, initial fluorescent investigations of the cpAz-mCh 
constructs showed that the quenching by Cu is nominal in Cu equivalents less than two and that 
the observed quenching cannot be restored by reducing the Cu using ascorbate (data not shown 
but available in PH notebook II, page 187). 
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Figure 6.13. Schematic representation of cpAz-mCh construct. 
Cu titration into the purified protein showed detectable Cu incorporation (figure 6.14) but the 
levels are much lower than the normal azurin variants. 
 
Figure 6.14. Cu incorporation into cpAz1-mCh. 
The EPR studies of the Cu loaded protein (the protein concentration was estimated using 
ε587= 78000 M-1cm-1) showed a distorted Cu binding site that is more similar to a type 2 Cu 
center as shown in figure 6.15. 
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Figure 6.15. EPR of cpAz-mCherry in a Cu-loaded form. (30 mW, 30 K, 4 g modulation) 
Fluorescent studies showed that although a decrease in fluorescent signal is observed upon 
Cu addition, the decrease is about the same as what one will see with just Cu and mCh (figure 
6.16). 
 
Figure 6.16. The left figure shows the effects of Cu titration in quenching the fluorescent from cpAz-mCh. The right 
figure, generated by Yang Yu, shows the same experiment but with mCh alone. 
To make sure that the free mCh and the one fused to azurin have similar properties, I measured 
the quantum yield of the protein in my cpAz-mCh construct using the equation below: 
Qy= # photons emitted/ # of photons absorbed 
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# of photons emitted can be estimated by the area under emission when you excite the sample 
and the # of photons absorbed depends on the concentration and the extinction coefficient which 
I assumed to be the same for mCh and cpAz-mCh.  
The calculated quantum yield for the cpAz-mCh is about 0.359 close to the one from mCh, 
0.22. Interestingly, keeping the sample in -80 decreased the quantum yield (maybe because it 
was exposed to light). 
 6.3.3.6. Attempts for domain insertion 
One way to decrease the distance between the two proteins is to insert one of them in the 
loops of another. Yang Yu tried some positions in mCh that were structurally analogous to the 
successful insertion positions in GFP. However, that failed. I picked positions 189-190 and 193-
194 (figure 6.17) that were known to retain mCherry fluorescent after being cut in the circularly 
permutated variants.34,35  
 
Figure 6.17. Positions of mCh that were tried to generate circularly permutated variants. The one in white retained 
fluorescence. The red dots show the positions I tried. Figure from ref 35 
The variants however failed to express functional mCh as observed by lack of color despite 
being expressed based on SDS-PAGE (figure 6.18). 
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Figure 6.18. 4-20% SDS gel, monitoring expression of domain inserted mCh-Az. The protein band is clearly visible, 
indicating that the protein is expressed. The lower band in the ladder is 10 kDa. 
6.4. Use of noncanonical amino acid, hydroxycoumarin 
6.4.1. Introduction 
The ability to incorporate noncanonical amino acids  (ncAAs) into a protein greatly expanded 
the repertoire of available functional groups to study proteins and add new modalities to them. 
While a large number of ncAAs can be incorporated into peptides using chemical synthesis,36 
most proteins are much bigger than the upper limits of the chemical synthesis, about 50 to 100 
amino acids.37 Expressed protein ligation (EPL) was a leap in incorporating ncAAs into proteins, 
combining the power of chemical synthesis and the ability to express the bigger part of the 
protein by homologous recombination (see figure 6.19).38-42 Despite the progress made in the 
possible ways the peptide can be linked to the protein, there are still limitations on the positions 
in proteins into which one can incorporate the ncAA of interest.  
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Figure 6.19. Schematic of a common EPL technique, adapted from Ref 39 
The emergence of an orthogonal tRNA-tRNA synthase method for incorporation of ncAAs 
developed by Peter Schulz opened new avenues in ncAA incorporation.43 This method enables 
scientists to incorporate the ncAA in a completely in vivo set up and express the protein with the 
ncAA incorporated in a stop codon that is placed in the position of interest, usually Amber stop 
codon.44-49 In order for the method to work, one need to evolve an unnatural pair of tRNA and 
tRNA synthetase that can recognize and incorporate the ncAA and not recognize other amino 
acids. The most common way of carrying out the selection is shown in figure 6.20. 
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Figure 6.20. General method of evolution of tRNA-tRNA synthase pair. Figure from Ref 44 
We used the same method to incorporate a fluorescent amino acid, hydroxycoumarin, into 
our protein as the fluorescent probe. The ncAA was designed and developed by our collaborator. 
Figure 6.21 shows some of the properties of this ncAA.50  
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Figure 6.21. Synthesis and UV-vis spectroscopy of hydroxycoumarin. Figure from Ref 50 
6.4.2. Materials and methods 
 6.4.2.1. Protein expression and purification 
The F114TAG (pET vector, kanr) and pEVol-Hq (CMr) were transformed into BL21 (DE3) 
cells from NEB using normal transformation protocol. However, the cells were plated on a plate 
containing both kanamycin and chloramphenicol. Protein expression was induced by addition of 
1 mM IPTG and 0.2 % arabinose. At the same time 12 mg/50 ml of the hydroxycoumarin was 
also added. Protein was purified as normal azurin but I skipped the precipitation step to avoid 
precipitating the protein. The purification was performed in a small scale. 
 6.4.2.2. Fluorescent studies 
Fluorescent studies were performed on a HORIBA Jobin Yvon Fuoromax-P using an 
excitation wavelength of 340 nm, a scan range from 390-450 nm, slit width of 2 nm in excitation 
and 2 nm at emission, integration time of 0.01 s with 0.5 nm increments. About 200µL of 10 µM 
protein was used for fluorescence measurements. 
 6.4.2.3. VMD analysis  
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I wrote the topology file for the hydroxycoumarin myself based on provided topologies in 
VMD. Below you may find the topology file: 
 
RESI COU          0.00 
GROUP 
ATOM N    NH1    -0.47  !     |              H1   O2 
ATOM HN   H       0.31  !  HN-N               |  || 
ATOM CA   CT1     0.07  !     |   HB1 HG1    C1--C2 
ATOM HA   HB      0.09  !     |   |    |    //     \ 
GROUP                   !  HA-CA—-CB—--CG--CD      O3 
ATOM CB   CT2    -0.26  !     |   |    |    \      / 
ATOM HB1  HA      0.13  !     |   HB2  HG2   C3==C4 
ATOM HB2  HA      0.13  !   O=C             /     \ 
ATOM CG   CT2    -0.26  !     |        H5--C5     C6—H6 
ATOM HG1  HA      0.13  !                   \\    // 
ATOM HG2  HA      0.13  !                    C7--C8 
GROUP                   !                    |      \ 
ATOM C    C       0.51  !                    H7     O4--H4 
ATOM O    O      -0.51  ! 
GROUP 
ATOM CD   CA      0.00 
ATOM C1   CA     -0.115 
ATOM H1   HP      0.115 
ATOM C2   CA      0.5 
ATOM O2   O      -0.5 
ATOM O3   OS -0.04 
ATOM C4   CT2     0.04 
GROUP 
ATOM C3   CT2    -0.03 
ATOM C5   CA     -0.085 
ATOM H5   HP      0.115 
ATOM C6   CA     -0.115 
ATOM H6   HP      0.115 
ATOM C7   CA     -0.115 
ATOM H7   HP      0.115 
ATOM C8   CA      0.11 
ATOM O4   OH1    -0.54 
ATOM H4   H       0.43 
BOND CB CA  N  HN  N  CA 
BOND C  CA  C  +N  CA HA  CB HB1  CB HB2 
BOND CB CG CG HG1 CG HG2 CG CD 
BOND CD C3  C3 C5  C5 H5 
BOND C1 C2  C1 H1  C2 O3 
BOND O3 C4  C4 C6 C6 H6 
BOND C6 C8  C8 O4 O4 H4 C7 C8  C7 H7 
DOUBLE O  C  CD C1 C3 C4 C5 C7  C6 C8  C2  O2 
IMPR N -C CA HN  C CA +N O 
CMAP -C  N  CA  C   N  CA  C  +N 
DONOR HN N  H4 O4 
ACCEPTOR O C O2 C2 
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I couldn’t generate a good parameters file for the molecule, so I never ran simulations with 
the ncAA. For my simulations, I just used Trp. 
6.4.3. Results and discussion 
 6.4.3.1. Purification 
I have designed three positions as candidates for incorporating hydroxycoumarin. Figure 6.22 
shows the designs. Residue Tyr72 seems the best position to me. Although it is not as close to 
the Cu site as Phe114, it has a lower chance to interfere with Cu binding. Met13 position was 
suggested by Yang Yu but I didn’t try it because it was very flexible. Since Chang Cui had 
already made the mutation for Phe114Hq, I went ahead with that one.  
 
Figure 6.22. VMD representation of hydroxycoumarin in different positions in Az. 
The expression yield was as expected for a ncAA-containing protein, poor. As shown in 
figure 6.23, both SDS-PAGE and the UV-vis are indicative of expression of the protein. The 
UV-vis data also shows the peak from hydroxycoumarin, suggesting the incorporation of the 
ncAA. 
 
Figure 6.23. SDS-PAGE of F114Hq shows clear expression band corresponding to molecular weight of the protein 
in the right-most lane. UV-vis features of the protein are also consistent with the presence of the fluorescent 
hydroxycoumarin. 
F114hq M13hq Y72hq 
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The Cu titration showed successful incorporation of Cu into the protein. The 635 nm peak 
however, looked different from other azurin variants, suggesting a possible rearrangement in the 
Cu site (figure 6.24). 
 
Figure 6.24. Cu titration into F114Hq. The blue spectrum is obtained after removing excess Cu by PD-10. 
 6.4.3.2. Fluorescent studies 
 The fluorescent studies on the F114Hq-Az showed that the quenching upon Cu titration into 
F114Hq-Az is more than the quenching resulted by adding holo-WTAz. Addition of Asc or 
dithionite however, did not restore the fluorescent. Adding more reducing equivalents just 
decreased the fluorescence even more. Figure 6.25 summarizes the results. 
	  	  	  
Figure 6.25. Summary of fluorescent studies on F114Hq-Az. 
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6.5. FlAsH dye 
6.5.1. Introduction and rationale 
Recent years has witnessed a significant progress in the field of small molecule sensors that 
can bind to specific sequences or motifs and can be detected by a signal, usually fluorescent read 
out. One such sensor is FlAsH. FlAsH is a bi-arsenate molecule designed by Roger Tsien and 
coworkers and was shown to have fluorescent signal upon binding to a special peptide motif, 
Cys-Cys-Xxx-Xxx-Cys-Cys, usually as a part of small helix (figure 6.26).51 This motif is very 
rare in natural proteins, hence by tagging a protein with this peptide, one can selectively monitor 
it inside a cell. The probe is shown to work very well in cellular conditions with bright 
fluorescence.51 The FlAsH molecule itself is also very stable and relatively easy to synthesize.52 
Later, the Schepartz group showed that FlAsH and its red analogue ReAsH are able to bind to 
loop regions as well as to two different proteins each of which has a di-Cys motif in them.53-55 
They used this property of the molecule to monitor binding of two proteins.53-55 Due to the high 
affinity of FlAsH to bind the motif and our previous success of fluorescent studies with Alexa 
Fluor, I decided to use FlAsH as a bright fluorophore that only fluoresce upon binding and can 
be quenched by Cu(II). Lack of other FlAsH binding motif will give binding specificity and 
since it is not covalent, the conjugation/binding may be more efficient than its covalent 
counterparts, such as Alexa Fluor. 
 
Figure 6.26. FlAsH and schematic representation of its mode of action. Figure from Life technologies website. 
6.5.2. Materials and methods 
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 6.5.2.1. Construct design, molecular dynamics simulations, and purification 
The constructs were designed for three different positions in azurin and are called Az-FlAsH-
1to3. The rationale behind each design is described in results and discussion section. Below you 
may find the designed primers for each site and the protein sequence for each of them. I used 
Gibson assembly to obtain the constructs. For FlAsH1 and FlAsH2, the primers were first 
designed for site directed mutagenesis but that didn’t work, so I mixed the two together and let 
anneal at room temperature for 2 hours and used that as the Gibson fragment. For FlAsH3, a 
separate Gibson fragment was ordered: 
Az_FlAsH_1: 
AECSVDIQGCCPGCCGQFNTNAITVDKSCKQFTVNLSHPGNLPKNVMGHNWVLSTAADMQGVVTDGMASGLDK
DYLKPDDSRVIAHTKLIGSGEKDSVTFDVSKLKEGEQYMFFCTFPGHSALMKGTLTLK 
FlAsH-1_Az_r 5'- GCC GCA GCA GCC CGG GCA GCA ACC CTG GAT ATC AAC GGA GC 
FlAsH-1_Az_f 5'- TGC TGC CCG GGC TGC TGC GGC CAG TTC AAC ACC AAC GCC 
FlAsH-1_f 
5'- GCT CCG TTG ATA TCC AGG GTT GCT GCC CGG GCT GCT GCG GCC AGT TCA 
ACA CCA ACG CC 
FlAsH-1_r 
5'- GGC GTT GGT GTT GAA CTG GCC GCA GCA GCC CGG GCA GCA ACC CTG GAT 
ATC AAC GGA GC 
Az_FlAsH_2: 
AECSVDIQGQFNTNAITVDKSCKQFTVNLSHPGNCCPGCCSGHNWVLSTAADMQGVVTDGMASGLDKDYLKPDD
SRVIAHTKLIGSGEKDSVTFDVSKLKEGEQYMFFCTFPGHSALMKGTLTLK 
FlAsH-2_Az_r 5'- GCT GCA GCA GCC CGG GCA GCA GTT ACC TGG GTG AGA CAG G 
FlAsH-2_Az_f 5'- TGC TGC CCG GGC TGC TGC AGC GGT CAC AAC TGG GTT CTG TCC 
FlAsH-2_f 
5'- CCT GTC TCA CCC AGG TAA CTG CTG CCC GGG CTG CTG CAG CGG TCA CAA 
CTG GGT TCT GTC C  
FlAsH-2_r 
5'- GGA CAG AAC CCA GTT GTG ACC GCT GCA GCA GCC CGG GCA GCA GTT ACC 
TGG GTG AGA CAG G  
Az_FlAsH_3: 
AECSVDIQGPGCCGSQFNTNAITVDKSCKQFTVNLSHPGCCPKNVMGHNWVLSTAADMQGVVTDGMASGLDKD
YLKPDDSRVIAHTKLIGSGEKDSVTFDVSKLKEGEQYMFFCTFPGHSALMKGTLTLK 
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FlAsH-3_site1_r 5'- GAT GGC GTT GGT GTT GAA CTG GCT GCC GCA GCA GCC CGG ACC CTG GAT 
ATC AAC GGA GCA TTC 
FlAsH-3_site2_f 5'- CCT GTC TCA CCC AGG TTG CTG CCC GAA GAA CGT TAT GGG TC 
Az_FlAsH3_Gibson 5'- GAA TGC TCC GTT GAT ATC CAG GGT CCG GGC TGC TGC GGC AGC CAG TTC 
AAC ACC AAC GCC ATC ACC GTC GAC AAG AGC TGC AAG CAG TTC ACT GTT 
AAC CTG TCT CAC CCA GGT TGC TGC CCG AAG AAC GTT ATG GGT C  
The primers were synthesized by IDT, Inc. and the constructs were confirmed through 
sequencing by ACGT, Inc.  
In order to make sure the constructs are well folded, molecular dynamics simulations on the 
designed proteins were performed. Since the constructs were not a result of simple mutagenesis, 
I used I-TASSER server56-58 to predict the structure of the given amino acid sequence first and 
then used that structure as initial point for PSF generation and molecular dynamics simulations. 
PVT cell was used with 10000 steps of minimization (2 fs/step) and 1 ns of simulation.59 
Proteins were expressed in small scale using common azurin purification protocol but the 
precipitation step was skipped. The purification was stopped after collecting fractions of a small 
SP-sepharose column due to small scale. The presence of samples was confirmed by running 
SDS-PAGE, 4-20%, 120 V, one hour. 
 6.5.2.2. Labeling method 
The FlAsH dye was purchased from Santa Cruz Biotech (sc-363644). The dye stock was 
prepared by dissolving a small amount of the dye in DMSO in a black tube to avoid light. The 
concentration of the stock was calculated using ε508= 41000 M-1cm-1. 
The labeling was performed using the method reported by Schepartz group with some 
modifications.53,54 In brief, 100 µl of 100 nM dye, diluted from the stock in 100 mM Tris-HCl pH 
8 + 75 mM NaCl+ 3.5 mM TCEP was mixed with 100 µl of protein exchanged into the same 
buffer in different concentrations. The reaction was kept at room temperature, in dark, for 90 min 
to complete. I avoided adding EDT and EDTA due to making the condition more stringent for 
dye binding and Cu binding, respectively. Later different concentrations of TCEP and different 
buffers were used as well. 
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 6.5.2.3. Spectroscopic studies 
Spectroscopic studies were performed either on a photo diode array HP instrument or on a 
Cary 5E spectrophotometer. Cu was titrated in an Eppendorf tube while stirring. 
 6.5.2.4. Fluorescent studies 
Fluorescent studies were performed on a HORIBA Jobin Yvon Fuoromax-P using an 
excitation wavelength of 508 nm, a scan range from 500-650 nm, slit width of 3 nm in excitation 
and 3 nm at emission, integration tume of 0.01 s with 0.5 nm increments.  The time course 
measurements were performed using the “time” option in the experiment type subdirectory of the 
instrument. The sample was excited at 508 nm and the 524 nm emission was monitored during a 
course of 300 sec with 1 sec intervals. 
6.5.2.5. NMR 
NMR samples were prepared by weighting the dry compounds and dissolving them in 
deuterated DMSO. The final concentration of the dye was about 3 mM and Cu and Zn salt were 
added to final of 5 molar equivalent to the dye. NMR tubes were covered with foil to protect the 
samples from light. 
6.5.3. Results and discussion 
 6.5.3.1. Construct design and expression 
 Three different designs were used to add the FlAsH binding motif to azurin. In the first 
design, Az_FlAsH_1 (figure 6.27), I inserted the binding motif in azurin loop 12 (the loop 
containing residue 12). This length of this loop varies the most among cupredoxins and is the one 
that is extended in nitrosocyanin so I thought that it would be more resistant to insertions. 
Molecular dynamics simulation showed that disulfide bond formation is not very likely with this 
design, however, there is a chance of the loop flipping outwards to the solvent and away from the 
Cu binding site. 
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Figure 6.27. Models of Az-FlAsh_1 before (left) and after (right) simulation. Initial model was generated by I-
TASSER. 
In the second design the motif is inserted in loop 44 (loop containing residue 44, see figure 
6.28). Such positioning will bring the FlAsH much closer to the Cu binding site. This design 
however has the drawback of being susceptible to disulfide formation. In addition, since it is 
very close to the Cu binding site, it may interfere with Cu binding. 
 
Figure 6.28. Models of Az-FlAsh_2 before (left) and after (right) simulation. Initial model was generated by I-
TASSER. 
Design 3 takes advantage of the study showing that FlAsH can bind to two separate peptides 
if each of them has a pair of di-Cys motif (figure 6.29). I incorporated one di-Cys motif in loop 
12 and one in loop 44. This way, the FlAsH is forced to bind right on top of the Cu binding site 
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and has a lower chance of interfering with the site as it is kept in place by two different sites of 
the protein. 
 
Figure 6.29. Models of Az-FlAsh_3 before (left) and after (right) simulation. Initial model was generated by I-
TASSER. 
SDS-PAGE showed that the small scale purification of all proteins resulted in yields enough 
for initial UV-vis and fluorescent studies. Figure 6.30 show a representative gel from construct 1: 
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Figure 6.30. Monitoring the expression of Az_FlAsH_1 by SDS-PAGE. 
6.5.3.2. Labeling of azurin with FlAsH 
The fluorescent studies clearly show specific labeling of azurin variants with the Cys-Cys-
Xxx-Xxx-Cys-Cys motif and not WT-Az (figure 6.31). Interestingly, FlAsH_3 construct showed 
better labeling efficiency. This observation can be either due to binding of two molecules of 
FlAsH per molecule of FlAsH_3 (since the motif is split) or due to better efficiency.  
 
Figure 6.31. Fluorescent studies show efficient labeling of FlAsH designs. 
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Labeling the proteins under different conditions resulted in several findings: a) As expected, 
increasing protein concentration increased the fluorescent signal; b) TCEP is necessary for the 
efficient labeling. One can lower the amount of added TCEP to 2 molar equivalents to the 
protein, but without TCEP labeling efficiency is negligible. Interestingly in acetate buffer higher 
concentrations of TCEP abolished the binding; c) Tris buffer is not necessary for the binding and 
ammonium acetate buffer at pH 6 works just as well. An overview of the results is shown in 
figure 6.32. 
 
Figure 6.32. Fluorescent monitoring of FlasH binding in different conditions. 
 6.5.3.3. Quenching by Cu  
In my initial Cu titration studies, I noticed that upon addition of Cu in excess to TCEP, 
fluorescent signal quenches beautifully. This quenching however, cannot be restored upon 
reducing the sample by ascorbate, even in excess. Representative results for FlAsH_1 is shown 
in fugure 6.33. 
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Figure 6.33. Quenching of FlAsH fluorescence by Cu titration. 
To find out whether the protein still binds Cu, I performed UV-vis spectroscopy trying to 
monitor 625 nm peak, indicator of Cu binding in a typical type 1 Cu site. The UV-vis results 
(figure 6.34) showed that the binding is much lower than the expected value and that the 
presence of TCEP interferes with Cu binding. That is the main reason I continued with only two 
molar equivalent of TCEP to protein for further fluorescent studies. The results is further 
complicated by the fact that interaction of Cu with TCEP generates a peak at 625 nm which later 
shifts to close to 700 nm. 
 
Figure 6.34. UV-vis results of Cu incorporation into Az_FlAsH variants. 
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Later I monitored the fluorescence quenching upon Cu addition, but not in a time course and 
I found out that addition of Cu resulted in a blue shift in fluorescent emission spectrum of all the 
samples (figure 6.35). Addition of Zn did not have such effect. The effect could not be reverted 
by ascorbate treatment and reduction of Cu (figure 6.35). 
 
 
Figure 6.35. Fluorescent analysis of Az_FlAsH shows interference in emission upon Cu, and not zn, addition.  
Interestingly, a distinct blue shift in the UV-vis spectra of the samples were also observed 
upon addition of Cu (figure 6.36). 
 
Figure 6.36. UV-vis analysis of FlAsH shows interference in emission upon Cu addition.  
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have a fluorescent signal, I used UV-vis to detect changes in the spectra and as shown in figure 
6.37, metal addition has a noticeable effect on the UV-vis spectra of FlAsH. In the case of the 
non-redox active metal, Zn, the effect is limited to increase in absorption. Cu in contrast results 
in both an increase and a shift in the spectra. Adding excess Cu causes first an increase and then 
a decrease in the intensity of the peak (figure 6.37).  
 
Figure 6.37. UV-vis analysis of FlAsH shows interference in emission upon Cu and Zn addition.  
Being bound to protein resulted in a bigger blue shift and probably slower reaction as more 
equivalents of Cu was required to observe the decrease in intensity (figure 6.38). 
 
Figure 6.38. Binding to protein causes some changes in the interaction between FlAsH and Cu.  
 6.5.3.5. NMR 
In order to find out whether the observed changes in UV-vis and fluorescent are a result of 
some structural changes in FlAsH or replacement of As with Cu, I planned to run NMR. Shiliang 
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ran NMR of samples of the dye, dye with Cu and dye with Zn in DMSO. However, he found out 
that the peaks were too broad. 
6.6. Summary and future directions 
Overall, our attempts to design a high-throughput screening set up to monitor the changes in 
redox state of the Cu in azurin was not very successful for different reasons. 
In terms of conjugation with Alexa Fluor, the main concern was lack of efficient labeling, 
which would highly decrease the chances of sampling the whole library. Moreover, interaction 
with other Cys containing proteins and the cell culture itself may impede the labeling even more. 
However, one can think of using Alexa Fluor dyes with a more selective and efficient labeling 
moiety. The problem with cell culture interference can be overcome by carrying out the 
conjugation step after osmotic shock when the pellet is resuspended in another buffer such as 
PBS. The conjugation is worth trying as it gave the best result in terms of recovery after 
reduction of Cu by ascorbate. 
Fusion of the protein with a fluorescent protein like mCherry is possibly the best method in 
terms of screening as one can be sure that all the proteins in the library are attached to the 
fluorophore. The current set up however suffers from two major problems. The first issue is the 
low amount of quenching observed upon Cu addition to the system. The quenching is similar to 
addition of free Cu and not quite enough for cell sorting. This low quenching can be a result of 
the distance between the two proteins. If that is the case, using more sophisticated methods to do 
the domain insertion,60 can be useful. The other major problem is the inconsistency of the data 
when the protein is expressed on the surface. We already know that azurin does not fold on the 
surface of the yeast and initial studies on mCh-Az purified from the membrane also showed lack 
of Cu binding. More careful experiments are required to confirm the improper folding of azurin 
on the surface, but if that is the case, one needs to perform rounds of directed evolution on the 
surface of either bacteria or yeast to obtain folded azurin variants. An alternative approach is to 
use a cleaner display system which is closer to in vitro set up, the so-called “megavalent bead 
display”.61 The approach is easy and doable and looks like a good new step.  
In terms of ncAA, the fluorescent studies need to be repeated carefully with free ncAA to see 
if the reductant and Cu have effects on the ncAA as expected. If that works well, playing with 
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the positions may be an idea next step since ncAA benefit from being small and can offer shorter 
distances compared to any protein-fusion approach. 
Finally, the FlAsH experiment failed due to undesired interaction of the metals with FlAsH. 
This interaction might be the reason why EDTA was added to binding buffer in previous reports. 
There is no report on this interaction and it worth being investigated. 
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 CHAPTER 7 
 
TUNING THE ACTIVITY OF MNCCP, A FUNCTIONAL MIMIC OF MANGANESE 
PEROXIDASE, USING SECONDARY COORDINATION INTERACTIONS 
* Portions of this chapter are from manuscript to be submitted “Exploring the role of secondary coordination interactions in a 
functional mimic of manganese peroxidase, MnCcP.1” (Hosseinzadeh P., Mirts E.N., Pfister T.D., Mayne C., Gao Y-G., 
Robnison H., Lu Y.) Mirts E.N. helped with some characterization and generated the figure for the activity assay of protein-free 
system. Pfister T.D. came up with original MnCcP.1 variants and some of the ideas for mutations. 
 
7.1. Introduction 
7.1.1. Lignin and its importance 
Lignin is the second most abundant biopolymer on earth, exceeded only by cellulose. It is a 
heterogeneous polymer of aromatic compounds, the only naturally synthesized polymer of this 
kind.1,2 Due to its richness of reducing equivalents, lignin represents a vast source of untapped, 
energety-producing molecules that could be used for the synthesis of commodity chemicals; 
especially aromatic compounds and biofuels. However, this highly polymerized molecule is very 
resistant to degradation.  
7.1.2. Current chemical methods for lignin degradation and their limitation 
The current chemical and thermochemical methods to degrade lignin are inefficient, often 
requiring either extreme conditions or expensive reagents.3-5 
In contrast, nature has devised efficient tools to degrade lignin in order to unlock the 
potential energy stored in the biopolymer. There are a number of microorganisms with 
ligninolytic (lignin degrading) activity the best of which are white rot fungi. These fungi possess 
the ability to substantially degrade lignin by means of a complicated network of interactions 
among many proteins. Three enzymes are mainly responsible for ligninolytic activity: lignin 
peroxidases (LiPs), manganese peroxidases (MnP) and Laccases.6-8 
MnP is the most common ligninolytic enzyme and is found in almost all species that 
efficiently degrade lignin.4 Unlike LiP and Laccase that must bind to lignin, MnP oxidizes lignin 
indirectly via release of Mn(III). This is highly advantageous because it eliminates complicated 
heterogeneous catalytic kinetics and broadens MnP’s substrate scope. MnP is a glycosylated 
heme protein secreted to the extracellular space. The reaction cycle of MnP is similar to other 
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peroxidases, starting by oxidation of a heme cofactor with hydrogen peroxide (H2O2). In the 
process of getting back to resting state, two equivalents of Mn(II) will be oxidized to Mn(III), 
which will be chelated by organic acids and released from enzyme. Mn(III) is, in turn, a potent 
oxidizing agent that can activate lignin and start its degradation, mainly by generation of radicals 
and oxidizing phenolic substrates. 1,4,8-10  
Despite the attractive peroperties of MnP for the degradation of lignin, its use has been 
limited due to difficulties in obtaining sufficient quantities. In its native system, MnP is 
produced only under nitrogen-limited conditions. Moreover, expression is limited by the 
availability of Mn and organic acids. Attempts to heterologously overexpress significant 
amounts of functional MnP in commonly used organisms like yeast and E. coli have not been 
successful thus far.11,12 
To meet the above challenges, novel approaches in catalysis toward new and more 
challenging targets are needed. For many years, two fields of catalysis science, biocatalysis and 
chemical catalysis, have been developed independently, each with its own advantages and 
disadvantages. Enzymes, particularly metalloenzymes, catalyze some of the most difficult 
reactions in nature, such as biomass conversion, small molecule activation and water oxidation, 
with high efficiency and selectivity, under mild conditions and in environmentally benign ways 
(e.g., using water as solvent and biocompatible/biodegradable materials). However, enzymes 
remain difficult to study and too expensive to synthesize. On the other hand, while most 
chemical catalysts are easier to synthesize and study, they are often not as efficient, selective, or 
environmentally benign as enzymes for important reactions such as biomass conversion.  
To combine the advantages of both bio- and chemical catalysis, biomimetic catalysts have 
been developed that use small organic molecules as ligands. These models provide much insight 
into the native systems that they mimic13-30 and provide deeper understanding about reaction 
mechanisms of the enzymes. Moreover, these catalysts have moved forward to mimic 
complicated enzymatic systems such as those involved in H2 generation,31 water splitting,32,33 and 
photosynthesis.34,35 
While much progress has been made in this area, there are still challenges.36 One critical 
barrier to success is the difficulty in designing and synthesizing highly structured ligands to 
stabilize functional transition states of the reactions. More importantly, long-range or non-
	   182	  
covalent interactions, such as hydrogen bonding and hydrophobicity, which are known to play 
critical roles in conferring and fine-tuning enzymatic reactivity and selectivity of the catalytic 
centers, are not easy to mimic using small organic molecules, as incorporating these structural 
features will require multiple step syntheses of complex macromolecular architectures with high 
rigidity and tunability.37-39 To address the importance of non-covalent interactions and the role of 
protein environment in secondary sphere interactions, several studies focused on designing semi-
synthetic models of enzymes that have a peptide conjugated to the synthetic core. Results of 
such experiments confirm the importance of non-covalent interactions in the activity. 40-43 While 
such success is promising, it remains difficult to apply to many other systems due to time, cost, 
and low yield.  
7.1.3. Brief introduction to MnCcP engineering 
Despite the attractive properties of MnP for lignin degradation, its application has been 
limited due to difficulties in obtaining sufficient quantities of functional protein, difficulty of 
genetic manipulation, and lack of thermal stability.4,11,44,45 There have been reports on efficient 
conversion of lignin to fuel precursors using biosynthetic models or organic catalysts with 
considerable success.46-51 However, most of these methods require extreme conditions such as 
high temperature and pressure.52 In a complementary approach, we and other groups have used 
easy-to-express proteins such as cytochrome c peroxidase (CcP)53,54 or DypB55 as the scaffold to 
mimic MnP function. 
CcP is a heme peroxidase natively found in baker’s yeast that shares significant structural 
similarity with MnP, especially around the active site (Figure 7.1). The overall catalytic cycle is 
also the same between these two proteins diverging only in the type of substrate oxidized 
(Scheme 7.1). As opposed to MnP, CcP can be overexpressed in large amounts in E.coli in its 
functional form. Previously, the Lu group has reported successful construction of a manganese 
binding site in CcP. The so called MnCcP protein then went through further improvements by 
rational design to make MnCcP.1 which was capable of binding Mn(II) and oxidizing it into 
Mn(III). 56,57  
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Scheme 7.1. Reaction cycles of MnP and CcP. 
Previously, we have reported successful construction of a Mn(II)-binding site in CcP by 
structural comparison of the Mn(II)-binding site in MnP (Figure 7.1c) with the corresponding 
region of CcP (Figure 7.1d) and then Gly41Glu, Val45Glu and His181Asp mutations (called 
MnCcP). 53 The protein then was further optimized through replacing Asp181 by Glu, replacing 
Glu41 back to Gly and mutating Asp37 to Glu  (called MnCcP.1),58 which was capable of 
binding Mn(II) and oxidizing it into Mn(III) (Figure 7.1). 
 
 
 
Figure 7.1. Structural comparison between MnP, CcP, and variants of MnCcP. (a) overlay of MnP (gray, PDB ID: 
1YYD) and CcP (orange, PDB ID:2CYP) showing high structural similarities, especially in the heme-binding site 
(b). Mn(II)-binding site in MnP (c) and corresponding site in MnCcP (d). An overlay between Mn(II)CcP (cyan, 
PDB ID: X) and Mn(II)P (gray, PDB ID: 1YYD).  
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Although these MnCcP biosynthetic models are capable of Mn(II) oxidation, their catalytic 
efficiency (0.6 mM-1s-1 for the most active variant) is not comparable with that of the native 
MnP (390-4340 mM-1s-1, see Table 1). To improve the design and increase MnP activity, we 
report herein a crystal structure of Mn(II)-bound MnCcP (Figure 7.1e).  
Structural comparison between Mn(II)P and Mn(II)MnCcP.1, and mutagenesis studies shed 
light on the roles of non-covalent interactions in the secondary coordination sphere of Mn(II) in 
tuning MnP activity, specifically mutations of Tyr36, Ile40, and Lys179 and their double and 
triple mutants (Table 7.1). We have found that H-bonding to primary ligands of Mn can have 
quite different effects, depending on the H-bonding acceptor atom. We have also demonstrated 
the importance of removing steric clashes and increasing flexibility, resulting in a mutant with 
~8-fold increase of catalytic efficiency than our initial design and a KM comparable to that of 
native MnPs. Finally, we show that such MnCcP mutants presented in this study display 
degradation activity towards phenolic lignin model compounds and alkali-treated lignin. In 
doing so, we have been able to shed additional light on the unique impacts of non-covalent 
interactions for imparting activity to metalloproteins.  
Table 7.1. Kinetic parameters of different MnPs, MnP mutants, and MnP mimics. 
enzyme KM(mM) kcat(s-1) kcat/KM(mM-1s-1) pH 
CcP (MI)59 3.2 0.19 0.06 5 
MnCcP59 4.1 0.42 0.10 5 
MnCcP.158  1.9 0.47 0.25 5 
MP6.854 0.65 0.26 0.33 5 
MnCcP259 7.6 4.6 0.60 5 
     
Y36F-MnCcP2 8 4.1 0.51 4.5 
Y36F-MnCcP.1 0.37 0.10 0.28 4.5 
I40G-MnCcP.1 0.28 0.46 1.63 4.5 
K179R-MnCcP.1 0.40 0.19 0.47 4.5 
I40G/K179R-MnCcP.1 0.48 0.39 0.81 4.5 
Y36F/I40G-MnCcP.1 0.28 0.28 1.02 4.5 
Y36F/K179R-MnCcP.1 1.10 0.62 0.56 4.5 
Y36F/I40G/K179R-
MnCcP.1 
0.57 0.46 0.80 4.5 
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Table 7.1 cont.     
N246A-DypB55 17 39 2.3 5.5 
     
Manganese peroxidase mutants    
PC-MnP(E35Q)60  4.4 0.77 0.18 4.5 
PC-MnP(E39Q)60 2.0 1.2 0.6 4.5 
PC-MnP(D179N)61 3.7 1.09 0.3 4.5 
PC-MnP(E35Q-D179N)60 8.1 0.29 0.04 4.5 
PC-MnP(R177E)62 3.9 25.5 6.5 4.5 
PC-MnP(R177K)63 2.3 257 112 4.5 
     
Native MnP    
PE-MnP PS364 0.2 78 390 5 
PE-MnP PS164 0.048 79 1649 5 
PC-MnP65 0.07 301 4340 4.5 
 
7.2. Materials and methods 
7.2.1. Materials and reagents: 
All the materials and reagents used in these studies were purchased from either Sigma or 
Fisher chemicals except when otherwise mentioned.  
7.2.2. Mutant protein generation, purification, and verification: 
The mutants were generated based on common site directed mutagenesis techniques which 
consists of a quick change PCR step using Pfu-UltraII (Agilent) followed by removal of the 
parent plasmid by DpnI (NEB) treatment and transformation into NEB-Turbo cells as described 
by the provider. The PCR primers for each mutant are listed below. Primers were synthesized by 
IDT, Inc. (The reverse primer is complementary to the sequence shown): 
Tyr36Phe: 5'- GGG AAG ATG ACG AAT TTG ACA ACT ATA TAG GC 
Ile40Gly: 5'-CGA ATA TGA CAA CTA TGG CGG CTA TGG GCC C 
Tyr36Phe/Ile40Gly: 5'- GGG AAG ATG ACG AAT TTG ACA ACT ATG GCG GCT ATG GGC CC 
Tyr36Phe2: 5'- GGG AAG ATG ACG AAT TTG AAA ACT ATA TAG GC 
Lys179Arg(His181Glu): 5'- CGC TCT GGG CAG AAC CGA GCT CAA G -3' 
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The plasmids were then extracted using QIAprep Spin Miniprep Kit and confirmed by 
sequencing in ACGT-Inc. sequencing company. 
Mutation bearing plasmids then transformed into BL21-DE3* competent E. coli cells 
(Invitrogen). Protein purification was performed based on previously developed protocol in our 
lab. 53,58 Briefly, the cells were grown in a 5 ml Lauria Broth media starter culture (10 g bacto 
trypton (BD), 5 g yeast extract (BD), and 10g sodium chloride (Fisher chemicals) in 1L) at 37 °C 
for 8 hours. Two flasks of 2 liter rich media (10 g bacto trypton, 8 g of yeast extract, 5 g sodium 
chloride) was inoculated by 1 ml of starter culture and grown for 16 hours at 37 °C. The culture 
was then induced by 1mM IPTG (GoldBio) for 4 hours at 37 °C. The protein was purified from 
cytosol by sonication using Misonix ultrasonic liquid processor. The process time was 6:00 min 
with 6 s pulses on and 12 s pulses off and an amplitude of 70. The supernatant then was batch-
bound to a DEAE column (GE Healthcare) and eluted with a gradient of KCl in phosphate 
buffer. The protein is then subjected to a sephedex S-100 gel filtration column (GE healthcare) 
and a second DEAE column. The mass of all proteins were verified using electron spray 
ionization mass spectroscopy (ESI-MS). ESI-MS were obtained on a Quattro II (Waters) ESI 
mass spectrometer maintained by the School of Chemical Sciences Mass Spectrometry 
Laboratory (Urbana, IL). Formic acid was used to ionize the protein upon injection. 
7.2.3. Protein crystallization, data collection and structure determination: 
The protein sample was concentrated using Centricon concentrators (10,000 molecular 
weight cutoff). Proteins were crystalized using a vapor diffusion hanging drop technique. One 
µL drop of 50 mg·ml-1 protein solution with 1mM MnSO4 was placed on siliconized glass with 1 
µL of well solution. The drop was then equilibrated against 500 µL of well solution, number 10 
of PEG/ion screen HR2-126 from Hampton research. Crystals for suitable X-ray analysis began 
to appear after 1 week and finished growth after 2-3 weeks. The crystals were soaked for several 
minutes in 30% PEG 400 in the well solution before mounting. The diffraction data was 
collected at Brookhaven National Laboratory (BNL). The data was phased and refined using 
CCP4 and Shelx97 suites respectively. Molecular replacement was used as phasing model using 
WT-CcP structure as a model (PDB ID: 2CYP). 
7.2.4. Kinetic experiments: 
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Kinetics experiments were performed on Agilent 8453 diode array (Agilent) instrument by 
monitoring increase in 270 nm absorption. The experiment begins by addition of 6-10 µM 
protein, 400 µL of different MnSO4 concentrations in overall 3000 µL of 500 mM malonate  
buffer, pH=4.5. Reactions started with addition of 25 µl of 10 mM H2O2. The data were then 
transferred to Origin 9.1 for analysis. The values of kcat and KM were analyzed based on 
Michaelis-Menten curve fitting. 
7.2.5. GC-MS studies: 
GC-Ms studies were performed on a 6890N network GC system from agilent technology 
with a network GC system 5973 mass selective detector. The measurement begins at an initial 
temperature of 50 °C for 3 min and ramping to 300 °C at 40 °C/min, paushing at the final 
temperature for 2.5 min. Samples were extracted by ethyl acetate and dried in a sodium sulfate 
column prior to injection. 
7.2.6. Molecular dynamics and simulation:  
Molecular dynamics were performed using visual molecular dynamics (VMD)66 and NAMD 
molecular dynamics simulation software.67 The structure of mutants was modeled using obtained 
MnCcP.1 stcruture and MnP (PDB ID: 1YYD, 1MNP). PSF files were generated using the 
PSFGEN suite in VMD. Proteins were solvated in a water box with a 15 Å buffer, and the 
overall structure was neutralized by 0.1 M NaCl. MD simulations were performed using 1000 or  
2000 steps of minimization followed by 2 ns of equilibration (2 fs/step) in a PVT format. 
7.2.7. HPLC analysis:   
Compounds 1, 2 were generously synthesized by Margaret Brown, from Michele Chang’s lab 
in Berkley. The reactions were performed in 50 mM sodium acetate buffer pH=4.5 as previously 
described.68 The reaction mixture contained 0.2or 50 uM protein (for compounds 1 or 2 
respectively), 1 µM final compound 1 or 2, 1/2.5 mM MnCl2 (1/2), and initiated with 1 mM 
H2O2. The reaction then stirred overnight at room temperature. Samples for HPLC analysis were 
prepared by centrifuging the reaction for 5 min at 20850 rcf in a bench top centrifuge. 10 uL of 
the samples were then injected into Agilent Eclipse XDB-C18 column (4.6*150, 5u) and run at 
0.5 ml/min. The program was as follows: 
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A: water with 0.1% formic acid, B:  Actonitrile with 0.1% formic acid 
0-2 min, 10% B; 8-11.5min, 90% B; 12-16min, 10% B 
Reactions for compound 1 were also carried out in the absence of MnCl2. Reactions for 
compound 2 was also carried out in the presence of 0.1 M reduced glutathione which was added 
10 min after addition of H2O2. 
The reaction with alkali treated lignin was carried out in 3 mL of 500 mM malonate buffer 
pH=4.5. 100 µL of 0.5 mM protein was added to the reaction with or without 200 µL of 500 mM 
MnSO4. 100 µL of 50 mM H2O2 was added and the reaction was shaking for 84 hours at 30 C or 
24 hours at 37 C. The samples were prepared by addition of 40 ul of 100% CCl3COOH to 400 
uL of the reaction. After mixing, the samples were centrifuged for 10 min at 4000 rpm.  
Samples were then loaded onto the column with 0.5 ml/min. The program was as follows: 
A: water with 0.1% formic acid, B: methanol with 0.1% formic acid 
0-10 min, gradient of 20-30% B; 10-24, gradient from 30% to 50% B; 24-50, gradient from 50% 
to 80% B. 
7.2.8. Mn-dependent peroxidation in the absence of protein: 
Reactions were carried out in stirring cuvette in a 1 mL volume containing 5 µL protein and 
MnSO4 to 5 mM in 500 mM malonate buffer, pH 4.5. Reactions were initiated by the addition of 
various amounts of H2O2 (10, 25, 50 µM final concentration).  Reactions proceeded for 2 min at 
room temperature and then filtered through a 10 kD centricon membrane for 4 min at 14,000 
rpm in a tabletop centrifuge.  The flow through was collected and diluted to a final volume of 2 
mL with malonate buffer.  Reduced ABTS was added to a concentration of 1 mM whereby it 
rapidly oxidized, and its concentration was assessed at 420 nm (ε420nm = 36.8 mM-1 cm-1). 
 
7.3. Results and discussion   
7.3.1. Crystal structure of Mn-bound MnCcP.1  
While the overall alignment of the Mn(II) binding site in our designed MnCcP.1 and MnP are 
very similar (Figure 7.1), the activities are still very different (Table 7.1). In order to understand 
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structural features responsible for Mn(II) binding and MnP activity, we obtained x-ray crystal 
structure of Mn(II)-bound MnCcP.1 (see crystallographic parameters in Table 7.2).  
Table 7.2. Data collection and refinement parameters for MnCcP-Mn crystal. 
Data collection  
Space Group P212121 
Cell dimension: 
       a, b, c (Å) 
       α, β, γ(o)  
 
44.43, 52.58, 136.48 
90.0, 90.0, 90.0 
 
Resolution (Å)  
 
1.65 
 
No. reflections 
 
39,151 
 
R-merge  0.092 
 
I/σI 24.2 
 
Redundancy  7.2 
 
Completeness (%) 100 
Refinement   
 
Resolution (Å) 10.0 – 1.65 
 
Rwork/Rfree 0.216/0.2412 
 
No. reflections 35,983 
No. atoms  
 
  Protein 2,356 
      
  Hem/Fe/Mn 42/1FE/1Mn 
        
Water 210 
B-factor  
        
Protein 25.04 
       
 Hem/Fe/Mn 16.5/14.3/32.3 
        
Water 34.1 
Rms. deviations  
        
Bond lengths(Å)  
 
0.008 
       
 Bond angles (°) 
 
2.026 
 
A more detailed investigation of the overlay of Mn(II)-bound MnCcP and MnP shown in 
figure 7.2 suggests several differences between carboxylate ligands to Mn(II) ion in two 
proteins. The difference in ligand positions is evident between Glu37 in MnCcP and Glu35 in 
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MnP (figure 7.2). While the relative position of carboxylate ligands are similar, Glu37-MnCcP is 
further away from Mn(II) ion, incapable of coordinating to Mn(II) ion in an optimal fashion 
(3.09 Å in MnCcP vs. 2.40 Å in MnP). Upon further inspection, we found that this different 
positioning of the Glu ligands is mainly due to the difference in the structures of the loops that 
carry the ligands in MnP and CcP (figure 7.2a). While the exact structural position 
corresponding to Glu35-MnP is located in Gly41 (figure 7.2a), previous studies in our group 
have shown that Gly41Glu  points away from the active site and cannot coordinate to Mn(II).58 
Furthermore, although the Glu181 ligand in MnCcP occupies the same structural position as 
Asp179- MnP, their orientations differ, causing a significant increase in distance from 2.41 Å in 
MnP to 4.26 Å in MnCcP.1 (figure 7.2).It was suggested that maybe a water ligand is directly 
coordinated to Mn that is stabilized by Glu181-MnCcP58 however, such water ligand is not 
observed in Mn(II)-MnCcP.1 structure. Another, more subtle difference is in terms of observed 
freedom of the ligands. Comparison of two Mn(II)-bound crystal structures of MnP (PDB ID: 
1MNP69, 1YYD70) with that Mn(II)-free apo-MnP (PDB ID: 1YZP70) suggests that the greatest 
degree of flexibility is located in the Glu39-MnP. However, the corresponding Glu45 in MnCcP 
retained its position in all our MnCcP.1 crystal structures (apo-MnCcP.1-PDB ID: 2IA858, 
Co(II)-MnCcP.1-PDB ID: 2ICV58, Mn(II)-MnCcP.1-PDB ID: ). Lack of flexibility in this 
residue may explain why the Glu45-MnCcP rotamer that is better for coordinating to Mn(II), 
similar to Glu39-MnP, is not observed. Such difference between the rotamers in the same 
structural position resulted in a 1.84 Å difference in distance between the carboxylate and Mn(II) 
(3.94 Å in MnCcP vs. 2.10 Å in MnP, figure 7.2b,c). These observations strongly suggest that 
the ability of primary ligands in coordinating with Mn(II) ion is highly dependent on proper 
distance and orientation of the coordinating atoms and even slight deviations from the optimal 
geometry can influence metal binding and hence the activity.,   
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Figure 7.2. (a) Structural comparison between Mn(II) binding site of MnP (gray, PDB ID: 1YYD) and Mn(II)-
MnCcP.1 (cyan, PDB ID: ). (b) Primary ligands of Mn(II) in MnP. (c) Primary ligands of Mn(II) in MnCcP.1. 
Heme is not shown in b,c.  
7.3.2. Removal of H-bond to primary ligands of Mn(II) by Tyr36Phe mutation 
Structural analysis of Mn(II)-MnCcP.1 suggest that Tyr36 is within hydrogen bonding 
distance to the carboxylate of Glu45-MnCcP ligand of Mn(II) with a distance of 2.83 Å (Figure 
7.3a). We hypothesized that this H-bond interaction may compete and thus weaken the ligand’s 
ability to coordinate to Mn(II) and thus decrease the MnP activity. Such interaction can stabilize 
the rotamer of Glu45-MnCcP.1 that is observed in the crystal structures, resulting in the 
observed low flexibility of the ligand. Lack of any residues in hydrogen bonding distance to the 
corresponding residue in MnP, Glu39-MnP, further suggests that removing this interaction can 
enhance Mn(II) binding. To test this hypothesis, we mutated Tyr36 to Phe in the MnCcP.1. We 
chose Phe because it differs from Tyr only by the –OH group that is responsible for the H-
bonding interactions, while minimizing other structural perturbations.  
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Figure 7.3. (a) Structure of Mn(II)-MnCcP.1 showing Tyr36 and its interaction with Glu45. (b) Salt bridge between 
Arg177 and Glu35 in MnP (PDB Id: 1YYD). (c) Possible H-bonding interaction between Lys179 and 
Glu37//Glu181 ligands in Mn(II)-MnCcP.1 structure (PDB ID: ). 
Activity assay (table 1, figure 2) showed thatTyr36Phe mutation improved the KM by 5 folds, 
indicating that removing the hydrogen bonding interactions to the primary ligands by Tyr36Phe 
mutation indeed improved the  binding to Mn(II) and thus KM. 
7.3.3. Improved orientation of Mn(II) ligand by introducing a H-bond through Lys179Arg 
mutation 
There have been multiple reports on conserved hydrogen bonds that help position the active 
site residues or substrates in the proper orientation to fine-tune catalytic efficiency of enzymes or 
tune reduction potential of metal centers.71-73 Inspired by such reports, we performed structure-
based sequence analysis of MnPs from multiple organisms and found that they share a conserved 
Arg positioned below Glu35-MnP, corresponding to Glu37-MnCcP, which may play a key role 
in proper positioning of the Glu ligand through a salt bridge. Mutagenesis studies on MnP from 
Phenorocheatea chrysosporium showed that replacing this residue by negatively charged or 
neutral residues decreased the activity by ~700 fold (table 7.1).62 
To investigate the role of this salt bridge in our MnCcP.1 model, we mutated Lys179 which 
occupies the same position as the conserved Arg in MnP, to an Arg. Both Lys and Arg have 
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Glu181	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positive charges and previous studies on native MnP have shown that mutation of Arg177 to Lys 
effects mostly KM of the enzyme, presumably through disfavoring optimal conformation for 
Mn(II) binding (table 1).63 However, analysis of MnP and MnCcP structures shows that the 
position of side chain of Arg177-MnP differs substantially from Lys179-MnCcP (Figure 4b,c). 
While Arg177-MnP is completely oriented towards Glu35-MnP and away from Glu179-MnP, 
Lys179-MnCcP is in between Glu37-MnCcP and Glu181-MnCcP. These observations suggest 
that Lys179Arg mutation may also affect kcat of MnCcP.1 by favoring the correct salt bridge 
formation. The activity assay on this mutant showed a two fold increase in the catalytic 
efficiency, mainly due to decrease of KM (table 1, figure 2), in agreement with starting 
hypothesis.  Molecular dynamics simulations on Lys179Arg-MnCcP.1 showed an enhanced 
hydrogen bonding interaction between this residue and Glu37 (from 3.32 to 2.72 Å). Consistent 
with the design, Arg179 moved further away from Glu181-MnCcP ligand (an increase of 0.5 Å), 
resulting in re-orientation of this ligand toward Mn(II) so that their distance is closer by almost 2 
Å. All mentioned observations are consistent with enhanced Mn(II) binding due to improved 
orientation of Mn(II) ligand. 
7.3.4. Relaxation of steric clashes in the ligand-containing loop by Ile40Gly mutation  
An overlay of MnP and MnCcP.1 suggests that the loop containing Glu35- and Glu39-MnP 
ligands differs substantially from the one containing Glu37- and Glu45-MnCcP ligands, leading 
to a different position of Glu37-MnCcP compared to Glu35-MnP (Figure 7.2a). A close 
inspection of Mn(II)-MnCcP.1 structure indicates that the side chain of Ile40-MnCcP can cause 
steric clashe with Glu37-MnCcP, preventing it from orienting towards Mn(II) (Figure 7.4a). To 
relieve this steric clash, we made the Ile40Gly mutation. By removing the steric clashes through 
Ile40Gly mutation, we give the Glu37 and Glu45 ligands in the loop of MnCcP.1  the freedom to 
better coordinate to Mn(II) ion, decreasing KM and thus increase kcat/KM. Molecular dynamics 
simulations of Ile49Gly-MnCcP.1 showed that indeed the distances between Glu37 and Glu45 
ligands decreased (figure 7.4b). As shown in table 7.1, Ile40Gly mutation results in the highest 
catalytic activity among all our mutations, arising primarily from a decrease in KM by 6.7 fold.  
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Figure 7.4. Mn(II)-binding site and corresponding distances between Mn(II) and Glu37 and Glu45 in (a) Mn(II)-
MnCcP.1 cyrtsal structure (PDB ID: ) and (b) MD simulated model of Ile40Gly-MnCcP.1 variant. 
7.3.5. Cumulative effect of mutations on the activity of MnCcP.1 
To investigate whether these mutations are accumulative, we made all possible double 
combinations of our mutants: Tyr36Phe/Lys179Arg, Tyr36Phe/Ile40Gly, Ile40Gly/Lys179Arg, 
and Tyr36Phe/Ile40Gly/Lys179Arg. As shown in Table 7.1 and Figure 7.5, 
Tyr36Phe/Lys179Arg double mutant showed MnP activity that equals to the combined activities 
of Tyr36Phe and Lys179Arg single mutant within the experimental error. This result is expected, 
since the Tyr36Phe and Lys179Arg mutations are involved in secondary sphere interactions to 
different ligands (Glu45 and Glu37/Glu181, respectively).  
Based on the activity results, Ile40Gly is the most effective single mutation. However, the 
effect of Ile40Gly mutation on catalytic efficiency was diminished by combination with either of 
the other two mutations. In the case of the Ile40Gly/Lys179Arg double mutant, the decrease in 
the catalytic efficiency compared with Ile40Gly was mainly due to a larger KM (Table 7.1), 
suggesting that the Lys179Arg and Ile40Gly mutations work antagonistically toward enhancing 
Mn(II) binding. This explanation makes sense because, while the Ile40Gly mutation increases 
the flexibility of the ligands in the loop to coordinate to Mn(II), the Lys179Arg mutation favors 
the formation of a salt bridge to the Glu37 ligand, hence rigidifying it. In contrast, while the 
Tyr36Phe/Ile40Gly double mutant displayed a similar KM as that in Ile40Gly mutant, the kcat 
decreased by two fold. Since Tyr36 is positioned in the same loop as Ile40, and both mutations 
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has the effect of increasing flexibility of the loop containing Glu37 and Glu45 ligands, it is 
possible that the combination of both mutations will lead to overall instability of the protein 
causing a lower kcat.  
The triple mutant, Tyr36Phe/Ile40Gly/Lys179Arg, has a KM that is higher than most other 
single and double variants, except for Tyr36Phe/Lys179Arg. Such increase in KM compared to 
other variants can be explained by the antagonist effect of mutations in enhancing Mn(II)-
binding. The kcat however stays relatively high, consistent with the dominant effect of Ile40Gly 
on increasing the kcat in all variants. The presence of both Ile40Gly and Tyr36Phe will decrease 
the effect of both on the activity as explained above. 
 
Figure 7.5. Catalytic efficiency of double and triple mutants of MnCcP.1. The observed effect is shown in solid red 
bars. The gray bars show the final catalytic efficiency expected if the effect of each mutation was additive.   
7.3.6. Activity assays of the combined triple mutant, Tyr36Phe/Ile40Gly/Lys179Arg-
MnCcP.1 
Mn(III) that is produced by the activity of MnP is later chelated out of the enzyme by organic 
acids such as oxalate or malonate that are secreted by the fungus and degrades phenolic 
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components of lignin.4,9,74,75 To demonstrate that our enzyme has the same activity and that 
Mn(III) is released from the active site, activity assays toward Mn(II) oxidation were performed 
with the triplet mutant.  
In contrast to MnP that is solely dependent on the Mn(II) presence for its activity, MnCcP.1 
mutants can perform peroxidation activity with both Mn-dependent and –independent pathways, 
with the latter being inherent to WT-CcP. To avoid the interference from the Mn(II)-independent 
pathway, we developed an assay in which we removed any reactive protein intermediates by 
membrane centrifugation and then assaying the flow-through for Mn-dependent catalytic 
activity. As was shown with MnP, Mn(III) produced in the reaction was capable of degrading 
phenolic compounds such as 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) as 
detected by UV-Vis spectroscopic analysis (Figure 7.6). Several studies have shown that MnP 
can degrade non-phenolic compounds in the presence of reduced sulfur groups such as 
glutathione and unsaturated fatty acids such as tween 80.4,76 However, we could not detect any 
degradation of veratryl alcohol by our protein in the presence of either of these compounds. High 
concentrations of Mn(III) in the presence of glutathione; however, could partially degrade 
veratryl alcohol to veratryl aldehyde (data not shown). 
 
 
Figure 7.6. Substrate oxidation by Mn(III) in the absence of protein. (a) Representative spectra from a reaction 
initiated with 25 µM H2O2 show the complete removal of protein (black) from solution following filtration and 
Mn(III) absorbance at 270 nm (magenta). The oxidized substrate rapidly forms upon the addition of excess ABTS 
(green). (b) The amount of Mn(III) formed in the reaction could be controlled by the amount of peroxide in solution. 
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Further, we tested the activity of our triple mutant on two previously reported lignin model 
compounds using HPLC.68 As with other hybrid MnPs,7,10,77,78 our mutant was able to degrade 
phenolic model compound (figure 7.7a) in the presence or absence of Mn(II). The Mn-
independent activity is consistent with previous observation with DyP2.68  
 
Figure 7.7. (a) Phenolic lignin model compound(b) The HPLC trace of degradation of the phenolic lignin model 
compound by Tyr36Phe/Ile40Gly/Lys179Arg. (c HPLC trace of alkali-treated lignin exposed to 
Tyr36Phe/Ile40Gly/Lys179Arg at different times. 
 
The protein again failed to degrade non-phenolic model compounds even in the presence of 
tween 80 and glutathione (Figure 7.8). 
 
Figure 7.8. Degradation of phenolic lignin model compound by triple mutant without Mn (a) HPLC traces of control 
reaction and reactivity of triple mutant towards non-phenolic lignin model compound shown in (b) 
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Finally, we tested the activity of the triple mutant on alkali treated lignin using HPLC based 
on previously reported methods. The protein showed some degradation activity above that of 
WT-CcP although, the detected activity was low (Figure 7.7b). Nevertheless, these results 
indicates that our models are capable of lignin degradation.  
7.4. Summary and conclusion 
Here we reported an engineered mimic of MnP which has catalytic efficiency 8-folds higher 
than the starting scaffold and >25-folds increase over WT-CcP protein. We further demonstrated 
that our mutant is a functional model of MnP that mimics its activity both in Mn(II) oxidation 
and substrate oxidation (Figure 7.9). Moreover, we obtained a mutant with KM value comparable 
to that of the native system (0.28 mM-1 for Ile40Gly and Tyr36phe/Ile40Gly vs. 0.2 for 
Pleurotus eryngii MnP PS3). Our study shed light into the role of non-covalent interactions 
around the metal binding site in improving the metal binding and overall activity. These overall 
guides can be used to enhance the activity of native enzymes or synthetic models to obtain better 
catalyst for biodegradation of aromatic compounds and delignification. 
 
   
Figure 7.9. Different secondary sphere positions investigated in this study and their effect on activity and metal 
affinity of MnCcP.1 
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I have also performed several other mutagenesis studies to enhance the activity of MnCcP. 
Previously; we showed that addition of W51F and W191F to older generation MnCcP mutants 
resulted in enhanced activity.58,79 Our previous data on W191F-MnCcP and W51F-MnCcP 
showed that the rate-limiting step in the activity of MnCcP is not reactivity of compound Iꞌ, but 
the reactivity of compound II. Combination of these mutations with my highest activity MnCcP 
however, failed to generate enhanced activity. I think this is due to the fact that the compound I 
generation is no longer the rate limiting step in this series of mutants. In another attempt to 
increase the reactivity of CpdI and CpdII, I decided to increase the distance between His 175 and 
Fe in heme. It has been reported that the distance between proximal His and heme-Fe in MnP 
and LiP is longer than common peroxidases and this results in a relatively lower reduction 
potential and increased activity. In order to push the His away from heme, I designed a176S and 
A176T mutations. The idea was that addition of an H-bond to His will move it away from the 
heme. The a176S was designed after structural comparison of MnP and CcP structure. A176T 
failed to incorporate heme. Heme incorporation yield was low in case of A176S and the heme 
was degraded upon reaction with H2O2. 
In my first three years I also designed a semi-high-throughput screening platform for directed 
evolution of MnCcP variants with enhance activity or stability. The screening method was based 
on using leucoberbelin blue (LBB) dye.80 LBB is a dye with intense absorption and good linear 
dynamic range that can react with Mn(III) or Mn(IV) but not Mn(II), therefore MnCcP activity 
can be monitored by screening 96-well plates at 625 nm after a Mn(II) oxidation reaction.  
Since we already have structural information about MnCcP in hand,	   58 I used iterative 
saturation mutagenesis to generate our first rounds of libraries using MnCcP.81 Assuming a 
sphere of 10 Å around the active site, I chose 8 sites as ISM locations each consisting of 1 to 3 
amino acids (figure 7.10). Common site-directed mutagenesis techniques was used to generate 
the libraries using primers with NDT codons.82 I chose this codon set because it has been shown 
to yield 95% coverage with less screening than required for the NNK set.82 To increase 
transformation efficiency and therefore the sampling of the library, electroporation was used 
instead of chemical transformation.  
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Figure 7.10. Positioning of 8 proposed ISM regions to increase activity. Regions are: A (40, 41), A’ (42, 44), B 
(48), C (83, 84, 85), C’ (86, 87), D (178, 179, 180), E (183, 184, 185), F (195). Right figure shows ISM sites for 
increasing the stability. The protein is colored based on B-factor (red, the lowest). 
The variance was very high because I could not get consistent expression all the time. After 
sequencing the hits, I obtained only about 5% mutagenesis rate, which is an indication of low 
mutagenesis rate. Interestingly the mutants I obtained were mostly far from the site.  
To increase the stability, I chose a combination of ISM and ep-PCR. The regions I chose for 
ISM are based on β-factors of residues in crystal structure as well as comparison between 
MnCcP and a thermophilic CcP (KLTH0F05170p from Lachancea thermotolerans). The sites 
with very high β-factor (>40)83 or those that deviate significantly from a thermophilic CcP are 
the target sites for ISM. High β-factor is an indicator of high flexibility I protein structure. It has 
been shown that sites with higher β-factor usually have lower stability. We will also try to alter 
residues that are part of a secondary structure because increasing the rigidity of a secondary 
structure will contribute greatly to overall stability (Figure 7.10, right) The designed oligos were 
designed so that they can be also used in the so called iSOR method as a means to spike the 
activity library to enhance stability.84 
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CHAPTER 8 
 
CHARACTERIZATION OF AN UNUSUAL CYTOCHROME C PEROXIDASE 
VARIANT WITH A HEME-PROTEIN CROSSLINK 
 
8.1. Introduction 
Heme is one of the most common cofactor used in biology. Several classes of proteins from 
electron transfer cytochromes to enzymes with versatile activity such as P450 contain heme as 
their active site group. There are several classes of heme found in biology. One interesting aspect 
of hemoproteins is the fact that the heme can be covalently attached to the protein moiety. In the 
most well-known case of cytochromes c, the covalent attachment of heme to two or one cysteins 
in the protein is a prerequisite for stability of the system and the geometry of the heme.1-3  The 
heme c mode of attachment has been reproduced in heme b containing proteins by introduction 
of cys residues.4 More interesting are the systems in which the heme is cross-linked to the protein 
after a reaction. Covalent attachments of cofatcors usually result in enhanced enzymatic activity 
and stability.5 It has been postulated that forming an adduct between heme and probably a 
glutamate residue in CYP4 family of proteins plays an important role in restricting the 
conformation of the heme and determining the specificity of the enzymes.	  6,7 
There are several reports of heme-protein cross-link in literature. Heme-His crosslink was 
observed in an engineered hemoglobin via Leu75His mutation. The cross-link formation was 
induced by reduction of heme by dithionate.8 Heme-His cross-link was observed in a hemoglobin 
before. Addition of dithionate in this case also resulted in complete cross-link formation. 
Interestingly, the authors showed that the reduction of heme is required and no crosslink was 
formed if a Zn-protophorphyrin was used.9 Transient formation of heme-His cross-link was 
observed in the active site of a chaperon.10 
Heme-Met cross-link is among the most common observed corss-links. These samples usually 
have a distinct green color and the Met usually forms a bond with the vinyl group on the heme. 
Such cross-link is observed in myeloperoxidase.11 A mutant version of ascorbate peroxidase, 
S160M, also shows a heme-Met linkage in a hydrogen peroxide dependent manner.12 
Heme-Tyr cross-links are also observed in several proteins. Mutation of residue 43 in 
myoglobin to a Tyr resulted in a crosslink between hydroxyl group of the Tyr and the heme 
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vinyl-4 group.13 The authors suggested a mechanism in which the hydroxyl group of the Tyr first 
attacks the α-carbon and then a common Markonikov reaction takes place. A band at 553 in 
pyridine treated sample was indicative of saturation of one of the vinyls. Guanidine 
hydrochloride unfolding also showed a bis-His (403, 410 nm) rather than a free heme (370 nm) 
spectral feature.	   13 A Tyr-heme crosslink was also observed in Ser160 variant of ascorbate 
peroxidase.14	  Structural studies of hydroxylamine oxidoreductase showed an unusual Tyr-heme 
crosslink in which the Tyr is linked to the heme by two linkages.15 
Heme can be crosslinked to other residues such as Trp, 14 Asp, and Glu.16Also in several cases 
attachment of heme to more than two amino acids is observed.	  11,14,16  
The mechanism of heme-protein cross-link formation can vary vastly even if the same amino acid is 
used as shown in case of cytochromes c.1-3  Moreover, in most cases the mechanism is not known. Most of 
the linkages described either require the addition of H2O214	  or are enhanced by that.11,16 Herein, I describe 
the characterization of a CcP variant that has an unknown heme-covalent crosslink. The crosslink 
formation does not require H2O2 or reductant as shown by previous studies. It forms due to a change in 
the loop of CcP that contains residue 180 as well as presence of a Cys near propionate of the heme. 
Removal of the Cys abolishes the cross-link formation. However, the position of the Cys is not well 
suited to form a crosslink. MS/MS studies suggested Met172 as a possible site of attachment. The Met172 
is very close to heme vinyl group and at the same structural position as reported for S160M ascorbate 
peroxidase. However, the spectroscopic features of the crosslinked protein and the lack of H2O2-
dependence cast doubt on the possibility of this residue being the site of crosslink.  
Another interesting feature about this protein is the observation of significant catalase activity in the 
“as-purified” form, which presumably had picked up some modified heme from the culture during the 
growth. Characterization and activity tests of this species is also discussed. 
8.2. Materials and methods 
8.2.1. Loop directed mutagenesis and construct design 
The construction of the loop-directed variants was carried out using Gibson assembly. Below 
you may see the primer pairs used: 
Loop_Cys: 
Primers to get the vector 
MnCcP_H181Loop_f: 5’- TTGTCCGCCTTGCCCAGAGCGTGAGC 
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MnCcP_H181Loop_r: 5’- CGATCGATGGGCCATGGGGAGCCGCTAACAACGTC 
Gibson fragment (obtained by annealing the two complementary strands I ordered) 
H181Loop: 5’- CGCTCTGGGCAAGGCGGATAAAGTGGATCAGACCATCGATGGGCCATGGGGAGC 
The final fragment was sequenced by ACGT, Inc.  
The Loop-Gly variant was obtained by sequencing another colony from the same plate of 
Loop-Cys! 
Gibson fragments to get loop-Ser and loop-Val as well as the primers for the vector are 
shown below.  
MnCcP_loop_f: 5’- CGCTAACAACGTCTTTACCAATGAGTTTT 
MnCcP_loop_r: 5’- TCTCTGTCATTCATATTAAGTCTTTGAAAA 
Cys-Val gblock: 5’- CAG AAC GTT TTT TCA AAG ACT TAA TAT GAA TGA CAG AGA AGT AGT TGC TCT TAT GGG GGC 
TCA CGC TCT GgT GAA GGC GGA TAA AGT GGA TCA GAC CAT CGA TGG GCC ATG GGG AGC CGC TAA CAA CGT CTT 
TAC CAA TGA GTT TTA CTT G  
Cys-Ser gblock: 5’- CAG AAC GTT TTT TCA AAG ACT TAA TAT GAA TGA CAG AGA AGT AGT TGC TCT TAT GGG GGC 
TCA CGC TCT GAG CAA GGC GGA TAA AGT GGA TCA GAC CAT CGA TGG GCC ATG GGG AGC CGC TAA CAA CGT CTT 
TAC CAA TGA GTT TTA CTT G  
 
The overall structure of the protein was predicted by uploading the protein sequence to I-
TASSER server.	  17-19 
8.2.2. Protein expression and purification 
Protein was expressed and purified similar to previously described method for CcP.	   20-22 In 
brief, 2 liters of Rich media was inoculated by 1 ml of starter culture and let grow overnight. The 
cells were then induced for four hours by addition of 1 mM IPTG. After sonication (details of 
sonication in chapter seven), the cells were diluted by adding water and buffer A (100 mM 
phosphate buffer pH 7 and 1 mM EDTA). The supernatant will then be added to equilibrated 
DEAE beads and the conductivity was set to be below 3 mΩ by adding water if necessary. After 
batch binding to the beads, the protein was eluted by a salt gradient. After the first DEAE 
column, the protein was concentrated and further purified by passing down a size exclusion 
column. After titrating heme into the protein, the holo-protein and free heme would be separated 
using a second DEAE column.  
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Addition of heme precursor, δ-amionlevulunic acid together with IPTG had no detectable 
effect on the yield of the green-CcP obtained.  
The modified method for heme incorporation is as follows (adapted from myoglobin 
purification):23 The protein is denatured by incubating for 20 min in 8 M guanidine 
hydrochloride. The denatured protein is then dripped into 750 ml of water, 33 mg potassium 
cyanide and 10 mg hemin. The hemin was previously dissolved in 2M KOH. The mixture is then 
stirred for one hour. It is then dialyzed against 10X volume of 100 mM potassium phosphate at 
pH 7 (or any other buffer) for four times, each time at least for four hours. The protein solution is 
then further purified by passing down a size exclusion column. 
ESI-mass spectroscopy was used to confirm the protein. In some cases SDS-PAGE was used 
on 4-20% pre-catsed gel to track the purification or modifications of the protein.  
8.2.3. Mn(II) oxidation assay 
Mn(II) oxidation assay was performed as previously described in chapter 7. In brief, the 
protein was added to 50 mM malonate solution, pH 4.5 supplemented with different 
concentrations of Mn(II). The reaction starts by addition of excess H2O2 and monitored by 
increase of 270 nm peak due to Mn(III)-malonate formation, using ε270 = 8500 M-1cm-1. 
8.2.4. Mass spectroscopy analysis 
Electrospray ionization mass spectroscopy (ESI-MS) was performed on a Waters ZMD 
quadropole instrument with a mass range of 2000 m/z in positive form. 
Trypsin digestion was performed using the Trypsin kit from Sigma. The protein was 
exchanged into ammonium bicarbonate buffer and then a 1:50 mixture of trypsin:protein was 
used for the reaction. The reaction went to completion overnight at 37 C. Samples were then run 
down on HPLC and heme-containing fragemtns were pulled-down. The fragments were then 
lyophilized and the powder was submitted to MS/MS analysis in the Roy Jay Craver 
Biotechnology center, Protein Sciences division by Peter Yau and Brian Imai. The fragments 
were analazyed using Mascot software. 
ICP-Ms was performed using a PerkinElmer-SCIEX ELAN DRCe instrument by Rudiger 
Laufhutt. 2 ml of 1 mM sample ws prepared and exchanged into water. 
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8.2.5. NMR sample preparation 
Heme extraction was performed as follows: the protein was exchanged into cold water using 
a PD-10 column and was diluted to 100 µM (ε280 = 80 mM-1cm-1). 1% v/v 2N HCl is added to the 
protein solution to acidify the protein and dissociate the proximal His (a change in the color can 
be observed). Equal volume of cold MEK (2-butanone, saturated with water) was added to the 
sample. After iverting a few times, the sample kept still so that the MEK and water layer got 
separate. The heme layer was then removed by a glass Pasteur pipette (similarly, the protein part 
can be eluted using a separation funnel). The process of adding MEK was repeated 2-3 more 
times to make sure all the heme was extracted. The protein with only heme-bound fraction was 
then dialyzed for four hours against water twice to get rid of the remaining MEK and several 
times against phosphate buffer, 50 mM, pH 7. 
The sample was prepared as Xiaotang Wang asked me to. I sent him 0.5 ml of about 2 M 
sample (for the green-CcP, I sent 2 M of the heme-containing fraction, about 10M of protein). 
The proteins were exchanged into 10% D2O through several exchanges by PD-10. All then 
centricons that I used for concentration from here on are washed multiple times with D2O. The 
final samples were frozen in liquid N2 without addition of any glassing agent and shipped on dry 
ice.  
8.2.6. HPLC analysis 
HPLC of the digested peptide was carried out on a Waters Delta 600 model with a dual 
absorbance detector. The program I used was initially used by Arnab Mukherjee and Kyle Miner 
and is called KDM_XL_post_digest_2short_2. Water with 0.1% TFA and acetonitrile with 0.1% 
TFA were used as buffers A and B, respectively. A C18 column was used and was washed first 
by 100% isopropanol at 0.1 ml/min in backward direction to make sure the column is clean. 
Column was then washed in the correct direction using 100% acetonitrile and after that was 
equilibrated with buffer A. The heme part was monitored at 390 nm (due to limitations of the 
lamp) and the peptide was monitored at 280 (or 250) nm. 
8.2.7. Spectroscopic analysis 
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UV-vis studies were performed on a photodiode array hp instrument or on a Cary 5E 
spectrophotometer. EPR was carried out on … at temperature of 15-5 K, 10 mW power, and 
modulation of 10 gauss. The samples were prepared with 20% glycerol as a glassing agent.  
Circular dichroism (CD) was performed on the instrument in Grueble lab. The protein was 
exchanged into 10 mM phosphate buffer, pH 7.0 in concentrations of 2-3 µM. Scanning was 
performed on 200-250 range and 250-500 range to monitor the soret. 
Hemochromogen assay was performed using a previously described protocol. The following 
solution was prepared as the buffer: 1 ml of 0.066 M NaOH, 660 µl of pyridine, 267 µl of water 
and 66 µl of sample or water. Protein concentration was set so that the intensity of the soret peak 
at the given solution is between 0.1 and 1 on hp. Use the above-mentioned solution as blank. 
Then add a small amount of dithionite (a tip) to the sample and keep taking spectra until the 
spectra gets stable. Blank again. Now repeat the same process of dithionite addition with the 
protein solution (don’t blank again). Reduction by dithionite results in the growth of heme in 
pyridine (pyridine takes the heme out). The concentration is then calculated based on the known 
extinction coefficient of heme b in pyridine solution (ε556= 36.4 mM-1cm-1). Assuming that all 
the heme is out of the protein, the extinction coefficient at 408 can be back-calculated using 
Beer’s law. 
8.2.8. Catalase assays 
In order to generate verdoheme from CuB-Mb, I used the protocol below:24 CuBMb purified 
by Ambika Bhagi-Domadaran was exchanged into 20 mM Tirs-HCl pH 8. The ε410 = 170 mM-
1cm-1 was used and R/z of 4.5 was obtained. 100 molar equivalent of TMPD-ascorbate was 
added to the sample from a stock of 100 mM TMPD/1M ascorbate. After 5 min the reduced oxy 
from will generate. Upon addition of 2 molar equivalent Cu, vedoheme will form in 10 min. The 
protein was passed down PD-10 column to release free Cu and excess TMPD/ascorbate (protein 
is green at this stage). 1 µl of 10M H2O2 was added as with other H2O2 assyas. 
The qualitative catalase assay was performed with some slight modification of a previously 
reported protocol.25 In brief to 100 µl of protein sample in different concetrations, 100 µl of 
tween 20 and 100 µl of undiluted H2O2 solution (30%). Samples were mixed and then sit aat 
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room temperature. Calibration curve can be made by measuring the length of the foam generated 
with different concentrations of catalase standard. 
The GC-MS studies were performed using 0.1 mM solution of protein with 100 molar 
equivalent of H2O2.  2 ml of the protein was degased using freeze-pump-thaw method. Four gas 
tight syringes with controlled release knob were placed above an empty flask and were under 
vacuum for half an hour. We had to use He gas for degassing as Ar has a signal close to O2. To 
completely remove Ar out of the Schlenk line, one of the lines remained open and He pressure 
was increased for a couple of minutes. Before starting the reaction, some samples of headspace 
were taken as control. The reaction started with addition of 100 µl of 100 mM H2O2 and stirred 
for 10 min. Samples from headspace were taken using the gas tight syringes. GC-MS was carried 
out in the mass spec facility. We used an HP-PLOTQ column with 30 m length and internal 
diameter of 0.32 mm a film of 20 µm and temperature range of -60 to 270. The program we used 
was optimized for separation of NO and NO2. It started with oven temperature of 50, initial 
temperature of 50 for 5 min. It then had a ramp of 25 deg/min and the final temperature was set 
to 200 for 20 min to wash everything out. We then changed the program a little to get better 
results. The intial temperature was set to 25 and the ramp was changed to 5 degree/min up to 100 
and it stayed at 100 for 5 min. 
A Clark-type O2 electrode was used for more quantitative measurement of the catalase 
activity in the mutants. Reaction volume in the chamber was set to 500 µl. The protein was in 
100 mM phosphate buffer pH 7.0. For catalase, different concentrations were set to 0, 5, 10, 50, 
100, 500, 1000 units, diluted from a 2000 unit/ml stock. Reaction started by addition of 10 µl of 
100 mM H2O2 solution using a syringe and mixing up a little. The rates were measured using the 
instrument settings itself. Since catalase has high binding, I washed the membrane with washing 
solution (1:10 dilution of 1L ethanol+500 ml 12 M HCl+500 ml water mixture). Each 
experiment was performed three times. Data were then analyzed with Origin 9.0 program to have 
another way of rate measurement.  
8.2.9. Cyclic voltammetry 
Cyclic voltammetry was performed using the previously reported protein film voltammetry 
technique.26,27 The protein was placed on the electrode surface either alone or with DDAB as a 
coadsorbate. The voltammagram was collected with 200 mV/s scan range in different ranges. 
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8.3. Results and discussion 
8.3.1. Design of the construct and the sequence 
The initial idea behind the design was to enhance the activity of our MnCcP variants (see 
chapter seven for details of this mutant). Comparing the structures of MnP and CcP, I noticed 
two major differences in the heme access channel and the loop around His180 in CcP. First, the 
access channel is much smaller in MnP which can result in enhanced binding to Mn(II) ion. 
Second, the carboxylates of His180Glu in MnCcP points away from the Mn-binding site whereas 
the loop in MnP is designed to force the ligand to stay close to the Mn ion (Figure 8.1).  
 
Figure 8.1. Comparison of the substrate-binding channel in MnCcP (not submitted to PDB yet, see chapter 7) in 
magenta and MnP (PDB ID 1YYD) in green. 
In lieu of these observations, I performed the loop directed mutagenesis. Sequencing results 
showed Gly178Cys mutation (Figure 8.2) but I decided to keep the protein and continue with 
that. Below you may find the sequence as well as the position of the mutation in the structure. 
 
Figure 8.2. Sequence of the Loop-Cys variant if CcP. The position of cys mutation is shown in red box. The Cys is 
also shown in the overlay structure in cyan (the structure of MnCcP is shown in brown). 
8.3.2. Protein purification and expression 
	  
	   212	  
To my surprise, the “apo-protein” came off as green (Figure 8.3). To my knowledge, none of 
the previous CcP mutants I purified had green pellet or green “apo” state. This state of protein 
will be called “Green-CcP” from now on. As observed by UV-vis spectra in figure 8.3, the 
protein contains some cofactor but in small amounts (about 15% or so, given the fact that the 
soret in CcP is usually same intensity as 280 nm peak). 
 
Figure 8.3. The pellet of “as-purified” loop-Cys is green as well as the protein before adding any heme. The spectra 
of green-CcP is shown in the right.  
ESI-MS of the green protein (figure 8.4) showed a mass (33703±5) very similar to expected 
mass (33704 Da).The mass after heme incorporation and second DEAE was very messy and 
showed a major peak with a mass of 34354 ± 5 Da, 648 Da more than the other smaller peak 
corresponding to the estimated mass (figure 8.4). This heme-loaded version of loop-Cys is called 
“Red-CcP” from here on.  
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Figure 8.4. ESI-MS of green-CcP (top), red-CcP (middle) and loop-Gly (bottom) 
Red sample has a normal UV-vis spectrum with the soret at 410 nm and R/z ratio of about 1, 
similar to other CcP mutants (figure 8.5). 
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Figure 8.5. UV-vis of red-CcP shows a typical holo-CcP spectra. 
Interestingly, the loop-Gly variant had normal cell pellets (golden-brownish) and a normal 
mass–spec (figure 8.4), as expected, even after heme addition (observed mass of 33682±5 Da, 
estimated mass of 33685.55). 
Overnight incubation of samples with H2O2 resulted in little to no change in the green-CcP 
mass spectrum. Some amount of crosslink was observed in the loop-Gly sample. The red-CcP 
was dirty as usual, but no significant increase in the crosslink signal was observed. The data is 
not shown but are available on page 5 of PH notebook IX. It worth mentioning that one time, I 
got no crosslink upon heme titration into the green-CcP. With that sample, H2O2 addition caused 
crosslink to form as I observed by heme extraction experiments. 
Further purification trials of the green-sample with DEAE column, Q-column and SEC 
showed that the reactive fraction is the one with the 680 nm shoulder. Since the Q-column was 
cumbersome and I lost lots of protein, I stopped doing that. Figure 8.6 shows a picture of the 
overall Q-column method and different peaks. The one in the green box is the most active 
fraction. 
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Figure 8.6. Q-column purification of green-CcP. The protein was eluted in a slow salt gradient. 
The process of denaturing the protein and then refolding it in the presence of the heme gave 
almost pure cross-linked red-CcP. The mass is 34369±5 Da, which is about 666 bigger than the 
apo-protein peak (figure 8.7). 
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Figure 8.7. ESI-MS of red-CcP after denaturation and refolding in the presence of heme. 
I tried to run SDS-PAGE with a reported method that showed heme-protein crosslink on gel,8	  
but my gel turned out to look super ugly (page 63, PH notebook XI) and not conclusive at all. 
Gel analysis of older samples show clear degradation of the protein by time (page 149, PH 
notebook XI). 
8.3.3. HPLC analysis 
HPLC analysis (figure 8.8) showed that in the digested red sample, and only in red sample, 
there are peptide fragments that contain heme peaks as well. Such peaks were not observed either 
in the digested green sample or in the digested holo-Loop-Gly samples. 
 
Figure 8.8. The left and middle plots show the HPLC trace monitored at 390 nm and 250 nm, respectively. Overlay 
of the two (right figure) for red-CcP shows peptide regions that overlap with heme absorption. 
8.3.4. Mass spec analysis 
After heme extraction, the majority of red-CcP remained heme-bound, suggesting a covalent 
linkage between heme and protein. Mass spec analysis of the small fractions of the heme that 
were successfully extracted gave a mass of 648 (figure 8.9), which is 32 units more than heme b 
(614), suggesting possible presence of O2-bound heme. Even after trypsin digestion, the heme 
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remained in the water containing part, suggesting that probably a very positive peptide was 
attached to the heme. 
 
Figure 8.9. EI mas spectroscopy of extracted heme from red-CcP. 
Initial MS/MS analysis of the data showed very low score Cys peptides and the modification 
was not clear. After getting the fully cross-linked red protein and upon some improvements on 
Mascot program, the MS/MS analysis yielded some peptides with the heme attached. Same 
peptide came out as a hit in some of my more concentrated samples from the red-CcP that was 
partially cross-linked. The mass search was done with heme b and heme b oxy, hyroxyheme, 
verdoheme and verdoheme oxy, ferric biliverdin and its oxy form. The search was set to find 
modifications on Cys, Asp, His, Met, and Arg residues.  Overall, the best hit from Mascot 
showed a heme modification on Met 172 (figure 8.10). Why this cross-link does not form in 
other CcP mutants and whether the obtained peptide is real (since the Cys coverage is usually 
very low) is still a matter of doubt. 
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Figure 8.10. The predicted structure of loop-Cys. The possible site of crosslink (Met172) is shown in a circle. 
ICP-MS data gave me a value of 11.25 ppm (or 11.25 g/1000L) of iron. Using this and given 
the molecular weight of iron (55.845) I calculated ε663= 16.8 mM-1cm-1. Using Beer’s law and 
assuming that the 663 nm peak and the 408 nm peak are from the same specie, I got ε408 = 77.33 
mM-1cm-1 which is very reasonable for heme in CcP. It seems that it’s not something with very 
high extinction coefficient, but only small amounts of it are present. The data is also close to the 
number I obtained from hemochromogen assay of the green-CcP (ε = 126.28 mM-1cm-1). 
8.3.5. Spectroscopic studies 
Running CD on the red-CcP and Loop-Gly variant showed similar features in 200-250 
region, indicating very similar 3D composition between the two. However, the 250-500 region 
that has heme soret showed significant differences between the two proteins, suggesting a change 
in heme environment in the red protein (Figure 8.11). This change can be either due to the 
crosslink or different orientation of the heme in the pocket. 
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Figure 8.11. CD of red-CcP and loop-Gly in regions from 200-250 nm and 250-500 nm. 
Hemochromogen assay gave a value of ε415 = 282.46 mM-1cm-1  for the red-CcP (figure 
8.12). 
 
Figure 8.12. Hemochromogen assay of green-CcP. Initial and final spectra are shown in black and red lines, 
respectively. 
EPR of red-CcP shows a low-spin state at higher pH and a high-spin state for the heme at 
lower pH values (Figure 8.13). The high spin signal goes away and instead a radical signal would 
appear as well as another signal as g = 4.2, similar to free Fe(III) or Fe(III)-biliverdin, an 
intermediate of heme degradation pathway.  
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Figure 8.13. EPR spectra of red-CcP and green-CcP before and after H2O2 treatment. (10 mW power, 10 G 
modulation, 15 K) 
There are several reasons that I think it is not verdoheme. First is that the protein had 
turnover during Mn(II) oxidation assay. Second reason is that 60% of the protein could be 
recovered after reaction with H2O2 and the third reason is that adding pyridine to the sample after 
H2O2 reaction did not give me the signature UV-vis of verdoheme (figure 8.14). 
 
Figure 8.14. On the left the spectra of red-CcP is shown. The solid line is the initial spectrum. The dashed and dotted 
lines are after 5 and 10 molar equivalent addition of H2O2, respectively. the dash-dot line is after addition of 
pyridine. As can be seen that line lacks the significant 680 feature of verdoheme in pyridine shown in the right 
figure. Right figure is from ref 24 
Running the EPR on the pure cross-linked red-CcP and green-CcP (figure 8.15) showed that 
the red-CcP has normal heme signature in pH 7 and is a mixture if high spin and low spin heme. 
Interestingly the green-CcP has a signal at g = 4.22 which is consistent with what is observed 
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after reaction of red-CcP with a large amount of H2O2. The identity of the signal still remains 
elusive. 
 
Figure 8.15. EPR spectrum of red-CcP (fully cross-linked) and green-CcP. (10 mW power, 10 g modulation, 15 K) 
NMR of control loop-Gly showed normal CcP spectra, but with low spin heme. The green-
CcP showed no paramagnetically shifted signal suggesting that it is either in Fe(II) state or is 
antiferromagentically coupled to a nearby radical. These results suggest that the EPR signal 
observed above is only a small percentage of the overall species there and most of it should be 
EPR silent. Adding potassium cyanide to the sample resulted in a shift in soret but no change in 
the visible region was observed. 
In order to change the possible antiferromagnetic coupling between the heme-iron and a 
radical, I oxidized the green-CcP with ferricyanide. Not much spectral change was observed 
except for possible decay of peak at 668 (figure 8.16, left). EPR of the ferricyanide treated 
sample clearly showed a decrease in the g=4.22 sample but no increase in any other signal 
(figure 8.16, right).  
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Figure 8.16. UV-vis and EPR spectra of green-CcP before and after reacting with excess ferricyanide. The protein is 
passed down PD-10 column to remove excess unreacted ferricyanide. 
NMR of the red-CcP showed a broad signal typical of high spin Fe(III), consistent with 
observed dominance of high spin signal in EPR. The sample was converted to low spin by 
addition if cyanide. The obtained spectrum from the low-spin sample was completely different 
from those of other b-type hemoproteins. One possible explanation for that was the fact that the 
heme is corss-linked to the protein. Unfortunately further sampling of the sample didn’t improve 
the signal to noise ratio and no more detailed structural information could be obtained. 
8.3.6. Peroxidase activity assay 
Mn(II) oxidation assay on the protein showed similar trends to my MnCcP.1 variants. 
However, the 410 nm soret peak didn’t shift as is the case for those variants and would only go 
down. 
Peroxidase assay with ABTS was adapted from Wiseman thesis.28 Assays usually are 
performed in a 50 mM sodium acetate buffer pH 4.5. I tried several different buffers. 1 mM H2O2 
and 0.4 mM ABTS are also present in the reaction solution. The protein is then added and the 
reaction is continued for 2 min. The activity is measured by dividing the final amount of 
oxidized ABTS (ε405 = 36800 M-1cm-1) by the time. One unit of enzymatic activity is defined by 
the amount of enzyme that decomposes 1 µmol of ABTS in 1 min at the buffer pH at room 
temperature.  
The peroxidase activity assay showed that the proteins are less efficient in peroxidase activity 
compared to other active MnCcP variants (figure 8.17). There are two important things to note. 
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First, the red-CcP retains most of its activity at pH 7.0 (about 70%) while the I40G.1 variant (see 
chapter 7) only retains 10% of activity. This observation is consistent with a more robust system. 
 
Figure 8.17. The left figure shows the overall trace of ABTS assay. On the right, the final results of the assay is 
shown. 
Second, the peroxidase assay is an end point assay that monitors the activity over he course 
of 2 min. comparing the kinetic trace of the red-CcP and I40G.1 suggests that in longer time 
points, the red-CcP can reaches the activity of I40G.1 (figure 8.18) and it is much slower but not 
overall worst. 
 
Figure 8.18. Time trace of ABTS assay for red-CcP and I40G.1. 
8.3.7. Catalase activity assay 
0 20 40 60 80 100 120
0.0
0.2
0.4
0.6
0.8
1.0
 Red-CcP
 I40G.1
ab
so
rb
an
ce
(7
37
 n
m
)
time
I40
G.
1_
pH
 4.
5
No
 C
ys
_p
H 
4.5
Re
d_
pH
 4.
5
I40
G.
1_
pH
 7
No
 C
ys
_p
H 
7
Re
d_
pH
 7
Gr
ee
n_
pH
 7
0
1
2
3
500 600 700 800 900
0.0
0.5
1.0
1.5
2.0
2.5
A
bs
/A
U
wavelength/nm
	   224	  
Unusual results during peroxidase assay as well as observation of bubbles in green-CcP 
suggested that the protein might have catalase activity. The bubble generation during H2O2 assay 
was so much that I couldn’t take any more spectra and had a huge baseline shift (reaction of 200 
µl protein with 1 µl of 10 M H2O2 in 2 ml final reaction buffer). 
The same assay with CuBMb-verdoheme resulted in complete loss of heme signal, which is 
not the case with the green-CcP (figire 8.19). 
 
Figure 8.19. The left figure shows UV-vis of green-CcP before and after reaction with H2O2. The right figure shows 
the same thing for CuBMb. 
The qualitative catalase assay showed O2 formation (figure 8.20). The calibration curve was 
not very nice but it gave a nice qualitative fast way of comparing things. Interestingly the red-
CcP has almost no catalase activity compared to the green one. 
 
Figure 8.20. Green-CcP generates bubbles in the cuvette when reacting with H2O2 as shown in the left figure. The 
left-most cuvette contains catalase as a control. The tubes on the right show the qualitative assay of catalase. Moving 
to the right, the amount of protein (here catalase) is increasing. 
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GC-Ms studies clearly showed the presence of O2 in our samples (figure 8.21). The amount 
observed was suggestive of a catalytic reaction with turnovers. The two different programs we 
tried didn’t give us better separation. Probably the best way to go is to use a more specialized 
column (the one I found is MolSeive 5A columns). The O2 signal is completely absent in the 
control sample (not shown in here, available on pages 11 and 14 of PH notebook X). 
 
Figure 8.21. GC-MS of the head space gas after reaction of green-CcP with H2O2 shows clear formation of O2. 
Results from the O2 production studies with O2 electrode showed that the protein is not an 
efficient catalase in most [H2O2]. The initial calculations showed an activity of 1500-3750 U/mg 
for the green-CcP depending on the method used for calculating the rates (compare to 2000-5000 
U/mg for catalase).  Taking into account that catalase is twice as big as CcP, the enzyme has 
about 35% activity of catalase activity. It should be noted that this activity happens only at high 
concentrations of H2O2. 
Later experiments showed that most CcP variants at that concentration have catalase activity 
(figure 8.22). This observation contradicts my previous observations of the huge amount of 
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bubbles formed by the green-CcP and not any other CcP variants. It may be due to saturation of 
the spectra or the concentrations being off. 
 
Figure 8.22. Quantification of O2 production from different CcP variants and catalase based on data from O2 
electrode. 
8.3.8. Cyclic voltammetry analysis 
The green-CcP did not show any signal in CV. However, the red protein gave a nice 
reversible peak at about -70 mV vs. SHE (figure 8.23). This value is much higher than normal 
CcP mutants (usually about -200) and very close to D235N variant. The higher reduction 
potential can explain why the protein is not an amazing peroxidase. 
 
Figure 8.23. voltammagram of red-CcP obtained using protein film voltammetry in a scan rate of 200 mV/sec. 
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8.3.9. Loop-Ser purification and characterization 
I obtained the loop-Ser variant after Gibson assembly. The purification protocol was exactly 
similar to the green and I obtained greenish pellet but less than the one from loop-Cys (about 3% 
compared to 20%, see figure 8.24). Below you may find the UV-vis of the fractions. The mass 
spec showed a mass of 33696±5 Da, which is about the calculated mass of 33688.  Interstingly 
this variant showed an impressive amount of catalase activity. 
 
Figure 8.24. UV-vis and ESI spectrum of loop-Ser variant shows small, but observable amount of green cofactor. 
8.4. Conclusion and future directions 
Overall, this loop-Cys CcP variant shows interesting features that worth pursuing. In terms of 
the green-CcP, my best guess is that the protein is taking up something from the media. This take 
up relies on the presence of Cys or some polar group as I observed the green species in the loop-
Ser variant too. Another confirmation to the claim is the fact that the amount of green species I 
obtain is highly dependent on my culture conditions. One way to go about this is to reduce the 
protein and then oxidize it again and see if we get the same species and if not it shows that there 
is a modification on the heme. The best way to go is to take the cofactor out using heme 
extraction and run NMR on that. Since the cofactor is not cross-linked, this should not be 
impossible to perform. 
As for the red-CcP, the best way to go is to obtain the structure by NMR. I am planning to 
send the peptide to Xiaotang Wang to give him a better chance to obtain the structure. Another 
way to go is to just run overall NMR on the sample. There are several possible other things to do 
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to obtain the mechanistic insight such as addition of heme in the presence or absence of O2 or 
reductant. It seems that the crosslink formation is O2 dependent so addition of heme in the 
anaerobic chamber can be a good way to go. Whether the protein is linked to the Met172 or not 
is still a matter of doubt. This is the same position that the crosslink was observed in the 
engineered ascorbat peroxidase. However, as suggested by the authors CcP has mechanisms to 
prevent this reaction. Also, in contrast to the ascorbate peroxidase study, the cross-link forms 
without the need to use H2O2 and the final species is red and not green. These observations cast 
doubt on the correctness of Met-heme crosslink. One way to test this is to mutate Met172 and see 
if the cross-link still forms.  
Loop-Val variant is a good control to see if the uptake of the cofactor is a result of the 
presence of more bulk in the place of original Gly or it needs a polar group as well. Since Loop-
Ser has very high catalytic activity but not an indicator of crosslink formation as far as I tested, it 
suggests that probably the heme environment and not the crosslink is responsible for catalase 
activity. Maybe the uptaken heme is reoriented in these variants or these variants took up a 
special type of modified heme. 
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